id	sid	tid	token	lemma	pos
hls-11379	1	1	hrev_master	hrev_master	NOUN
hls-11379	1	2	healthcare	healthcare	NOUN
hls-11379	1	3	in	in	ADP
hls-11379	1	4	low	low	ADJ
hls-11379	1	5	-	-	PUNCT
hls-11379	1	6	resource	resource	NOUN
hls-11379	1	7	settings	setting	NOUN
hls-11379	1	8	2023	2023	NUM
hls-11379	1	9	;	;	PUNCT
hls-11379	1	10	volume	volume	NOUN
hls-11379	1	11	11(s2):11379	11(s2):11379	NUM
hls-11379	1	12	helicobacter	helicobacter	NOUN
hls-11379	1	13	pylori	pylori	NOUN
hls-11379	1	14	infection	infection	NOUN
hls-11379	1	15	and	and	CCONJ
hls-11379	1	16	non	non	ADJ
hls-11379	1	17	-	-	ADJ
hls-11379	1	18	alcoholic	alcoholic	ADJ
hls-11379	1	19	fatty	fatty	NOUN
hls-11379	1	20	liver	liver	NOUN
hls-11379	1	21	disease	disease	NOUN
hls-11379	1	22	.	.	PUNCT
hls-11379	2	1	is	be	AUX
hls-11379	2	2	there	there	PRON
hls-11379	2	3	a	a	DET
hls-11379	2	4	relationship	relationship	NOUN
hls-11379	2	5	?	?	PUNCT
hls-11379	3	1	neveen	neveen	PROPN
hls-11379	3	2	rashad	rashad	VERB
hls-11379	3	3	mostafa,1	mostafa,1	NOUN
hls-11379	3	4	abeer	abeer	PROPN
hls-11379	3	5	a.m.	a.m.	PROPN
hls-11379	4	1	ali,2	ali,2	PROPN
hls-11379	4	2	mona	mona	PROPN
hls-11379	4	3	gamalludin	gamalludin	PROPN
hls-11379	4	4	alkaphoury,3	alkaphoury,3	PROPN
hls-11379	4	5	roy	roy	PROPN
hls-11379	4	6	rillera	rillera	PROPN
hls-11379	4	7	marzo4,5	marzo4,5	PROPN
hls-11379	4	8	1department	1department	NUM
hls-11379	4	9	of	of	ADP
hls-11379	4	10	experimental	experimental	ADJ
hls-11379	4	11	and	and	CCONJ
hls-11379	4	12	clinical	clinical	ADJ
hls-11379	4	13	internal	internal	ADJ
hls-11379	4	14	medicine	medicine	NOUN
hls-11379	4	15	,	,	PUNCT
hls-11379	4	16	medical	medical	ADJ
hls-11379	4	17	research	research	PROPN
hls-11379	4	18	institute	institute	PROPN
hls-11379	4	19	,	,	PUNCT
hls-11379	4	20	alexandria	alexandria	PROPN
hls-11379	4	21	university	university	PROPN
hls-11379	4	22	,	,	PUNCT
hls-11379	4	23	egypt	egypt	PROPN
hls-11379	4	24	;	;	PUNCT
hls-11379	4	25	2department	2department	NUM
hls-11379	4	26	of	of	ADP
hls-11379	4	27	chemical	chemical	ADJ
hls-11379	4	28	pathology	pathology	PROPN
hls-11379	4	29	,	,	PUNCT
hls-11379	4	30	medical	medical	PROPN
hls-11379	4	31	research	research	PROPN
hls-11379	4	32	institute	institute	PROPN
hls-11379	4	33	,	,	PUNCT
hls-11379	4	34	alexandria	alexandria	PROPN
hls-11379	4	35	university	university	PROPN
hls-11379	4	36	,	,	PUNCT
hls-11379	4	37	egypt	egypt	PROPN
hls-11379	4	38	;	;	PUNCT
hls-11379	4	39	3department	3department	NUM
hls-11379	4	40	of	of	ADP
hls-11379	4	41	diagnostic	diagnostic	ADJ
hls-11379	4	42	radiology	radiology	NOUN
hls-11379	4	43	,	,	PUNCT
hls-11379	4	44	ain	ain	PROPN
hls-11379	4	45	shams	shams	PROPN
hls-11379	4	46	university	university	PROPN
hls-11379	4	47	,	,	PUNCT
hls-11379	4	48	egypt	egypt	PROPN
hls-11379	4	49	;	;	PUNCT
hls-11379	4	50	4department	4department	NUM
hls-11379	4	51	of	of	ADP
hls-11379	4	52	community	community	NOUN
hls-11379	4	53	medicine	medicine	NOUN
hls-11379	4	54	,	,	PUNCT
hls-11379	4	55	international	international	ADJ
hls-11379	4	56	medical	medical	ADJ
hls-11379	4	57	school	school	NOUN
hls-11379	4	58	,	,	PUNCT
hls-11379	4	59	management	management	NOUN
hls-11379	4	60	and	and	CCONJ
hls-11379	4	61	science	science	NOUN
hls-11379	4	62	university	university	PROPN
hls-11379	4	63	,	,	PUNCT
hls-11379	4	64	shah	shah	PROPN
hls-11379	4	65	alam	alam	PROPN
hls-11379	4	66	,	,	PUNCT
hls-11379	4	67	malaysia	malaysia	PROPN
hls-11379	4	68	;	;	PUNCT
hls-11379	4	69	5global	5global	NUM
hls-11379	4	70	public	public	ADJ
hls-11379	4	71	health	health	NOUN
hls-11379	4	72	,	,	PUNCT
hls-11379	4	73	jeffrey	jeffrey	PROPN
hls-11379	4	74	cheah	cheah	PROPN
hls-11379	4	75	school	school	PROPN
hls-11379	4	76	of	of	ADP
hls-11379	4	77	medicine	medicine	NOUN
hls-11379	4	78	and	and	CCONJ
hls-11379	4	79	health	health	NOUN
hls-11379	4	80	sciences	sciences	PROPN
hls-11379	4	81	,	,	PUNCT
hls-11379	4	82	monash	monash	PROPN
hls-11379	4	83	university	university	PROPN
hls-11379	4	84	malaysia	malaysia	PROPN
hls-11379	4	85	,	,	PUNCT
hls-11379	4	86	kuala	kuala	PROPN
hls-11379	4	87	lumpur	lumpur	PROPN
hls-11379	4	88	,	,	PUNCT
hls-11379	4	89	malaysia	malaysia	PROPN
hls-11379	4	90	abstract	abstract	NOUN
hls-11379	4	91	the	the	DET
hls-11379	4	92	most	most	ADV
hls-11379	4	93	prevalent	prevalent	ADJ
hls-11379	4	94	infection	infection	NOUN
hls-11379	4	95	that	that	PRON
hls-11379	4	96	causes	cause	VERB
hls-11379	4	97	chronic	chronic	ADJ
hls-11379	4	98	gastritis	gastritis	NOUN
hls-11379	4	99	,	,	PUNCT
hls-11379	4	100	gastric	gastric	ADJ
hls-11379	4	101	ulcers	ulcer	NOUN
hls-11379	4	102	,	,	PUNCT
hls-11379	4	103	and	and	CCONJ
hls-11379	4	104	gastric	gastric	ADJ
hls-11379	4	105	cancer	cancer	NOUN
hls-11379	4	106	is	be	AUX
hls-11379	4	107	helicobacter	helicobacter	NOUN
hls-11379	4	108	pylori	pylori	ADJ
hls-11379	4	109	infection	infection	NOUN
hls-11379	4	110	.	.	PUNCT
hls-11379	5	1	recent	recent	ADJ
hls-11379	5	2	research	research	NOUN
hls-11379	5	3	has	have	AUX
hls-11379	5	4	implicated	implicate	VERB
hls-11379	5	5	h.	h.	NOUN
hls-11379	5	6	pylori	pylori	NOUN
hls-11379	5	7	in	in	ADP
hls-11379	5	8	the	the	DET
hls-11379	5	9	pathogenesis	pathogenesis	NOUN
hls-11379	5	10	of	of	ADP
hls-11379	5	11	non	non	ADJ
hls-11379	5	12	-	-	ADJ
hls-11379	5	13	gastrointestinal	gastrointestinal	ADJ
hls-11379	5	14	diseases	disease	NOUN
hls-11379	5	15	such	such	ADJ
hls-11379	5	16	as	as	ADP
hls-11379	5	17	cardiovascular	cardiovascular	ADJ
hls-11379	5	18	,	,	PUNCT
hls-11379	5	19	autoimmune	autoimmune	ADJ
hls-11379	5	20	,	,	PUNCT
hls-11379	5	21	and	and	CCONJ
hls-11379	5	22	metabolic	metabolic	NOUN
hls-11379	5	23	disorders	disorder	NOUN
hls-11379	5	24	.	.	PUNCT
hls-11379	6	1	in	in	ADP
hls-11379	6	2	addition	addition	NOUN
hls-11379	6	3	,	,	PUNCT
hls-11379	6	4	since	since	SCONJ
hls-11379	6	5	h.	h.	PROPN
hls-11379	6	6	pylori	pylori	NOUN
hls-11379	6	7	is	be	AUX
hls-11379	6	8	believed	believe	VERB
hls-11379	6	9	to	to	PART
hls-11379	6	10	be	be	AUX
hls-11379	6	11	implicated	implicate	VERB
hls-11379	6	12	in	in	ADP
hls-11379	6	13	insulin	insulin	NOUN
hls-11379	6	14	resistance	resistance	NOUN
hls-11379	6	15	,	,	PUNCT
hls-11379	6	16	numerous	numerous	ADJ
hls-11379	6	17	studies	study	NOUN
hls-11379	6	18	have	have	AUX
hls-11379	6	19	been	be	AUX
hls-11379	6	20	conducted	conduct	VERB
hls-11379	6	21	to	to	PART
hls-11379	6	22	determine	determine	VERB
hls-11379	6	23	the	the	DET
hls-11379	6	24	relationship	relationship	NOUN
hls-11379	6	25	between	between	ADP
hls-11379	6	26	h.	h.	PROPN
hls-11379	6	27	pylori	pylori	ADJ
hls-11379	6	28	infection	infection	NOUN
hls-11379	6	29	and	and	CCONJ
hls-11379	6	30	nonalcoholic	nonalcoholic	NOUN
hls-11379	6	31	fatty	fatty	NOUN
hls-11379	6	32	liver	liver	NOUN
hls-11379	6	33	diseases	disease	NOUN
hls-11379	6	34	(	(	PUNCT
hls-11379	6	35	nafld	nafld	ADV
hls-11379	6	36	)	)	PUNCT
hls-11379	6	37	,	,	PUNCT
hls-11379	6	38	but	but	CCONJ
hls-11379	6	39	the	the	DET
hls-11379	6	40	results	result	NOUN
hls-11379	6	41	have	have	AUX
hls-11379	6	42	been	be	AUX
hls-11379	6	43	contested	contest	VERB
hls-11379	6	44	.	.	PUNCT
hls-11379	7	1	the	the	DET
hls-11379	7	2	purpose	purpose	NOUN
hls-11379	7	3	of	of	ADP
hls-11379	7	4	this	this	DET
hls-11379	7	5	study	study	NOUN
hls-11379	7	6	is	be	AUX
hls-11379	7	7	to	to	PART
hls-11379	7	8	determine	determine	VERB
hls-11379	7	9	the	the	DET
hls-11379	7	10	relationship	relationship	NOUN
hls-11379	7	11	between	between	ADP
hls-11379	7	12	h.	h.	PROPN
hls-11379	7	13	pylori	pylori	ADJ
hls-11379	7	14	infection	infection	NOUN
hls-11379	7	15	and	and	CCONJ
hls-11379	7	16	nonalcoholic	nonalcoholic	NOUN
hls-11379	7	17	fatty	fatty	NOUN
hls-11379	7	18	liver	liver	NOUN
hls-11379	7	19	diseases	disease	NOUN
hls-11379	7	20	.	.	PUNCT
hls-11379	8	1	one	one	NUM
hls-11379	8	2	hundred	hundred	NUM
hls-11379	8	3	patients	patient	NOUN
hls-11379	8	4	were	be	AUX
hls-11379	8	5	examined	examine	VERB
hls-11379	8	6	via	via	ADP
hls-11379	8	7	urea	urea	NOUN
hls-11379	8	8	breath	breath	NOUN
hls-11379	8	9	test	test	NOUN
hls-11379	8	10	for	for	ADP
hls-11379	8	11	the	the	DET
hls-11379	8	12	presence	presence	NOUN
hls-11379	8	13	of	of	ADP
hls-11379	8	14	h.	h.	PROPN
hls-11379	8	15	pylori	pylori	ADJ
hls-11379	8	16	infection	infection	NOUN
hls-11379	8	17	and	and	CCONJ
hls-11379	8	18	vibration	vibration	NOUN
hls-11379	8	19	-	-	PUNCT
hls-11379	8	20	controlled	control	VERB
hls-11379	8	21	transient	transient	ADJ
hls-11379	8	22	elastography	elastography	NOUN
hls-11379	8	23	for	for	ADP
hls-11379	8	24	the	the	DET
hls-11379	8	25	diagnosis	diagnosis	NOUN
hls-11379	8	26	of	of	ADP
hls-11379	8	27	non	non	ADJ
hls-11379	8	28	-	-	ADJ
hls-11379	8	29	alcoholic	alcoholic	ADJ
hls-11379	8	30	fatty	fatty	NOUN
hls-11379	8	31	liver	liver	NOUN
hls-11379	8	32	disease	disease	NOUN
hls-11379	8	33	.	.	PUNCT
hls-11379	9	1	after	after	ADP
hls-11379	9	2	adjusting	adjust	VERB
hls-11379	9	3	for	for	ADP
hls-11379	9	4	other	other	ADJ
hls-11379	9	5	variables	variable	NOUN
hls-11379	9	6	,	,	PUNCT
hls-11379	9	7	age	age	NOUN
hls-11379	9	8	,	,	PUNCT
hls-11379	9	9	body	body	NOUN
hls-11379	9	10	mass	mass	NOUN
hls-11379	9	11	index	index	NOUN
hls-11379	9	12	(	(	PUNCT
hls-11379	9	13	bmi	bmi	PROPN
hls-11379	9	14	)	)	PUNCT
hls-11379	9	15	,	,	PUNCT
hls-11379	9	16	and	and	CCONJ
hls-11379	9	17	h.	h.	PROPN
hls-11379	9	18	pylori	pylori	NOUN
hls-11379	9	19	infection	infection	NOUN
hls-11379	9	20	were	be	AUX
hls-11379	9	21	associated	associate	VERB
hls-11379	9	22	with	with	ADP
hls-11379	9	23	elastography	elastography	NOUN
hls-11379	9	24	248db	248db	NOUN
hls-11379	9	25	/	/	SYM
hls-11379	9	26	m.	m.	NOUN
hls-11379	9	27	infection	infection	NOUN
hls-11379	9	28	with	with	ADP
hls-11379	9	29	h.	h.	PROPN
hls-11379	9	30	pylori	pylori	NOUN
hls-11379	9	31	contributes	contribute	VERB
hls-11379	9	32	to	to	ADP
hls-11379	9	33	the	the	DET
hls-11379	9	34	development	development	NOUN
hls-11379	9	35	of	of	ADP
hls-11379	9	36	nafld	nafld	ADJ
hls-11379	9	37	,	,	PUNCT
hls-11379	9	38	and	and	CCONJ
hls-11379	9	39	its	its	PRON
hls-11379	9	40	eradication	eradication	NOUN
hls-11379	9	41	may	may	AUX
hls-11379	9	42	influence	influence	VERB
hls-11379	9	43	prognosis	prognosis	NOUN
hls-11379	9	44	.	.	PUNCT
hls-11379	10	1	introduction	introduction	NOUN
hls-11379	10	2	helicobacter	helicobacter	NOUN
hls-11379	10	3	pylori	pylori	NOUN
hls-11379	10	4	infection	infection	NOUN
hls-11379	10	5	is	be	AUX
hls-11379	10	6	a	a	DET
hls-11379	10	7	prevalent	prevalent	ADJ
hls-11379	10	8	condition	condition	NOUN
hls-11379	10	9	worldwide	worldwide	ADV
hls-11379	10	10	,	,	PUNCT
hls-11379	10	11	particularly	particularly	ADV
hls-11379	10	12	in	in	ADP
hls-11379	10	13	developing	develop	VERB
hls-11379	10	14	countries	country	NOUN
hls-11379	10	15	.	.	PUNCT
hls-11379	11	1	it	it	PRON
hls-11379	11	2	is	be	AUX
hls-11379	11	3	considered	consider	VERB
hls-11379	11	4	the	the	DET
hls-11379	11	5	most	most	ADV
hls-11379	11	6	common	common	ADJ
hls-11379	11	7	cause	cause	NOUN
hls-11379	11	8	of	of	ADP
hls-11379	11	9	gastric	gastric	ADJ
hls-11379	11	10	mucosa	mucosa	NOUN
hls-11379	11	11	causing	cause	VERB
hls-11379	11	12	chronic	chronic	ADJ
hls-11379	11	13	gastritis	gastritis	NOUN
hls-11379	11	14	,	,	PUNCT
hls-11379	11	15	gastric	gastric	ADJ
hls-11379	11	16	ulcers	ulcer	NOUN
hls-11379	11	17	,	,	PUNCT
hls-11379	11	18	and	and	CCONJ
hls-11379	11	19	gastric	gastric	ADJ
hls-11379	11	20	cancer.1	cancer.1	NOUN
hls-11379	11	21	recently	recently	ADV
hls-11379	11	22	,	,	PUNCT
hls-11379	11	23	h.	h.	PROPN
hls-11379	11	24	pylori	pylori	NOUN
hls-11379	11	25	was	be	AUX
hls-11379	11	26	found	find	VERB
hls-11379	11	27	to	to	PART
hls-11379	11	28	be	be	AUX
hls-11379	11	29	involved	involve	VERB
hls-11379	11	30	in	in	ADP
hls-11379	11	31	the	the	DET
hls-11379	11	32	pathogenesis	pathogenesis	NOUN
hls-11379	11	33	of	of	ADP
hls-11379	11	34	other	other	ADJ
hls-11379	11	35	non	non	ADJ
hls-11379	11	36	-	-	ADJ
hls-11379	11	37	gastric	gastric	ADJ
hls-11379	11	38	diseases	disease	NOUN
hls-11379	11	39	,	,	PUNCT
hls-11379	11	40	and	and	CCONJ
hls-11379	11	41	involved	involve	VERB
hls-11379	11	42	in	in	ADP
hls-11379	11	43	the	the	DET
hls-11379	11	44	pathogenesis	pathogenesis	NOUN
hls-11379	11	45	of	of	ADP
hls-11379	11	46	insulin	insulin	NOUN
hls-11379	11	47	resistance	resistance	NOUN
hls-11379	11	48	and	and	CCONJ
hls-11379	11	49	several	several	ADJ
hls-11379	11	50	metabolic	metabolic	NOUN
hls-11379	11	51	and	and	CCONJ
hls-11379	11	52	autoimmune	autoimmune	ADJ
hls-11379	11	53	diseases	disease	NOUN
hls-11379	11	54	that	that	PRON
hls-11379	11	55	affects	affect	VERB
hls-11379	11	56	the	the	DET
hls-11379	11	57	liver.2	liver.2	ADJ
hls-11379	11	58	nonalcoholic	nonalcoholic	NOUN
hls-11379	11	59	fatty	fatty	NOUN
hls-11379	11	60	liver	liver	NOUN
hls-11379	11	61	disease	disease	NOUN
hls-11379	11	62	(	(	PUNCT
hls-11379	11	63	nafld	nafld	ADV
hls-11379	11	64	)	)	PUNCT
hls-11379	11	65	is	be	AUX
hls-11379	11	66	a	a	DET
hls-11379	11	67	group	group	NOUN
hls-11379	11	68	of	of	ADP
hls-11379	11	69	metabolic	metabolic	NOUN
hls-11379	11	70	diseases	disease	NOUN
hls-11379	11	71	caused	cause	VERB
hls-11379	11	72	mainly	mainly	ADV
hls-11379	11	73	by	by	ADP
hls-11379	11	74	insulin	insulin	NOUN
hls-11379	11	75	resistance	resistance	NOUN
hls-11379	11	76	with	with	ADP
hls-11379	11	77	hereditary	hereditary	ADJ
hls-11379	11	78	susceptibility	susceptibility	NOUN
hls-11379	11	79	.	.	PUNCT
hls-11379	12	1	it	it	PRON
hls-11379	12	2	is	be	AUX
hls-11379	12	3	considered	consider	VERB
hls-11379	12	4	a	a	DET
hls-11379	12	5	manifestation	manifestation	NOUN
hls-11379	12	6	of	of	ADP
hls-11379	12	7	metabolic	metabolic	NOUN
hls-11379	12	8	syndrome	syndrome	NOUN
hls-11379	12	9	in	in	ADP
hls-11379	12	10	the	the	DET
hls-11379	12	11	liver	liver	NOUN
hls-11379	12	12	,	,	PUNCT
hls-11379	12	13	in	in	ADP
hls-11379	12	14	the	the	DET
hls-11379	12	15	absence	absence	NOUN
hls-11379	12	16	of	of	ADP
hls-11379	12	17	alcohol	alcohol	NOUN
hls-11379	12	18	consumption	consumption	NOUN
hls-11379	12	19	,	,	PUNCT
hls-11379	12	20	and	and	CCONJ
hls-11379	12	21	includes	include	VERB
hls-11379	12	22	nonalcoholic	nonalcoholic	ADJ
hls-11379	12	23	fatty	fatty	NOUN
hls-11379	12	24	liver	liver	NOUN
hls-11379	12	25	,	,	PUNCT
hls-11379	12	26	nonalcoholic	nonalcoholic	PROPN
hls-11379	12	27	steatohepatitis	steatohepatitis	NOUN
hls-11379	12	28	,	,	PUNCT
hls-11379	12	29	liver	liver	NOUN
hls-11379	12	30	fibrosis	fibrosis	NOUN
hls-11379	12	31	,	,	PUNCT
hls-11379	12	32	and	and	CCONJ
hls-11379	12	33	cirrhosis.3	cirrhosis.3	PRON
hls-11379	12	34	nafld	nafld	ADV
hls-11379	12	35	is	be	AUX
hls-11379	12	36	a	a	DET
hls-11379	12	37	common	common	ADJ
hls-11379	12	38	disease	disease	NOUN
hls-11379	12	39	condition	condition	NOUN
hls-11379	12	40	affecting	affect	VERB
hls-11379	12	41	25	25	NUM
hls-11379	12	42	%	%	NOUN
hls-11379	12	43	of	of	ADP
hls-11379	12	44	the	the	DET
hls-11379	12	45	population	population	NOUN
hls-11379	12	46	worldwide	worldwide	ADV
hls-11379	12	47	,	,	PUNCT
hls-11379	12	48	with	with	ADP
hls-11379	12	49	higher	high	ADJ
hls-11379	12	50	prevalence	prevalence	NOUN
hls-11379	12	51	rates	rate	NOUN
hls-11379	12	52	observed	observe	VERB
hls-11379	12	53	in	in	ADP
hls-11379	12	54	the	the	DET
hls-11379	12	55	middle	middle	PROPN
hls-11379	12	56	east	east	PROPN
hls-11379	12	57	(	(	PUNCT
hls-11379	12	58	32	32	NUM
hls-11379	12	59	%	%	NOUN
hls-11379	12	60	)	)	PUNCT
hls-11379	12	61	,	,	PUNCT
hls-11379	12	62	and	and	CCONJ
hls-11379	12	63	in	in	ADP
hls-11379	12	64	latin	latin	PROPN
hls-11379	12	65	america	america	PROPN
hls-11379	12	66	(	(	PUNCT
hls-11379	12	67	31%).4	31%).4	NUM
hls-11379	12	68	hepatic	hepatic	NOUN
hls-11379	12	69	lipid	lipid	NOUN
hls-11379	12	70	homeostasis	homeostasis	NOUN
hls-11379	12	71	is	be	AUX
hls-11379	12	72	controlled	control	VERB
hls-11379	12	73	by	by	ADP
hls-11379	12	74	signaling	signal	VERB
hls-11379	12	75	/	/	SYM
hls-11379	12	76	transcriptional	transcriptional	ADJ
hls-11379	12	77	pathways	pathway	NOUN
hls-11379	12	78	mediated	mediate	VERB
hls-11379	12	79	by	by	ADP
hls-11379	12	80	hormones	hormone	NOUN
hls-11379	12	81	,	,	PUNCT
hls-11379	12	82	transcription	transcription	NOUN
hls-11379	12	83	factors	factor	NOUN
hls-11379	12	84	,	,	PUNCT
hls-11379	12	85	and	and	CCONJ
hls-11379	12	86	nuclear	nuclear	ADJ
hls-11379	12	87	receptors	receptor	NOUN
hls-11379	12	88	.	.	PUNCT
hls-11379	13	1	triglyceride	triglyceride	ADP
hls-11379	13	2	accumulation	accumulation	NOUN
hls-11379	13	3	mostly	mostly	ADV
hls-11379	13	4	is	be	AUX
hls-11379	13	5	considered	consider	VERB
hls-11379	13	6	the	the	DET
hls-11379	13	7	first	first	ADJ
hls-11379	13	8	step	step	NOUN
hls-11379	13	9	in	in	ADP
hls-11379	13	10	the	the	DET
hls-11379	13	11	development	development	NOUN
hls-11379	13	12	of	of	ADP
hls-11379	13	13	nafld	nafld	ADJ
hls-11379	13	14	and	and	CCONJ
hls-11379	13	15	results	result	NOUN
hls-11379	13	16	from	from	ADP
hls-11379	13	17	a	a	DET
hls-11379	13	18	disturbed	disturbed	ADJ
hls-11379	13	19	balance	balance	NOUN
hls-11379	13	20	between	between	ADP
hls-11379	13	21	tg	tg	PROPN
hls-11379	13	22	production	production	NOUN
hls-11379	13	23	and	and	CCONJ
hls-11379	13	24	utilization	utilization	NOUN
hls-11379	13	25	and	and	CCONJ
hls-11379	13	26	unregulated	unregulated	ADJ
hls-11379	13	27	insulin	insulin	NOUN
hls-11379	13	28	signaling	signal	VERB
hls-11379	13	29	at	at	ADP
hls-11379	13	30	the	the	DET
hls-11379	13	31	level	level	NOUN
hls-11379	13	32	of	of	ADP
hls-11379	13	33	the	the	DET
hls-11379	13	34	adipose	adipose	NOUN
hls-11379	13	35	tissue.5	tissue.5	VERB
hls-11379	13	36	in	in	ADP
hls-11379	13	37	obese	obese	ADJ
hls-11379	13	38	and	and	CCONJ
hls-11379	13	39	diabetic	diabetic	ADJ
hls-11379	13	40	patients	patient	NOUN
hls-11379	13	41	with	with	ADP
hls-11379	13	42	insulin	insulin	NOUN
hls-11379	13	43	resistance	resistance	NOUN
hls-11379	13	44	there	there	PRON
hls-11379	13	45	is	be	VERB
hls-11379	13	46	increased	increase	VERB
hls-11379	13	47	lipolysis	lipolysis	NOUN
hls-11379	13	48	with	with	ADP
hls-11379	13	49	increased	increase	VERB
hls-11379	13	50	formation	formation	NOUN
hls-11379	13	51	of	of	ADP
hls-11379	13	52	nonesterified	nonesterified	ADJ
hls-11379	13	53	fatty	fatty	NOUN
hls-11379	13	54	acids	acid	NOUN
hls-11379	13	55	directed	direct	VERB
hls-11379	13	56	to	to	ADP
hls-11379	13	57	the	the	DET
hls-11379	13	58	liver	liver	NOUN
hls-11379	13	59	where	where	SCONJ
hls-11379	13	60	they	they	PRON
hls-11379	13	61	are	be	AUX
hls-11379	13	62	taken	take	VERB
hls-11379	13	63	up	up	ADP
hls-11379	13	64	by	by	ADP
hls-11379	13	65	hepatocytes.6	hepatocytes.6	PROPN
hls-11379	13	66	cd36	cd36	PROPN
hls-11379	13	67	also	also	ADV
hls-11379	13	68	facilitates	facilitate	VERB
hls-11379	13	69	their	their	PRON
hls-11379	13	70	uptake	uptake	NOUN
hls-11379	13	71	and	and	CCONJ
hls-11379	13	72	accumulation	accumulation	NOUN
hls-11379	13	73	in	in	ADP
hls-11379	13	74	other	other	ADJ
hls-11379	13	75	cell	cell	NOUN
hls-11379	13	76	types	type	NOUN
hls-11379	13	77	(	(	PUNCT
hls-11379	13	78	macrophages	macrophage	NOUN
hls-11379	13	79	,	,	PUNCT
hls-11379	13	80	adipocytes	adipocyte	NOUN
hls-11379	13	81	,	,	PUNCT
hls-11379	13	82	enterocytes	enterocyte	NOUN
hls-11379	13	83	,	,	PUNCT
hls-11379	13	84	and	and	CCONJ
hls-11379	13	85	myocytes	myocyte	NOUN
hls-11379	13	86	)	)	PUNCT
hls-11379	13	87	.	.	PUNCT
hls-11379	14	1	cd36	cd36	PROPN
hls-11379	14	2	has	have	AUX
hls-11379	14	3	been	be	AUX
hls-11379	14	4	shown	show	VERB
hls-11379	14	5	to	to	PART
hls-11379	14	6	rise	rise	VERB
hls-11379	14	7	in	in	ADP
hls-11379	14	8	animal	animal	NOUN
hls-11379	14	9	models	model	NOUN
hls-11379	14	10	with	with	ADP
hls-11379	14	11	hepatic	hepatic	ADJ
hls-11379	14	12	steatosis	steatosis	NOUN
hls-11379	14	13	.	.	PUNCT
hls-11379	15	1	in	in	ADP
hls-11379	15	2	humans	human	NOUN
hls-11379	15	3	,	,	PUNCT
hls-11379	15	4	morbidly	morbidly	ADV
hls-11379	15	5	obese	obese	ADJ
hls-11379	15	6	patients	patient	NOUN
hls-11379	15	7	with	with	ADP
hls-11379	15	8	nafld	nafld	ADV
hls-11379	15	9	showed	show	VERB
hls-11379	15	10	a	a	DET
hls-11379	15	11	correlation	correlation	NOUN
hls-11379	15	12	between	between	ADP
hls-11379	15	13	messenger	messenger	NOUN
hls-11379	15	14	rna	rna	NOUN
hls-11379	15	15	levels	level	NOUN
hls-11379	15	16	of	of	ADP
hls-11379	15	17	cd36	cd36	PROPN
hls-11379	15	18	and	and	CCONJ
hls-11379	15	19	liver	liver	NOUN
hls-11379	15	20	fat	fat	ADJ
hls-11379	15	21	content.7	content.7	PROPN
hls-11379	15	22	it	it	PRON
hls-11379	15	23	has	have	AUX
hls-11379	15	24	been	be	AUX
hls-11379	15	25	shown	show	VERB
hls-11379	15	26	that	that	SCONJ
hls-11379	15	27	there	there	PRON
hls-11379	15	28	are	be	VERB
hls-11379	15	29	other	other	ADJ
hls-11379	15	30	two	two	NUM
hls-11379	15	31	factors	factor	NOUN
hls-11379	15	32	contributing	contribute	VERB
hls-11379	15	33	to	to	ADP
hls-11379	15	34	fat	fat	ADJ
hls-11379	15	35	accumulation	accumulation	NOUN
hls-11379	15	36	in	in	ADP
hls-11379	15	37	the	the	DET
hls-11379	15	38	liver	liver	NOUN
hls-11379	15	39	,	,	PUNCT
hls-11379	15	40	these	these	DET
hls-11379	15	41	factors	factor	NOUN
hls-11379	15	42	are	be	AUX
hls-11379	15	43	dietary	dietary	ADJ
hls-11379	15	44	fat	fat	NOUN
hls-11379	15	45	and	and	CCONJ
hls-11379	15	46	de	de	ADJ
hls-11379	15	47	novo	novo	NOUN
hls-11379	15	48	lipogenesis	lipogenesis	NOUN
hls-11379	15	49	.	.	PUNCT
hls-11379	16	1	two	two	NUM
hls-11379	16	2	enzymes	enzyme	NOUN
hls-11379	16	3	catalyze	catalyze	NOUN
hls-11379	16	4	hepatic	hepatic	ADJ
hls-11379	16	5	correspondence	correspondence	NOUN
hls-11379	16	6	:	:	PUNCT
hls-11379	16	7	neveen	neveen	PROPN
hls-11379	16	8	rashad	rashad	PROPN
hls-11379	16	9	mostafa	mostafa	PROPN
hls-11379	16	10	,	,	PUNCT
hls-11379	16	11	department	department	NOUN
hls-11379	16	12	of	of	ADP
hls-11379	16	13	experimental	experimental	ADJ
hls-11379	16	14	and	and	CCONJ
hls-11379	16	15	clinical	clinical	ADJ
hls-11379	16	16	internal	internal	ADJ
hls-11379	16	17	medicine	medicine	NOUN
hls-11379	16	18	,	,	PUNCT
hls-11379	16	19	medical	medical	ADJ
hls-11379	16	20	research	research	PROPN
hls-11379	16	21	institute	institute	PROPN
hls-11379	16	22	,	,	PUNCT
hls-11379	16	23	alexandria	alexandria	PROPN
hls-11379	16	24	university	university	PROPN
hls-11379	16	25	,	,	PUNCT
hls-11379	16	26	egypt	egypt	PROPN
hls-11379	16	27	.	.	PUNCT
hls-11379	17	1	e	e	X
hls-11379	17	2	-	-	NOUN
hls-11379	17	3	mail	mail	NOUN
hls-11379	17	4	:	:	PUNCT
hls-11379	17	5	doctor.aj.2000@gmail.com	doctor.aj.2000@gmail.com	X
hls-11379	17	6	key	key	ADJ
hls-11379	17	7	words	word	NOUN
hls-11379	17	8	:	:	PUNCT
hls-11379	17	9	helicobacter	helicobacter	NOUN
hls-11379	17	10	pylori	pylori	NOUN
hls-11379	17	11	,	,	PUNCT
hls-11379	17	12	lipid	lipid	NOUN
hls-11379	17	13	,	,	PUNCT
hls-11379	17	14	non	non	ADJ
hls-11379	17	15	-	-	ADJ
hls-11379	17	16	alcoholic	alcoholic	ADJ
hls-11379	17	17	fatty	fatty	NOUN
hls-11379	17	18	liver	liver	NOUN
hls-11379	17	19	.	.	PUNCT
hls-11379	18	1	contributions	contribution	NOUN
hls-11379	18	2	:	:	PUNCT
hls-11379	18	3	nrm	nrm	ADJ
hls-11379	18	4	,	,	PUNCT
hls-11379	18	5	data	datum	NOUN
hls-11379	18	6	collection	collection	NOUN
hls-11379	18	7	,	,	PUNCT
hls-11379	18	8	manuscript	manuscript	NOUN
hls-11379	18	9	drafting	drafting	NOUN
hls-11379	18	10	and	and	CCONJ
hls-11379	18	11	statistical	statistical	ADJ
hls-11379	18	12	analysis	analysis	NOUN
hls-11379	18	13	;	;	PUNCT
hls-11379	18	14	aama	aama	NOUN
hls-11379	18	15	,	,	PUNCT
hls-11379	18	16	biochemical	biochemical	ADJ
hls-11379	18	17	assay	assay	NOUN
hls-11379	18	18	;	;	PUNCT
hls-11379	18	19	mgak	mgak	NOUN
hls-11379	18	20	,	,	PUNCT
hls-11379	18	21	elastography	elastography	NOUN
hls-11379	18	22	;	;	PUNCT
hls-11379	18	23	rrm	rrm	PROPN
hls-11379	18	24	,	,	PUNCT
hls-11379	18	25	manuscript	manuscript	NOUN
hls-11379	18	26	editing	editing	NOUN
hls-11379	18	27	,	,	PUNCT
hls-11379	18	28	language	language	NOUN
hls-11379	18	29	revision	revision	NOUN
hls-11379	18	30	.	.	PUNCT
hls-11379	19	1	conflict	conflict	NOUN
hls-11379	19	2	of	of	ADP
hls-11379	19	3	interest	interest	NOUN
hls-11379	19	4	:	:	PUNCT
hls-11379	19	5	the	the	DET
hls-11379	19	6	authors	author	NOUN
hls-11379	19	7	declare	declare	VERB
hls-11379	19	8	no	no	DET
hls-11379	19	9	potential	potential	ADJ
hls-11379	19	10	conflict	conflict	NOUN
hls-11379	19	11	of	of	ADP
hls-11379	19	12	interest	interest	NOUN
hls-11379	19	13	,	,	PUNCT
hls-11379	19	14	and	and	CCONJ
hls-11379	19	15	all	all	DET
hls-11379	19	16	authors	author	NOUN
hls-11379	19	17	confirm	confirm	VERB
hls-11379	19	18	accuracy	accuracy	NOUN
hls-11379	19	19	.	.	PUNCT
hls-11379	20	1	ethics	ethic	NOUN
hls-11379	20	2	approval	approval	NOUN
hls-11379	20	3	and	and	CCONJ
hls-11379	20	4	consent	consent	NOUN
hls-11379	20	5	to	to	PART
hls-11379	20	6	participate	participate	VERB
hls-11379	20	7	:	:	PUNCT
hls-11379	20	8	the	the	DET
hls-11379	20	9	study	study	NOUN
hls-11379	20	10	was	be	AUX
hls-11379	20	11	approved	approve	VERB
hls-11379	20	12	by	by	ADP
hls-11379	20	13	the	the	DET
hls-11379	20	14	medical	medical	PROPN
hls-11379	20	15	research	research	PROPN
hls-11379	20	16	institute	institute	PROPN
hls-11379	20	17	hospital	hospital	PROPN
hls-11379	20	18	’s	’s	PART
hls-11379	20	19	local	local	ADJ
hls-11379	20	20	ethics	ethic	NOUN
hls-11379	20	21	committee	committee	NOUN
hls-11379	20	22	,	,	PUNCT
hls-11379	20	23	which	which	PRON
hls-11379	20	24	follows	follow	VERB
hls-11379	20	25	the	the	DET
hls-11379	20	26	helsinki	helsinki	PROPN
hls-11379	20	27	declaration	declaration	PROPN
hls-11379	20	28	terms	term	NOUN
hls-11379	20	29	.	.	PUNCT
hls-11379	21	1	informed	informed	ADJ
hls-11379	21	2	consent	consent	NOUN
hls-11379	21	3	was	be	AUX
hls-11379	21	4	taken	take	VERB
hls-11379	21	5	from	from	ADP
hls-11379	21	6	all	all	DET
hls-11379	21	7	participants	participant	NOUN
hls-11379	21	8	.	.	PUNCT
hls-11379	22	1	consent	consent	VERB
hls-11379	22	2	for	for	ADP
hls-11379	22	3	publication	publication	NOUN
hls-11379	22	4	:	:	PUNCT
hls-11379	22	5	the	the	DET
hls-11379	22	6	manuscript	manuscript	NOUN
hls-11379	22	7	does	do	AUX
hls-11379	22	8	not	not	PART
hls-11379	22	9	contain	contain	VERB
hls-11379	22	10	any	any	DET
hls-11379	22	11	individual	individual	ADJ
hls-11379	22	12	person	person	NOUN
hls-11379	22	13	’s	’s	PART
hls-11379	22	14	data	datum	NOUN
hls-11379	22	15	in	in	ADP
hls-11379	22	16	any	any	DET
hls-11379	22	17	form	form	NOUN
hls-11379	22	18	.	.	PUNCT
hls-11379	23	1	availability	availability	NOUN
hls-11379	23	2	of	of	ADP
hls-11379	23	3	data	datum	NOUN
hls-11379	23	4	and	and	CCONJ
hls-11379	23	5	materials	material	NOUN
hls-11379	23	6	:	:	PUNCT
hls-11379	23	7	data	datum	NOUN
hls-11379	23	8	sharing	sharing	NOUN
hls-11379	23	9	is	be	AUX
hls-11379	23	10	not	not	PART
hls-11379	23	11	applicable	applicable	ADJ
hls-11379	23	12	as	as	SCONJ
hls-11379	23	13	no	no	DET
hls-11379	23	14	dataset	dataset	NOUN
hls-11379	23	15	was	be	AUX
hls-11379	23	16	generated	generate	VERB
hls-11379	23	17	or	or	CCONJ
hls-11379	23	18	analyzed	analyze	VERB
hls-11379	23	19	during	during	ADP
hls-11379	23	20	the	the	DET
hls-11379	23	21	current	current	ADJ
hls-11379	23	22	study	study	NOUN
hls-11379	23	23	.	.	PUNCT
hls-11379	24	1	received	receive	VERB
hls-11379	24	2	for	for	ADP
hls-11379	24	3	publication	publication	NOUN
hls-11379	24	4	:	:	PUNCT
hls-11379	24	5	11	11	NUM
hls-11379	24	6	april	april	PROPN
hls-11379	24	7	2023	2023	NUM
hls-11379	24	8	.	.	PUNCT
hls-11379	25	1	accepted	accept	VERB
hls-11379	25	2	for	for	ADP
hls-11379	25	3	publication	publication	NOUN
hls-11379	25	4	:	:	PUNCT
hls-11379	25	5	10	10	NUM
hls-11379	25	6	june	june	PROPN
hls-11379	25	7	2023	2023	NUM
hls-11379	25	8	.	.	PUNCT
hls-11379	26	1	this	this	DET
hls-11379	26	2	work	work	NOUN
hls-11379	26	3	is	be	AUX
hls-11379	26	4	licensed	license	VERB
hls-11379	26	5	under	under	ADP
hls-11379	26	6	a	a	DET
hls-11379	26	7	creative	creative	ADJ
hls-11379	26	8	commons	common	NOUN
hls-11379	26	9	attribution	attribution	NOUN
hls-11379	26	10	4.0	4.0	NUM
hls-11379	26	11	license	license	NOUN
hls-11379	26	12	(	(	PUNCT
hls-11379	26	13	by	by	ADP
hls-11379	26	14	-	-	PUNCT
hls-11379	26	15	nc	nc	PROPN
hls-11379	26	16	4.0	4.0	NUM
hls-11379	26	17	)	)	PUNCT
hls-11379	26	18	.	.	PUNCT
hls-11379	27	1	©	©	PROPN
hls-11379	27	2	copyright	copyright	NOUN
hls-11379	27	3	:	:	PUNCT
hls-11379	27	4	the	the	DET
hls-11379	27	5	author(s	author(s	PROPN
hls-11379	27	6	)	)	PUNCT
hls-11379	27	7	,	,	PUNCT
hls-11379	27	8	2023	2023	NUM
hls-11379	27	9	licensee	licensee	NOUN
hls-11379	27	10	pagepress	pagepress	NOUN
hls-11379	27	11	,	,	PUNCT
hls-11379	27	12	italy	italy	PROPN
hls-11379	27	13	healthcare	healthcare	PROPN
hls-11379	27	14	in	in	ADP
hls-11379	27	15	low	low	ADJ
hls-11379	27	16	-	-	PUNCT
hls-11379	27	17	resource	resource	NOUN
hls-11379	27	18	settings	setting	NOUN
hls-11379	27	19	2023	2023	NUM
hls-11379	27	20	;	;	PUNCT
hls-11379	27	21	11(s2):11379	11(s2):11379	NUM
hls-11379	27	22	doi:10.4081	doi:10.4081	NOUN
hls-11379	27	23	/	/	SYM
hls-11379	27	24	hls.2023.11379	hls.2023.11379	PROPN
hls-11379	27	25	publisher	publisher	NOUN
hls-11379	27	26	's	's	PART
hls-11379	27	27	note	note	NOUN
hls-11379	27	28	:	:	PUNCT
hls-11379	27	29	all	all	DET
hls-11379	27	30	claims	claim	NOUN
hls-11379	27	31	expressed	express	VERB
hls-11379	27	32	in	in	ADP
hls-11379	27	33	this	this	DET
hls-11379	27	34	article	article	NOUN
hls-11379	27	35	are	be	AUX
hls-11379	27	36	solely	solely	ADV
hls-11379	27	37	those	those	PRON
hls-11379	27	38	of	of	ADP
hls-11379	27	39	the	the	DET
hls-11379	27	40	authors	author	NOUN
hls-11379	27	41	and	and	CCONJ
hls-11379	27	42	do	do	AUX
hls-11379	27	43	not	not	PART
hls-11379	27	44	necessarily	necessarily	ADV
hls-11379	27	45	represent	represent	VERB
hls-11379	27	46	those	those	PRON
hls-11379	27	47	of	of	ADP
hls-11379	27	48	their	their	PRON
hls-11379	27	49	affiliated	affiliated	ADJ
hls-11379	27	50	organizations	organization	NOUN
hls-11379	27	51	,	,	PUNCT
hls-11379	27	52	or	or	CCONJ
hls-11379	27	53	those	those	PRON
hls-11379	27	54	of	of	ADP
hls-11379	27	55	the	the	DET
hls-11379	27	56	publisher	publisher	NOUN
hls-11379	27	57	,	,	PUNCT
hls-11379	27	58	the	the	DET
hls-11379	27	59	editors	editor	NOUN
hls-11379	27	60	and	and	CCONJ
hls-11379	27	61	the	the	DET
hls-11379	27	62	reviewers	reviewer	NOUN
hls-11379	27	63	.	.	PUNCT
hls-11379	28	1	any	any	DET
hls-11379	28	2	product	product	NOUN
hls-11379	28	3	that	that	PRON
hls-11379	28	4	may	may	AUX
hls-11379	28	5	be	be	AUX
hls-11379	28	6	evaluated	evaluate	VERB
hls-11379	28	7	in	in	ADP
hls-11379	28	8	this	this	DET
hls-11379	28	9	article	article	NOUN
hls-11379	28	10	or	or	CCONJ
hls-11379	28	11	claim	claim	NOUN
hls-11379	28	12	that	that	PRON
hls-11379	28	13	may	may	AUX
hls-11379	28	14	be	be	AUX
hls-11379	28	15	made	make	VERB
hls-11379	28	16	by	by	ADP
hls-11379	28	17	its	its	PRON
hls-11379	28	18	manufacturer	manufacturer	NOUN
hls-11379	28	19	is	be	AUX
hls-11379	28	20	not	not	PART
hls-11379	28	21	guaranteed	guarantee	VERB
hls-11379	28	22	or	or	CCONJ
hls-11379	28	23	endorsed	endorse	VERB
hls-11379	28	24	by	by	ADP
hls-11379	28	25	the	the	DET
hls-11379	28	26	publisher	publisher	NOUN
hls-11379	28	27	.	.	PUNCT
hls-11379	29	1	[	[	X
hls-11379	29	2	page	page	NOUN
hls-11379	29	3	12	12	NUM
hls-11379	29	4	]	]	PUNCT
hls-11379	30	1	[	[	X
hls-11379	30	2	healthcare	healthcare	NOUN
hls-11379	30	3	in	in	ADP
hls-11379	30	4	low	low	ADJ
hls-11379	30	5	-	-	PUNCT
hls-11379	30	6	resource	resource	NOUN
hls-11379	30	7	settings	setting	NOUN
hls-11379	30	8	2023	2023	NUM
hls-11379	30	9	;	;	PUNCT
hls-11379	30	10	11(s2):11379	11(s2):11379	NUM
hls-11379	30	11	]	]	X
hls-11379	30	12	non	non	ADJ
hls-11379	30	13	-co	-co	PROPN
hls-11379	30	14	mmerc	mmerc	PROPN
hls-11379	30	15	ial	ial	PROPN
hls-11379	30	16	us	us	PROPN
hls-11379	30	17	e	e	NOUN
hls-11379	30	18	o	o	NOUN
hls-11379	30	19	nly	nly	ADV
hls-11379	30	20	fatty	fatty	VERB
hls-11379	30	21	acid	acid	NOUN
hls-11379	30	22	synthesis	synthesis	NOUN
hls-11379	30	23	which	which	PRON
hls-11379	30	24	is	be	AUX
hls-11379	30	25	acetyl	acetyl	NOUN
hls-11379	30	26	-	-	PUNCT
hls-11379	30	27	coa	coa	NOUN
hls-11379	30	28	carboxylase	carboxylase	NOUN
hls-11379	30	29	and	and	CCONJ
hls-11379	30	30	fatty	fatty	NOUN
hls-11379	30	31	acid	acid	NOUN
hls-11379	30	32	synthase	synthase	NOUN
hls-11379	30	33	and	and	CCONJ
hls-11379	30	34	are	be	AUX
hls-11379	30	35	controlled	control	VERB
hls-11379	30	36	by	by	ADP
hls-11379	30	37	insulin	insulin	NOUN
hls-11379	30	38	and	and	CCONJ
hls-11379	30	39	by	by	ADP
hls-11379	30	40	glucose	glucose	NOUN
hls-11379	30	41	through	through	ADP
hls-11379	30	42	liver	liver	NOUN
hls-11379	30	43	x	x	NOUN
hls-11379	30	44	receptors	receptor	NOUN
hls-11379	30	45	which	which	PRON
hls-11379	30	46	directly	directly	ADV
hls-11379	30	47	induce	induce	VERB
hls-11379	30	48	acetyl	acetyl	NOUN
hls-11379	30	49	-	-	PUNCT
hls-11379	30	50	coa	coa	NOUN
hls-11379	30	51	carboxylase	carboxylase	NOUN
hls-11379	30	52	and	and	CCONJ
hls-11379	30	53	fatty	fatty	NOUN
hls-11379	30	54	acid	acid	NOUN
hls-11379	30	55	synthase	synthase	NOUN
hls-11379	30	56	.	.	PUNCT
hls-11379	31	1	de	de	ADJ
hls-11379	31	2	novo	novo	NOUN
hls-11379	31	3	lipogenesis	lipogenesis	NOUN
hls-11379	31	4	is	be	AUX
hls-11379	31	5	markedly	markedly	ADV
hls-11379	31	6	increased	increase	VERB
hls-11379	31	7	in	in	ADP
hls-11379	31	8	nafld	nafld	ADJ
hls-11379	31	9	mainly	mainly	ADV
hls-11379	31	10	due	due	ADP
hls-11379	31	11	to	to	ADP
hls-11379	31	12	the	the	DET
hls-11379	31	13	coexistent	coexistent	ADJ
hls-11379	31	14	hyperinsulinemia	hyperinsulinemia	NOUN
hls-11379	31	15	and	and	CCONJ
hls-11379	31	16	increased	increase	VERB
hls-11379	31	17	intake	intake	NOUN
hls-11379	31	18	of	of	ADP
hls-11379	31	19	simple	simple	ADJ
hls-11379	31	20	sugars.6	sugars.6	PROPN
hls-11379	31	21	the	the	DET
hls-11379	31	22	mechanism	mechanism	NOUN
hls-11379	31	23	claimed	claim	VERB
hls-11379	31	24	to	to	PART
hls-11379	31	25	be	be	AUX
hls-11379	31	26	involved	involve	VERB
hls-11379	31	27	in	in	ADP
hls-11379	31	28	the	the	DET
hls-11379	31	29	development	development	NOUN
hls-11379	31	30	of	of	ADP
hls-11379	31	31	nafld	nafld	PROPN
hls-11379	31	32	is	be	AUX
hls-11379	31	33	the	the	DET
hls-11379	31	34	“	"	PUNCT
hls-11379	31	35	second	second	ADJ
hls-11379	31	36	hit	hit	VERB
hls-11379	31	37	hypothesis	hypothesis	NOUN
hls-11379	31	38	”	"	PUNCT
hls-11379	31	39	which	which	PRON
hls-11379	31	40	is	be	AUX
hls-11379	31	41	the	the	DET
hls-11379	31	42	oxidative	oxidative	ADJ
hls-11379	31	43	stress	stress	NOUN
hls-11379	31	44	,	,	PUNCT
hls-11379	31	45	as	as	SCONJ
hls-11379	31	46	the	the	DET
hls-11379	31	47	“	"	PUNCT
hls-11379	31	48	first	first	ADJ
hls-11379	31	49	hit	hit	NOUN
hls-11379	31	50	”	"	PUNCT
hls-11379	31	51	usually	usually	ADV
hls-11379	31	52	is	be	AUX
hls-11379	31	53	the	the	DET
hls-11379	31	54	fat	fat	ADJ
hls-11379	31	55	accumulation	accumulation	NOUN
hls-11379	31	56	in	in	ADP
hls-11379	31	57	hepatocytes	hepatocyte	NOUN
hls-11379	31	58	,	,	PUNCT
hls-11379	31	59	and	and	CCONJ
hls-11379	31	60	the	the	DET
hls-11379	31	61	“	"	PUNCT
hls-11379	31	62	second	second	ADJ
hls-11379	31	63	hit	hit	NOUN
hls-11379	31	64	”	"	PUNCT
hls-11379	31	65	is	be	AUX
hls-11379	31	66	the	the	DET
hls-11379	31	67	oxidation	oxidation	NOUN
hls-11379	31	68	that	that	PRON
hls-11379	31	69	causes	cause	VERB
hls-11379	31	70	hepatic	hepatic	ADJ
hls-11379	31	71	injury.8	injury.8	PROPN
hls-11379	31	72	recently	recently	ADV
hls-11379	31	73	,	,	PUNCT
hls-11379	31	74	the	the	DET
hls-11379	31	75	“	"	PUNCT
hls-11379	31	76	multiple	multiple	ADJ
hls-11379	31	77	hits	hit	NOUN
hls-11379	31	78	”	"	PUNCT
hls-11379	31	79	hypothesis	hypothesis	NOUN
hls-11379	31	80	is	be	AUX
hls-11379	31	81	more	more	ADV
hls-11379	31	82	reliable	reliable	ADJ
hls-11379	31	83	and	and	CCONJ
hls-11379	31	84	accepted	accept	VERB
hls-11379	31	85	,	,	PUNCT
hls-11379	31	86	as	as	SCONJ
hls-11379	31	87	proposed	propose	VERB
hls-11379	31	88	by	by	ADP
hls-11379	31	89	takaki	takaki	NOUN
hls-11379	31	90	et	et	PROPN
hls-11379	31	91	al	al	PROPN
hls-11379	31	92	.	.	PROPN
hls-11379	31	93	,9	,9	PUNCT
hls-11379	31	94	and	and	CCONJ
hls-11379	32	1	buzzetti	buzzetti	PROPN
hls-11379	32	2	et	et	PROPN
hls-11379	32	3	al	al	PROPN
hls-11379	32	4	.	.	PROPN
hls-11379	32	5	,10	,10	PUNCT
hls-11379	33	1	they	they	PRON
hls-11379	33	2	found	find	VERB
hls-11379	33	3	that	that	SCONJ
hls-11379	33	4	multiple	multiple	ADJ
hls-11379	33	5	factors	factor	NOUN
hls-11379	33	6	work	work	VERB
hls-11379	33	7	together	together	ADV
hls-11379	33	8	on	on	ADP
hls-11379	33	9	genetically	genetically	ADV
hls-11379	33	10	predisposed	predispose	VERB
hls-11379	33	11	subjects	subject	NOUN
hls-11379	33	12	that	that	PRON
hls-11379	33	13	lead	lead	VERB
hls-11379	33	14	to	to	ADP
hls-11379	33	15	the	the	DET
hls-11379	33	16	development	development	NOUN
hls-11379	33	17	of	of	ADP
hls-11379	33	18	nafld	nafld	NOUN
hls-11379	33	19	;	;	PUNCT
hls-11379	33	20	these	these	DET
hls-11379	33	21	factors	factor	NOUN
hls-11379	33	22	include	include	VERB
hls-11379	33	23	insulin	insulin	NOUN
hls-11379	33	24	resistance	resistance	NOUN
hls-11379	33	25	,	,	PUNCT
hls-11379	33	26	adipose	adipose	ADP
hls-11379	33	27	tissue	tissue	NOUN
hls-11379	33	28	hormones	hormone	NOUN
hls-11379	33	29	,	,	PUNCT
hls-11379	33	30	nutrition	nutrition	NOUN
hls-11379	33	31	,	,	PUNCT
hls-11379	33	32	and	and	CCONJ
hls-11379	33	33	gut	gut	NOUN
hls-11379	33	34	microbiota	microbiota	NOUN
hls-11379	33	35	.	.	PUNCT
hls-11379	34	1	khosravi	khosravi	VERB
hls-11379	34	2	et	et	PROPN
hls-11379	34	3	al	al	PROPN
hls-11379	34	4	.	.	PROPN
hls-11379	34	5	,11	,11	PUNCT
hls-11379	34	6	found	find	VERB
hls-11379	34	7	that	that	SCONJ
hls-11379	34	8	h.	h.	PROPN
hls-11379	34	9	pylori	pylori	ADJ
hls-11379	34	10	infection	infection	NOUN
hls-11379	34	11	was	be	AUX
hls-11379	34	12	related	relate	VERB
hls-11379	34	13	to	to	PART
hls-11379	34	14	gut	gut	VERB
hls-11379	34	15	microbiota	microbiota	NOUN
hls-11379	34	16	by	by	ADP
hls-11379	34	17	using	use	VERB
hls-11379	34	18	germ	germ	NOUN
hls-11379	34	19	-	-	PUNCT
hls-11379	34	20	free	free	ADJ
hls-11379	34	21	and	and	CCONJ
hls-11379	34	22	specific	specific	ADJ
hls-11379	34	23	pathogen	pathogen	NOUN
hls-11379	34	24	-	-	PUNCT
hls-11379	34	25	free	free	ADJ
hls-11379	34	26	mice	mouse	NOUN
hls-11379	34	27	and	and	CCONJ
hls-11379	34	28	found	find	VERB
hls-11379	34	29	that	that	SCONJ
hls-11379	34	30	there	there	PRON
hls-11379	34	31	is	be	VERB
hls-11379	34	32	a	a	DET
hls-11379	34	33	strong	strong	ADJ
hls-11379	34	34	relation	relation	NOUN
hls-11379	34	35	between	between	ADP
hls-11379	34	36	normal	normal	ADJ
hls-11379	34	37	gut	gut	NOUN
hls-11379	34	38	microbiota	microbiota	NOUN
hls-11379	34	39	and	and	CCONJ
hls-11379	34	40	infection	infection	NOUN
hls-11379	34	41	with	with	ADP
hls-11379	34	42	h.	h.	PROPN
hls-11379	34	43	pylori	pylori	NOUN
hls-11379	34	44	which	which	PRON
hls-11379	34	45	alters	alter	VERB
hls-11379	34	46	the	the	DET
hls-11379	34	47	metabolism	metabolism	NOUN
hls-11379	34	48	and	and	CCONJ
hls-11379	34	49	induce	induce	VERB
hls-11379	34	50	gut	gut	NOUN
hls-11379	34	51	inflammation	inflammation	NOUN
hls-11379	34	52	considering	consider	VERB
hls-11379	34	53	h.	h.	PROPN
hls-11379	34	54	pylori	pylori	NOUN
hls-11379	34	55	as	as	ADP
hls-11379	34	56	one	one	NUM
hls-11379	34	57	of	of	ADP
hls-11379	34	58	the	the	DET
hls-11379	34	59	mechanisms	mechanism	NOUN
hls-11379	34	60	that	that	PRON
hls-11379	34	61	cause	cause	VERB
hls-11379	34	62	nafld	nafld	ADV
hls-11379	34	63	through	through	ADP
hls-11379	34	64	gut	gut	NOUN
hls-11379	34	65	microbiota	microbiota	NOUN
hls-11379	34	66	dysbiosis	dysbiosis	NOUN
hls-11379	34	67	.	.	PUNCT
hls-11379	35	1	this	this	PRON
hls-11379	35	2	was	be	AUX
hls-11379	35	3	confirmed	confirm	VERB
hls-11379	35	4	by	by	ADP
hls-11379	35	5	sumida	sumida	PROPN
hls-11379	35	6	et	et	PROPN
hls-11379	35	7	al	al	PROPN
hls-11379	35	8	.	.	PROPN
hls-11379	35	9	,12	,12	PUNCT
hls-11379	35	10	as	as	SCONJ
hls-11379	35	11	they	they	PRON
hls-11379	35	12	found	find	VERB
hls-11379	35	13	that	that	DET
hls-11379	35	14	invasion	invasion	NOUN
hls-11379	35	15	of	of	ADP
hls-11379	35	16	h.	h.	PROPN
hls-11379	35	17	pylori	pylori	NOUN
hls-11379	35	18	into	into	ADP
hls-11379	35	19	intestinal	intestinal	ADJ
hls-11379	35	20	mucosa	mucosa	NOUN
hls-11379	35	21	may	may	AUX
hls-11379	35	22	increase	increase	VERB
hls-11379	35	23	gut	gut	NOUN
hls-11379	35	24	permeability	permeability	NOUN
hls-11379	35	25	and	and	CCONJ
hls-11379	35	26	alter	alter	VERB
hls-11379	35	27	gut	gut	NOUN
hls-11379	35	28	microbiota	microbiota	NOUN
hls-11379	35	29	and	and	CCONJ
hls-11379	35	30	subsequently	subsequently	ADV
hls-11379	35	31	increase	increase	VERB
hls-11379	35	32	the	the	DET
hls-11379	35	33	passage	passage	NOUN
hls-11379	35	34	of	of	ADP
hls-11379	35	35	bacterial	bacterial	ADJ
hls-11379	35	36	endotoxin	endotoxin	NOUN
hls-11379	35	37	through	through	ADP
hls-11379	35	38	the	the	DET
hls-11379	35	39	portal	portal	ADJ
hls-11379	35	40	vein	vein	ADJ
hls-11379	35	41	to	to	ADP
hls-11379	35	42	the	the	DET
hls-11379	35	43	liver	liver	NOUN
hls-11379	35	44	and	and	CCONJ
hls-11379	35	45	initiate	initiate	VERB
hls-11379	35	46	inflammation	inflammation	NOUN
hls-11379	35	47	and	and	CCONJ
hls-11379	35	48	considered	consider	VERB
hls-11379	35	49	as	as	ADP
hls-11379	35	50	one	one	NUM
hls-11379	35	51	of	of	ADP
hls-11379	35	52	the	the	DET
hls-11379	35	53	multiple	multiple	ADJ
hls-11379	35	54	hits	hit	NOUN
hls-11379	35	55	causing	cause	VERB
hls-11379	35	56	nafld	nafld	ADJ
hls-11379	35	57	.	.	PUNCT
hls-11379	36	1	in	in	ADP
hls-11379	36	2	this	this	DET
hls-11379	36	3	study	study	NOUN
hls-11379	36	4	,	,	PUNCT
hls-11379	36	5	we	we	PRON
hls-11379	36	6	are	be	AUX
hls-11379	36	7	aiming	aim	VERB
hls-11379	36	8	at	at	ADP
hls-11379	36	9	finding	find	VERB
hls-11379	36	10	the	the	DET
hls-11379	36	11	relationship	relationship	NOUN
hls-11379	36	12	between	between	ADP
hls-11379	36	13	h.	h.	PROPN
hls-11379	36	14	pylori	pylori	ADJ
hls-11379	36	15	infection	infection	NOUN
hls-11379	36	16	and	and	CCONJ
hls-11379	36	17	the	the	DET
hls-11379	36	18	development	development	NOUN
hls-11379	36	19	of	of	ADP
hls-11379	36	20	nafld	nafld	PROPN
hls-11379	36	21	.	.	PUNCT
hls-11379	37	1	materials	material	NOUN
hls-11379	37	2	and	and	CCONJ
hls-11379	37	3	methods	method	NOUN
hls-11379	37	4	study	study	NOUN
hls-11379	37	5	design	design	NOUN
hls-11379	37	6	and	and	CCONJ
hls-11379	37	7	population	population	NOUN
hls-11379	37	8	this	this	DET
hls-11379	37	9	study	study	NOUN
hls-11379	37	10	was	be	AUX
hls-11379	37	11	conducted	conduct	VERB
hls-11379	37	12	on	on	ADP
hls-11379	37	13	100	100	NUM
hls-11379	37	14	patients	patient	NOUN
hls-11379	37	15	,	,	PUNCT
hls-11379	37	16	50	50	NUM
hls-11379	37	17	of	of	ADP
hls-11379	37	18	whom	whom	PRON
hls-11379	37	19	were	be	AUX
hls-11379	37	20	diagnosed	diagnose	VERB
hls-11379	37	21	with	with	ADP
hls-11379	37	22	h.	h.	PROPN
hls-11379	37	23	pylori	pylori	ADJ
hls-11379	37	24	infection	infection	NOUN
hls-11379	37	25	while	while	SCONJ
hls-11379	37	26	the	the	DET
hls-11379	37	27	other	other	ADJ
hls-11379	37	28	50	50	NUM
hls-11379	37	29	were	be	AUX
hls-11379	37	30	not	not	PART
hls-11379	37	31	.	.	PUNCT
hls-11379	38	1	the	the	DET
hls-11379	38	2	patients	patient	NOUN
hls-11379	38	3	were	be	AUX
hls-11379	38	4	examined	examine	VERB
hls-11379	38	5	for	for	ADP
hls-11379	38	6	the	the	DET
hls-11379	38	7	presence	presence	NOUN
hls-11379	38	8	of	of	ADP
hls-11379	38	9	fatty	fatty	ADJ
hls-11379	38	10	liver	liver	NOUN
hls-11379	38	11	in	in	ADP
hls-11379	38	12	the	the	DET
hls-11379	38	13	absence	absence	NOUN
hls-11379	38	14	of	of	ADP
hls-11379	38	15	alcohol	alcohol	NOUN
hls-11379	38	16	consumption	consumption	NOUN
hls-11379	38	17	.	.	PUNCT
hls-11379	39	1	they	they	PRON
hls-11379	39	2	were	be	AUX
hls-11379	39	3	selected	select	VERB
hls-11379	39	4	from	from	ADP
hls-11379	39	5	either	either	DET
hls-11379	39	6	outpatient	outpatient	NOUN
hls-11379	39	7	clinics	clinic	NOUN
hls-11379	39	8	or	or	CCONJ
hls-11379	39	9	inpatient	inpatient	NOUN
hls-11379	39	10	wards	ward	NOUN
hls-11379	39	11	of	of	ADP
hls-11379	39	12	the	the	DET
hls-11379	39	13	medical	medical	PROPN
hls-11379	39	14	research	research	PROPN
hls-11379	39	15	institute	institute	NOUN
hls-11379	39	16	for	for	ADP
hls-11379	39	17	any	any	DET
hls-11379	39	18	medical	medical	ADJ
hls-11379	39	19	reason	reason	NOUN
hls-11379	39	20	during	during	ADP
hls-11379	39	21	the	the	DET
hls-11379	39	22	period	period	NOUN
hls-11379	39	23	from	from	ADP
hls-11379	39	24	june	june	PROPN
hls-11379	39	25	2022	2022	NUM
hls-11379	39	26	to	to	ADP
hls-11379	39	27	december	december	PROPN
hls-11379	39	28	2022	2022	NUM
hls-11379	39	29	,	,	PUNCT
hls-11379	39	30	in	in	ADP
hls-11379	39	31	alexandria	alexandria	PROPN
hls-11379	39	32	,	,	PUNCT
hls-11379	39	33	egypt	egypt	PROPN
hls-11379	39	34	.	.	PUNCT
hls-11379	40	1	participants	participant	NOUN
hls-11379	40	2	with	with	ADP
hls-11379	40	3	dm	dm	PROPN
hls-11379	40	4	,	,	PUNCT
hls-11379	40	5	hypertension	hypertension	NOUN
hls-11379	40	6	,	,	PUNCT
hls-11379	40	7	alcohol	alcohol	NOUN
hls-11379	40	8	consumption	consumption	NOUN
hls-11379	40	9	,	,	PUNCT
hls-11379	40	10	and	and	CCONJ
hls-11379	40	11	chronic	chronic	ADJ
hls-11379	40	12	liver	liver	NOUN
hls-11379	40	13	disease	disease	NOUN
hls-11379	40	14	were	be	AUX
hls-11379	40	15	excluded	exclude	VERB
hls-11379	40	16	from	from	ADP
hls-11379	40	17	the	the	DET
hls-11379	40	18	study	study	NOUN
hls-11379	40	19	.	.	PUNCT
hls-11379	41	1	informed	informed	ADJ
hls-11379	41	2	consent	consent	NOUN
hls-11379	41	3	was	be	AUX
hls-11379	41	4	obtained	obtain	VERB
hls-11379	41	5	from	from	ADP
hls-11379	41	6	all	all	DET
hls-11379	41	7	patients	patient	NOUN
hls-11379	41	8	in	in	ADP
hls-11379	41	9	a	a	DET
hls-11379	41	10	case	case	NOUN
hls-11379	41	11	-	-	PUNCT
hls-11379	41	12	control	control	NOUN
hls-11379	41	13	study	study	NOUN
hls-11379	41	14	and	and	CCONJ
hls-11379	41	15	approved	approve	VERB
hls-11379	41	16	by	by	ADP
hls-11379	41	17	the	the	DET
hls-11379	41	18	medical	medical	PROPN
hls-11379	41	19	research	research	PROPN
hls-11379	41	20	institute	institute	PROPN
hls-11379	41	21	ethics	ethics	PROPN
hls-11379	41	22	committee	committee	PROPN
hls-11379	41	23	.	.	PUNCT
hls-11379	42	1	clinical	clinical	ADJ
hls-11379	42	2	data	datum	NOUN
hls-11379	42	3	the	the	DET
hls-11379	42	4	clinical	clinical	ADJ
hls-11379	42	5	data	datum	NOUN
hls-11379	42	6	collected	collect	VERB
hls-11379	42	7	included	include	VERB
hls-11379	42	8	:	:	PUNCT
hls-11379	42	9	i	i	PRON
hls-11379	42	10	)	)	PUNCT
hls-11379	42	11	thorough	thorough	ADJ
hls-11379	42	12	clinical	clinical	ADJ
hls-11379	42	13	examination	examination	NOUN
hls-11379	42	14	including	include	VERB
hls-11379	42	15	weight	weight	NOUN
hls-11379	42	16	and	and	CCONJ
hls-11379	42	17	height	height	NOUN
hls-11379	42	18	;	;	PUNCT
hls-11379	42	19	ii	ii	X
hls-11379	42	20	)	)	PUNCT
hls-11379	42	21	routine	routine	ADJ
hls-11379	42	22	laboratory	laboratory	NOUN
hls-11379	42	23	investigations	investigation	NOUN
hls-11379	42	24	include	include	VERB
hls-11379	42	25	liver	liver	NOUN
hls-11379	42	26	function	function	NOUN
hls-11379	42	27	tests	test	NOUN
hls-11379	42	28	,	,	PUNCT
hls-11379	42	29	renal	renal	ADJ
hls-11379	42	30	function	function	NOUN
hls-11379	42	31	tests	test	NOUN
hls-11379	42	32	,	,	PUNCT
hls-11379	42	33	lipid	lipid	NOUN
hls-11379	42	34	profiles	profile	NOUN
hls-11379	42	35	,	,	PUNCT
hls-11379	42	36	electrolytes	electrolyte	NOUN
hls-11379	42	37	,	,	PUNCT
hls-11379	42	38	complete	complete	ADJ
hls-11379	42	39	blood	blood	NOUN
hls-11379	42	40	pictures	picture	NOUN
hls-11379	42	41	,	,	PUNCT
hls-11379	42	42	and	and	CCONJ
hls-11379	42	43	fasting	fast	VERB
hls-11379	42	44	blood	blood	NOUN
hls-11379	42	45	sugar;13	sugar;13	PROPN
hls-11379	42	46	iii	iii	PROPN
hls-11379	42	47	)	)	PUNCT
hls-11379	42	48	the	the	DET
hls-11379	42	49	urea	urea	NOUN
hls-11379	42	50	breath	breath	NOUN
hls-11379	42	51	test	test	NOUN
hls-11379	42	52	was	be	AUX
hls-11379	42	53	done	do	VERB
hls-11379	42	54	for	for	ADP
hls-11379	42	55	the	the	DET
hls-11379	42	56	diagnosis	diagnosis	NOUN
hls-11379	42	57	of	of	ADP
hls-11379	42	58	h.	h.	PROPN
hls-11379	42	59	pylori	pylori	PROPN
hls-11379	42	60	infection;14	infection;14	PROPN
hls-11379	42	61	iv	iv	PROPN
hls-11379	42	62	)	)	PUNCT
hls-11379	42	63	nfld	nfld	PROPN
hls-11379	42	64	was	be	AUX
hls-11379	42	65	diagnosed	diagnose	VERB
hls-11379	42	66	using	use	VERB
hls-11379	42	67	vibration	vibration	NOUN
hls-11379	42	68	-	-	PUNCT
hls-11379	42	69	controlled	control	VERB
hls-11379	42	70	transient	transient	ADJ
hls-11379	42	71	elastography	elastography	NOUN
hls-11379	42	72	,	,	PUNCT
hls-11379	42	73	the	the	DET
hls-11379	42	74	cut	cut	NOUN
hls-11379	42	75	-	-	PUNCT
hls-11379	42	76	off	off	NOUN
hls-11379	42	77	for	for	ADP
hls-11379	42	78	steatosis	steatosis	NOUN
hls-11379	42	79	is	be	AUX
hls-11379	42	80	>	>	X
hls-11379	42	81	248	248	NUM
hls-11379	42	82	db	db	PROPN
hls-11379	42	83	/	/	SYM
hls-11379	42	84	m.15	m.15	NOUN
hls-11379	42	85	statistical	statistical	ADJ
hls-11379	42	86	analysis	analysis	NOUN
hls-11379	42	87	data	datum	NOUN
hls-11379	42	88	were	be	AUX
hls-11379	42	89	fed	feed	VERB
hls-11379	42	90	to	to	ADP
hls-11379	42	91	the	the	DET
hls-11379	42	92	computer	computer	NOUN
hls-11379	42	93	and	and	CCONJ
hls-11379	42	94	analyzed	analyze	VERB
hls-11379	42	95	using	use	VERB
hls-11379	42	96	ibm	ibm	PROPN
hls-11379	42	97	spss	spss	PROPN
hls-11379	42	98	software	software	NOUN
hls-11379	42	99	package	package	NOUN
hls-11379	42	100	version	version	NOUN
hls-11379	42	101	20.0	20.0	NUM
hls-11379	42	102	.	.	PUNCT
hls-11379	43	1	(	(	PUNCT
hls-11379	43	2	armonk	armonk	PROPN
hls-11379	43	3	,	,	PUNCT
hls-11379	43	4	ny	ny	PROPN
hls-11379	43	5	:	:	PROPN
hls-11379	43	6	ibm	ibm	PROPN
hls-11379	43	7	corp	corp	PROPN
hls-11379	43	8	)	)	PUNCT
hls-11379	43	9	.	.	PUNCT
hls-11379	44	1	categorical	categorical	ADJ
hls-11379	44	2	data	datum	NOUN
hls-11379	44	3	were	be	AUX
hls-11379	44	4	represented	represent	VERB
hls-11379	44	5	as	as	ADP
hls-11379	44	6	numbers	number	NOUN
hls-11379	44	7	and	and	CCONJ
hls-11379	44	8	percentages	percentage	NOUN
hls-11379	44	9	.	.	PUNCT
hls-11379	45	1	the	the	DET
hls-11379	45	2	chi	chi	ADJ
hls-11379	45	3	-	-	PUNCT
hls-11379	45	4	square	square	ADJ
hls-11379	45	5	test	test	NOUN
hls-11379	45	6	was	be	AUX
hls-11379	45	7	applied	apply	VERB
hls-11379	45	8	to	to	PART
hls-11379	45	9	investigate	investigate	VERB
hls-11379	45	10	the	the	DET
hls-11379	45	11	association	association	NOUN
hls-11379	45	12	between	between	ADP
hls-11379	45	13	the	the	DET
hls-11379	45	14	categorical	categorical	ADJ
hls-11379	45	15	variables	variable	NOUN
hls-11379	45	16	.	.	PUNCT
hls-11379	46	1	for	for	ADP
hls-11379	46	2	continuous	continuous	ADJ
hls-11379	46	3	data	datum	NOUN
hls-11379	46	4	,	,	PUNCT
hls-11379	46	5	they	they	PRON
hls-11379	46	6	were	be	AUX
hls-11379	46	7	tested	test	VERB
hls-11379	46	8	for	for	ADP
hls-11379	46	9	normality	normality	NOUN
hls-11379	46	10	by	by	ADP
hls-11379	46	11	the	the	DET
hls-11379	46	12	shapiro	shapiro	PROPN
hls-11379	46	13	-	-	PUNCT
hls-11379	46	14	wilk	wilk	NOUN
hls-11379	46	15	test	test	NOUN
hls-11379	46	16	.	.	PUNCT
hls-11379	47	1	quantitative	quantitative	ADJ
hls-11379	47	2	data	datum	NOUN
hls-11379	47	3	were	be	AUX
hls-11379	47	4	expressed	express	VERB
hls-11379	47	5	as	as	ADP
hls-11379	47	6	a	a	DET
hls-11379	47	7	range	range	NOUN
hls-11379	47	8	(	(	PUNCT
hls-11379	47	9	minimum	minimum	NOUN
hls-11379	47	10	and	and	CCONJ
hls-11379	47	11	maximum	maximum	ADJ
hls-11379	47	12	)	)	PUNCT
hls-11379	47	13	,	,	PUNCT
hls-11379	47	14	mean	mean	VERB
hls-11379	47	15	,	,	PUNCT
hls-11379	47	16	standard	standard	ADJ
hls-11379	47	17	deviation	deviation	NOUN
hls-11379	47	18	,	,	PUNCT
hls-11379	47	19	and	and	CCONJ
hls-11379	47	20	median	median	PROPN
hls-11379	47	21	.	.	PUNCT
hls-11379	48	1	student	student	PROPN
hls-11379	48	2	t	t	PROPN
hls-11379	48	3	-	-	PUNCT
hls-11379	48	4	test	test	NOUN
hls-11379	48	5	was	be	AUX
hls-11379	48	6	used	use	VERB
hls-11379	48	7	to	to	PART
hls-11379	48	8	compare	compare	VERB
hls-11379	48	9	two	two	NUM
hls-11379	48	10	groups	group	NOUN
hls-11379	48	11	for	for	ADP
hls-11379	48	12	normally	normally	ADV
hls-11379	48	13	distributed	distribute	VERB
hls-11379	48	14	quantitative	quantitative	ADJ
hls-11379	48	15	variables	variable	NOUN
hls-11379	48	16	.	.	PUNCT
hls-11379	49	1	on	on	ADP
hls-11379	49	2	the	the	DET
hls-11379	49	3	other	other	ADJ
hls-11379	49	4	hand	hand	NOUN
hls-11379	49	5	,	,	PUNCT
hls-11379	49	6	the	the	DET
hls-11379	49	7	mann	mann	PROPN
hls-11379	49	8	-	-	PUNCT
hls-11379	49	9	whitney	whitney	PROPN
hls-11379	49	10	test	test	NOUN
hls-11379	49	11	was	be	AUX
hls-11379	49	12	used	use	VERB
hls-11379	49	13	to	to	PART
hls-11379	49	14	compare	compare	VERB
hls-11379	49	15	two	two	NUM
hls-11379	49	16	groups	group	NOUN
hls-11379	49	17	for	for	ADP
hls-11379	49	18	not	not	PART
hls-11379	49	19	normally	normally	ADV
hls-11379	49	20	distributed	distribute	VERB
hls-11379	49	21	quantitative	quantitative	ADJ
hls-11379	49	22	variables	variable	NOUN
hls-11379	49	23	.	.	PUNCT
hls-11379	50	1	and	and	CCONJ
hls-11379	50	2	receiver	receiver	ADV
hls-11379	50	3	operating	operate	VERB
hls-11379	50	4	characteristic	characteristic	ADJ
hls-11379	50	5	curve	curve	NOUN
hls-11379	50	6	(	(	PUNCT
hls-11379	50	7	roc	roc	PROPN
hls-11379	50	8	)	)	PUNCT
hls-11379	50	9	was	be	AUX
hls-11379	50	10	used	use	VERB
hls-11379	50	11	to	to	PART
hls-11379	50	12	determine	determine	VERB
hls-11379	50	13	the	the	DET
hls-11379	50	14	diagnostic	diagnostic	ADJ
hls-11379	50	15	performance	performance	NOUN
hls-11379	50	16	of	of	ADP
hls-11379	50	17	the	the	DET
hls-11379	50	18	markers	marker	NOUN
hls-11379	50	19	,	,	PUNCT
hls-11379	50	20	an	an	DET
hls-11379	50	21	area	area	NOUN
hls-11379	50	22	of	of	ADP
hls-11379	50	23	more	more	ADJ
hls-11379	50	24	than	than	ADP
hls-11379	50	25	50	50	NUM
hls-11379	50	26	%	%	NOUN
hls-11379	50	27	gives	give	VERB
hls-11379	50	28	an	an	DET
hls-11379	50	29	acceptable	acceptable	ADJ
hls-11379	50	30	performance	performance	NOUN
hls-11379	50	31	,	,	PUNCT
hls-11379	50	32	and	and	CCONJ
hls-11379	50	33	an	an	DET
hls-11379	50	34	area	area	NOUN
hls-11379	50	35	of	of	ADP
hls-11379	50	36	about	about	ADV
hls-11379	50	37	100	100	NUM
hls-11379	50	38	%	%	NOUN
hls-11379	50	39	is	be	AUX
hls-11379	50	40	the	the	DET
hls-11379	50	41	best	good	ADJ
hls-11379	50	42	performance	performance	NOUN
hls-11379	50	43	for	for	ADP
hls-11379	50	44	the	the	DET
hls-11379	50	45	test	test	NOUN
hls-11379	50	46	.	.	PUNCT
hls-11379	51	1	the	the	DET
hls-11379	51	2	significance	significance	NOUN
hls-11379	51	3	of	of	ADP
hls-11379	51	4	the	the	DET
hls-11379	51	5	obtained	obtain	VERB
hls-11379	51	6	results	result	NOUN
hls-11379	51	7	was	be	AUX
hls-11379	51	8	judged	judge	VERB
hls-11379	51	9	at	at	ADP
hls-11379	51	10	the	the	DET
hls-11379	51	11	5	5	NUM
hls-11379	51	12	%	%	NOUN
hls-11379	51	13	level	level	NOUN
hls-11379	51	14	.	.	PUNCT
hls-11379	52	1	results	result	VERB
hls-11379	52	2	the	the	DET
hls-11379	52	3	effect	effect	NOUN
hls-11379	52	4	of	of	ADP
hls-11379	52	5	demographic	demographic	ADJ
hls-11379	52	6	data	datum	NOUN
hls-11379	52	7	on	on	ADP
hls-11379	52	8	nafld	nafld	PROPN
hls-11379	52	9	was	be	AUX
hls-11379	52	10	tested	test	VERB
hls-11379	52	11	,	,	PUNCT
hls-11379	52	12	and	and	CCONJ
hls-11379	52	13	we	we	PRON
hls-11379	52	14	found	find	VERB
hls-11379	52	15	that	that	SCONJ
hls-11379	52	16	fatty	fatty	NOUN
hls-11379	52	17	liver	liver	NOUN
hls-11379	52	18	is	be	AUX
hls-11379	52	19	more	more	ADV
hls-11379	52	20	common	common	ADJ
hls-11379	52	21	in	in	ADP
hls-11379	52	22	females	female	NOUN
hls-11379	52	23	but	but	CCONJ
hls-11379	52	24	not	not	PART
hls-11379	52	25	statistically	statistically	ADV
hls-11379	52	26	significant	significant	ADJ
hls-11379	52	27	.	.	PUNCT
hls-11379	53	1	p=0.680	p=0.680	NOUN
hls-11379	53	2	,	,	PUNCT
hls-11379	53	3	while	while	SCONJ
hls-11379	53	4	age	age	NOUN
hls-11379	53	5	was	be	AUX
hls-11379	53	6	significantly	significantly	ADV
hls-11379	53	7	related	relate	VERB
hls-11379	53	8	to	to	PART
hls-11379	53	9	fatty	fatty	VERB
hls-11379	53	10	liver	liver	NOUN
hls-11379	53	11	where	where	SCONJ
hls-11379	53	12	the	the	DET
hls-11379	53	13	mean	mean	ADJ
hls-11379	53	14	age	age	NOUN
hls-11379	53	15	in	in	ADP
hls-11379	53	16	patients	patient	NOUN
hls-11379	53	17	with	with	ADP
hls-11379	53	18	steatosis	steatosis	NOUN
hls-11379	53	19	was	be	AUX
hls-11379	53	20	52.5±12.4	52.5±12.4	NUM
hls-11379	53	21	years	year	NOUN
hls-11379	53	22	,	,	PUNCT
hls-11379	53	23	and	and	CCONJ
hls-11379	53	24	the	the	DET
hls-11379	53	25	mean	mean	ADJ
hls-11379	53	26	age	age	NOUN
hls-11379	53	27	of	of	ADP
hls-11379	53	28	patients	patient	NOUN
hls-11379	53	29	without	without	ADP
hls-11379	53	30	steatosis	steatosis	NOUN
hls-11379	53	31	was	be	AUX
hls-11379	53	32	38.2±14.3	38.2±14.3	NUM
hls-11379	53	33	(	(	PUNCT
hls-11379	53	34	p<0.001	p<0.001	PROPN
hls-11379	53	35	)	)	PUNCT
hls-11379	53	36	.	.	PUNCT
hls-11379	54	1	bmi	bmi	PROPN
hls-11379	54	2	also	also	ADV
hls-11379	54	3	was	be	AUX
hls-11379	54	4	a	a	DET
hls-11379	54	5	risk	risk	NOUN
hls-11379	54	6	factor	factor	NOUN
hls-11379	54	7	for	for	ADP
hls-11379	54	8	steatosis	steatosis	NOUN
hls-11379	54	9	,	,	PUNCT
hls-11379	54	10	where	where	SCONJ
hls-11379	54	11	the	the	DET
hls-11379	54	12	mean	mean	ADJ
hls-11379	54	13	bmi	bmi	NOUN
hls-11379	54	14	in	in	ADP
hls-11379	54	15	patients	patient	NOUN
hls-11379	54	16	with	with	ADP
hls-11379	54	17	nafld	nafld	PROPN
hls-11379	54	18	was	be	AUX
hls-11379	54	19	32±3.9	32±3.9	NUM
hls-11379	54	20	kg	kg	NOUN
hls-11379	54	21	/	/	SYM
hls-11379	54	22	m2	m2	PROPN
hls-11379	54	23	,	,	PUNCT
hls-11379	54	24	and	and	CCONJ
hls-11379	54	25	in	in	ADP
hls-11379	54	26	patients	patient	NOUN
hls-11379	54	27	without	without	ADP
hls-11379	54	28	nafld	nafld	PROPN
hls-11379	54	29	was	be	AUX
hls-11379	54	30	28.8±4.3kg	28.8±4.3kg	NUM
hls-11379	54	31	/	/	SYM
hls-11379	54	32	m2	m2	PROPN
hls-11379	54	33	,	,	PUNCT
hls-11379	54	34	p<0.001	p<0.001	X
hls-11379	54	35	(	(	PUNCT
hls-11379	54	36	table	table	NOUN
hls-11379	54	37	1	1	NUM
hls-11379	54	38	)	)	PUNCT
hls-11379	54	39	.	.	PUNCT
hls-11379	55	1	various	various	ADJ
hls-11379	55	2	biochemical	biochemical	ADJ
hls-11379	55	3	markers	marker	NOUN
hls-11379	55	4	were	be	AUX
hls-11379	55	5	evaluated	evaluate	VERB
hls-11379	55	6	for	for	ADP
hls-11379	55	7	their	their	PRON
hls-11379	55	8	relationship	relationship	NOUN
hls-11379	55	9	to	to	ADP
hls-11379	55	10	nafld	nafld	ADV
hls-11379	55	11	,	,	PUNCT
hls-11379	55	12	including	include	VERB
hls-11379	55	13	liver	liver	NOUN
hls-11379	55	14	enzymes	enzyme	NOUN
hls-11379	55	15	such	such	ADJ
hls-11379	55	16	as	as	ADP
hls-11379	55	17	alanine	alanine	NOUN
hls-11379	55	18	aminotransferase	aminotransferase	NOUN
hls-11379	55	19	(	(	PUNCT
hls-11379	55	20	alt	alt	PROPN
hls-11379	55	21	)	)	PUNCT
hls-11379	55	22	,	,	PUNCT
hls-11379	55	23	aspartate	aspartate	NOUN
hls-11379	55	24	aminotransferase	aminotransferase	NOUN
hls-11379	55	25	(	(	PUNCT
hls-11379	55	26	ast	ast	PROPN
hls-11379	55	27	)	)	PUNCT
hls-11379	55	28	,	,	PUNCT
hls-11379	55	29	total	total	ADJ
hls-11379	55	30	cholesterol	cholesterol	NOUN
hls-11379	55	31	(	(	PUNCT
hls-11379	55	32	tc	tc	NOUN
hls-11379	55	33	)	)	PUNCT
hls-11379	55	34	,	,	PUNCT
hls-11379	55	35	low	low	ADJ
hls-11379	55	36	-	-	PUNCT
hls-11379	55	37	density	density	NOUN
hls-11379	55	38	lipoprotein	lipoprotein	ADJ
hls-11379	55	39	(	(	PUNCT
hls-11379	55	40	ldl	ldl	NOUN
hls-11379	55	41	)	)	PUNCT
hls-11379	55	42	,	,	PUNCT
hls-11379	55	43	high	high	ADJ
hls-11379	55	44	-	-	PUNCT
hls-11379	55	45	density	density	NOUN
hls-11379	55	46	lipoprotein	lipoprotein	ADJ
hls-11379	55	47	(	(	PUNCT
hls-11379	55	48	hdl	hdl	NOUN
hls-11379	55	49	)	)	PUNCT
hls-11379	55	50	,	,	PUNCT
hls-11379	55	51	and	and	CCONJ
hls-11379	55	52	triglyceride	triglyceride	ADJ
hls-11379	55	53	level	level	NOUN
hls-11379	55	54	(	(	PUNCT
hls-11379	55	55	tg	tg	PROPN
hls-11379	55	56	)	)	PUNCT
hls-11379	55	57	.	.	PUNCT
hls-11379	56	1	however	however	ADV
hls-11379	56	2	,	,	PUNCT
hls-11379	56	3	none	none	NOUN
hls-11379	56	4	of	of	ADP
hls-11379	56	5	these	these	DET
hls-11379	56	6	markers	marker	NOUN
hls-11379	56	7	showed	show	VERB
hls-11379	56	8	a	a	DET
hls-11379	56	9	significant	significant	ADJ
hls-11379	56	10	relationship	relationship	NOUN
hls-11379	56	11	with	with	ADP
hls-11379	56	12	nafld	nafld	ADJ
hls-11379	56	13	(	(	PUNCT
hls-11379	56	14	table	table	NOUN
hls-11379	56	15	2	2	NUM
hls-11379	56	16	)	)	PUNCT
hls-11379	56	17	.	.	PUNCT
hls-11379	57	1	article	article	NOUN
hls-11379	57	2	table	table	VERB
hls-11379	57	3	1	1	NUM
hls-11379	57	4	.	.	X
hls-11379	58	1	relation	relation	NOUN
hls-11379	58	2	between	between	ADP
hls-11379	58	3	elastography	elastography	NOUN
hls-11379	58	4	and	and	CCONJ
hls-11379	58	5	demographic	demographic	ADJ
hls-11379	58	6	data	datum	NOUN
hls-11379	58	7	.	.	PUNCT
hls-11379	59	1	total	total	ADJ
hls-11379	59	2	n	n	NOUN
hls-11379	59	3	=	=	SYM
hls-11379	59	4	100	100	NUM
hls-11379	59	5	elastography	elastography	NOUN
hls-11379	59	6	test	test	NOUN
hls-11379	59	7	of	of	ADP
hls-11379	59	8	sig	sig	NOUN
hls-11379	59	9	.	.	PUNCT
hls-11379	60	1	p	p	X
hls-11379	60	2	≤248	≤248	PROPN
hls-11379	60	3	db	db	PROPN
hls-11379	60	4	/	/	SYM
hls-11379	60	5	m	m	PROPN
hls-11379	60	6	>	>	X
hls-11379	60	7	248	248	NUM
hls-11379	60	8	db	db	PROPN
hls-11379	60	9	/	/	SYM
hls-11379	60	10	m	m	PROPN
hls-11379	60	11	gender	gender	NOUN
hls-11379	60	12	male	male	NOUN
hls-11379	60	13	(	(	PUNCT
hls-11379	60	14	%	%	NOUN
hls-11379	60	15	)	)	PUNCT
hls-11379	60	16	38	38	NUM
hls-11379	60	17	(	(	PUNCT
hls-11379	60	18	38.0	38.0	NUM
hls-11379	60	19	)	)	PUNCT
hls-11379	60	20	18	18	NUM
hls-11379	60	21	(	(	PUNCT
hls-11379	60	22	36.0	36.0	NUM
hls-11379	60	23	)	)	PUNCT
hls-11379	60	24	20	20	NUM
hls-11379	60	25	(	(	PUNCT
hls-11379	60	26	40.0	40.0	NUM
hls-11379	60	27	χ2=	χ2=	NOUN
hls-11379	60	28	0.170	0.170	NUM
hls-11379	60	29	0.680	0.680	NUM
hls-11379	60	30	female	female	ADJ
hls-11379	60	31	(	(	PUNCT
hls-11379	60	32	%	%	NOUN
hls-11379	60	33	)	)	PUNCT
hls-11379	60	34	62	62	NUM
hls-11379	60	35	(	(	PUNCT
hls-11379	60	36	62.0	62.0	NUM
hls-11379	60	37	)	)	PUNCT
hls-11379	60	38	32	32	NUM
hls-11379	60	39	(	(	PUNCT
hls-11379	60	40	64.0	64.0	NUM
hls-11379	60	41	)	)	PUNCT
hls-11379	60	42	30	30	NUM
hls-11379	60	43	(	(	PUNCT
hls-11379	60	44	60.0	60.0	NUM
hls-11379	60	45	)	)	PUNCT
hls-11379	60	46	age	age	NOUN
hls-11379	60	47	(	(	PUNCT
hls-11379	60	48	years	year	NOUN
hls-11379	60	49	)	)	PUNCT
hls-11379	60	50	mean±sd	mean±sd	ADP
hls-11379	61	1	45.4±15.1	45.4±15.1	NUM
hls-11379	61	2	38.2±14.3	38.2±14.3	NUM
hls-11379	61	3	52.5±12.4	52.5±12.4	NUM
hls-11379	61	4	u=566.0	u=566.0	NOUN
hls-11379	61	5	*	*	PUNCT
hls-11379	61	6	<	<	NOUN
hls-11379	61	7	0.001	0.001	NUM
hls-11379	61	8	*	*	ADJ
hls-11379	61	9	median	median	NOUN
hls-11379	61	10	(	(	PUNCT
hls-11379	61	11	min	min	NOUN
hls-11379	61	12	-	-	PUNCT
hls-11379	61	13	max	max	NOUN
hls-11379	61	14	)	)	PUNCT
hls-11379	61	15	46	46	NUM
hls-11379	61	16	(	(	PUNCT
hls-11379	61	17	19	19	NUM
hls-11379	61	18	-	-	SYM
hls-11379	61	19	68	68	NUM
hls-11379	61	20	)	)	PUNCT
hls-11379	61	21	35	35	NUM
hls-11379	61	22	(	(	PUNCT
hls-11379	61	23	19	19	NUM
hls-11379	61	24	-	-	SYM
hls-11379	61	25	66	66	NUM
hls-11379	61	26	)	)	PUNCT
hls-11379	61	27	57	57	NUM
hls-11379	61	28	(	(	PUNCT
hls-11379	61	29	29	29	NUM
hls-11379	61	30	-	-	SYM
hls-11379	61	31	68	68	NUM
hls-11379	61	32	)	)	PUNCT
hls-11379	61	33	bmi	bmi	NOUN
hls-11379	61	34	(	(	PUNCT
hls-11379	61	35	kg	kg	NOUN
hls-11379	61	36	/	/	SYM
hls-11379	61	37	m2	m2	PROPN
hls-11379	61	38	)	)	PUNCT
hls-11379	62	1	mean±sd	mean±sd	ADP
hls-11379	62	2	30.4±4.37	30.4±4.37	NUM
hls-11379	62	3	28.8±4.3	28.8±4.3	NUM
hls-11379	62	4	32±3.9	32±3.9	NUM
hls-11379	62	5	t=3.963	t=3.963	NUM
hls-11379	62	6	*	*	PUNCT
hls-11379	62	7	<	<	X
hls-11379	62	8	0.001	0.001	NUM
hls-11379	62	9	*	*	ADJ
hls-11379	62	10	median	median	NOUN
hls-11379	62	11	(	(	PUNCT
hls-11379	62	12	min	min	NOUN
hls-11379	62	13	-	-	PUNCT
hls-11379	62	14	max	max	NOUN
hls-11379	62	15	)	)	PUNCT
hls-11379	62	16	30.5	30.5	NUM
hls-11379	62	17	(	(	PUNCT
hls-11379	62	18	18.5	18.5	NUM
hls-11379	62	19	-	-	SYM
hls-11379	62	20	38	38	NUM
hls-11379	62	21	)	)	PUNCT
hls-11379	62	22	29.0	29.0	NUM
hls-11379	62	23	(	(	PUNCT
hls-11379	62	24	18.5	18.5	NUM
hls-11379	62	25	-	-	SYM
hls-11379	62	26	37.0	37.0	NUM
hls-11379	62	27	)	)	PUNCT
hls-11379	62	28	32	32	NUM
hls-11379	62	29	(	(	PUNCT
hls-11379	62	30	26	26	NUM
hls-11379	62	31	-	-	SYM
hls-11379	62	32	38	38	NUM
hls-11379	62	33	)	)	PUNCT
hls-11379	62	34	sd	sd	NOUN
hls-11379	62	35	,	,	PUNCT
hls-11379	62	36	standard	standard	ADJ
hls-11379	62	37	deviation	deviation	NOUN
hls-11379	62	38	;	;	PUNCT
hls-11379	62	39	χ2	χ2	PROPN
hls-11379	62	40	,	,	PUNCT
hls-11379	62	41	chi	chi	ADJ
hls-11379	62	42	-	-	PUNCT
hls-11379	62	43	square	square	NOUN
hls-11379	62	44	test	test	NOUN
hls-11379	62	45	;	;	PUNCT
hls-11379	62	46	t	t	X
hls-11379	62	47	,	,	PUNCT
hls-11379	62	48	student	student	NOUN
hls-11379	62	49	t	t	PROPN
hls-11379	62	50	-	-	PUNCT
hls-11379	62	51	test	test	NOUN
hls-11379	62	52	;	;	PUNCT
hls-11379	62	53	u	u	NOUN
hls-11379	62	54	,	,	PUNCT
hls-11379	62	55	mann	mann	PROPN
hls-11379	62	56	-	-	PUNCT
hls-11379	62	57	whitney	whitney	PROPN
hls-11379	62	58	test	test	NOUN
hls-11379	62	59	.	.	PUNCT
hls-11379	63	1	*	*	PUNCT
hls-11379	63	2	statistically	statistically	ADV
hls-11379	63	3	significant	significant	ADJ
hls-11379	63	4	at	at	ADP
hls-11379	63	5	p≤0.05	p≤0.05	NOUN
hls-11379	63	6	.	.	PUNCT
hls-11379	64	1	[	[	X
hls-11379	64	2	healthcare	healthcare	NOUN
hls-11379	64	3	in	in	ADP
hls-11379	64	4	low	low	ADJ
hls-11379	64	5	-	-	PUNCT
hls-11379	64	6	resource	resource	NOUN
hls-11379	64	7	settings	setting	NOUN
hls-11379	64	8	2023	2023	NUM
hls-11379	64	9	;	;	PUNCT
hls-11379	65	1	11(s2):11379	11(s2):11379	NUM
hls-11379	65	2	]	]	X
hls-11379	66	1	[	[	X
hls-11379	66	2	page	page	NOUN
hls-11379	66	3	13	13	NUM
hls-11379	66	4	]	]	PUNCT
hls-11379	66	5	non	non	ADJ
hls-11379	66	6	-co	-co	PROPN
hls-11379	66	7	mmerc	mmerc	PROPN
hls-11379	66	8	ial	ial	PROPN
hls-11379	66	9	us	us	PROPN
hls-11379	66	10	e	e	NOUN
hls-11379	66	11	o	o	PROPN
hls-11379	66	12	nly	nly	ADV
hls-11379	66	13	the	the	DET
hls-11379	66	14	relation	relation	NOUN
hls-11379	66	15	between	between	ADP
hls-11379	66	16	nafld	nafld	ADJ
hls-11379	66	17	and	and	CCONJ
hls-11379	66	18	h.	h.	PROPN
hls-11379	66	19	pylori	pylori	NOUN
hls-11379	66	20	infection	infection	NOUN
hls-11379	66	21	was	be	AUX
hls-11379	66	22	examined	examine	VERB
hls-11379	66	23	,	,	PUNCT
hls-11379	66	24	revealing	reveal	VERB
hls-11379	66	25	a	a	DET
hls-11379	66	26	prevalence	prevalence	NOUN
hls-11379	66	27	of	of	ADP
hls-11379	66	28	h.	h.	PROPN
hls-11379	66	29	pylori	pylori	ADJ
hls-11379	66	30	infection	infection	NOUN
hls-11379	66	31	in	in	ADP
hls-11379	66	32	patients	patient	NOUN
hls-11379	66	33	with	with	ADP
hls-11379	66	34	nafld	nafld	PROPN
hls-11379	66	35	was	be	AUX
hls-11379	66	36	68	68	NUM
hls-11379	66	37	%	%	NOUN
hls-11379	66	38	and	and	CCONJ
hls-11379	66	39	in	in	ADP
hls-11379	66	40	patients	patient	NOUN
hls-11379	66	41	without	without	ADP
hls-11379	66	42	nafld	nafld	ADJ
hls-11379	66	43	32	32	NUM
hls-11379	66	44	%	%	NOUN
hls-11379	66	45	.	.	PUNCT
hls-11379	67	1	additionally	additionally	ADV
hls-11379	67	2	,	,	PUNCT
hls-11379	67	3	we	we	PRON
hls-11379	67	4	found	find	VERB
hls-11379	67	5	that	that	SCONJ
hls-11379	67	6	the	the	DET
hls-11379	67	7	mean	mean	ADJ
hls-11379	67	8	elastography	elastography	NOUN
hls-11379	67	9	value	value	NOUN
hls-11379	67	10	in	in	ADP
hls-11379	67	11	h.	h.	PROPN
hls-11379	67	12	pylori	pylori	NOUN
hls-11379	67	13	+	+	PROPN
hls-11379	67	14	ve	ve	VERB
hls-11379	67	15	patients	patient	NOUN
hls-11379	67	16	was	be	AUX
hls-11379	67	17	250.4±33.59	250.4±33.59	NUM
hls-11379	67	18	db	db	PROPN
hls-11379	67	19	/	/	SYM
hls-11379	67	20	m	m	PROPN
hls-11379	67	21	,	,	PUNCT
hls-11379	67	22	while	while	SCONJ
hls-11379	67	23	the	the	DET
hls-11379	67	24	mean	mean	NOUN
hls-11379	67	25	in	in	ADP
hls-11379	67	26	h.	h.	PROPN
hls-11379	67	27	pylori	pylori	PROPN
hls-11379	67	28	-	-	PUNCT
hls-11379	67	29	ve	ve	VERB
hls-11379	67	30	patients	patient	NOUN
hls-11379	67	31	was	be	AUX
hls-11379	67	32	229.3±33.83	229.3±33.83	NUM
hls-11379	67	33	db	db	PROPN
hls-11379	67	34	/	/	SYM
hls-11379	67	35	m	m	PROPN
hls-11379	67	36	,	,	PUNCT
hls-11379	67	37	p=0.002	p=0.002	X
hls-11379	67	38	(	(	PUNCT
hls-11379	67	39	table	table	NOUN
hls-11379	67	40	3	3	NUM
hls-11379	67	41	)	)	PUNCT
hls-11379	67	42	.	.	PUNCT
hls-11379	68	1	furthermore	furthermore	ADV
hls-11379	68	2	,	,	PUNCT
hls-11379	68	3	h.	h.	PROPN
hls-11379	68	4	pylori	pylori	NOUN
hls-11379	68	5	was	be	AUX
hls-11379	68	6	found	find	VERB
hls-11379	68	7	to	to	PART
hls-11379	68	8	have	have	VERB
hls-11379	68	9	a	a	DET
hls-11379	68	10	significant	significant	ADJ
hls-11379	68	11	prognostic	prognostic	ADJ
hls-11379	68	12	performance	performance	NOUN
hls-11379	68	13	of	of	ADP
hls-11379	68	14	h.	h.	PROPN
hls-11379	68	15	pylori	pylori	ADJ
hls-11379	68	16	infection	infection	NOUN
hls-11379	68	17	with	with	ADP
hls-11379	68	18	elastography	elastography	NOUN
hls-11379	68	19	values	value	NOUN
hls-11379	68	20	≥248	≥248	PRON
hls-11379	68	21	db	db	PROPN
hls-11379	68	22	/	/	SYM
hls-11379	68	23	m	m	PROPN
hls-11379	68	24	,	,	PUNCT
hls-11379	68	25	(	(	PUNCT
hls-11379	68	26	95	95	NUM
hls-11379	68	27	%	%	NOUN
hls-11379	68	28	ci	ci	NOUN
hls-11379	68	29	0.582	0.582	NUM
hls-11379	68	30	-	-	PUNCT
hls-11379	68	31	0.794	0.794	NUM
hls-11379	68	32	,	,	PUNCT
hls-11379	68	33	p=0.001	p=0.001	NUM
hls-11379	68	34	,	,	PUNCT
hls-11379	68	35	sensitivity	sensitivity	NOUN
hls-11379	68	36	68	68	NUM
hls-11379	68	37	%	%	NOUN
hls-11379	68	38	and	and	CCONJ
hls-11379	68	39	specificity	specificity	NOUN
hls-11379	68	40	68	68	NUM
hls-11379	68	41	%	%	NOUN
hls-11379	68	42	;	;	PUNCT
hls-11379	68	43	table	table	NOUN
hls-11379	68	44	4	4	NUM
hls-11379	68	45	,	,	PUNCT
hls-11379	68	46	figure	figure	NOUN
hls-11379	68	47	1	1	NUM
hls-11379	68	48	)	)	PUNCT
hls-11379	68	49	.	.	PUNCT
hls-11379	69	1	assessment	assessment	NOUN
hls-11379	69	2	of	of	ADP
hls-11379	69	3	various	various	ADJ
hls-11379	69	4	biochemical	biochemical	ADJ
hls-11379	69	5	markers	marker	NOUN
hls-11379	69	6	,	,	PUNCT
hls-11379	69	7	demographic	demographic	ADJ
hls-11379	69	8	data	datum	NOUN
hls-11379	69	9	,	,	PUNCT
hls-11379	69	10	and	and	CCONJ
hls-11379	69	11	h.	h.	PROPN
hls-11379	69	12	pylori	pylori	ADJ
hls-11379	69	13	infection	infection	NOUN
hls-11379	69	14	in	in	ADP
hls-11379	69	15	patients	patient	NOUN
hls-11379	69	16	with	with	ADP
hls-11379	69	17	and	and	CCONJ
hls-11379	69	18	without	without	ADP
hls-11379	69	19	nafld	nafld	ADJ
hls-11379	69	20	in	in	ADP
hls-11379	69	21	a	a	DET
hls-11379	69	22	univariate	univariate	ADJ
hls-11379	69	23	analysis	analysis	NOUN
hls-11379	69	24	showed	show	VERB
hls-11379	69	25	that	that	SCONJ
hls-11379	69	26	age	age	NOUN
hls-11379	69	27	,	,	PUNCT
hls-11379	69	28	bmi	bmi	NOUN
hls-11379	69	29	,	,	PUNCT
hls-11379	69	30	and	and	CCONJ
hls-11379	69	31	h.	h.	PROPN
hls-11379	69	32	pylori	pylori	NOUN
hls-11379	69	33	infection	infection	NOUN
hls-11379	69	34	were	be	AUX
hls-11379	69	35	associated	associate	VERB
hls-11379	69	36	with	with	ADP
hls-11379	69	37	elastography	elastography	NOUN
hls-11379	69	38	≥	≥	NUM
hls-11379	69	39	248	248	NUM
hls-11379	69	40	db	db	PROPN
hls-11379	69	41	/	/	SYM
hls-11379	69	42	m	m	PROPN
hls-11379	69	43	after	after	ADP
hls-11379	69	44	adjustment	adjustment	NOUN
hls-11379	69	45	with	with	ADP
hls-11379	69	46	other	other	ADJ
hls-11379	69	47	variables	variable	NOUN
hls-11379	69	48	.	.	PUNCT
hls-11379	70	1	multivariate	multivariate	NOUN
hls-11379	70	2	analysis	analysis	NOUN
hls-11379	70	3	showed	show	VERB
hls-11379	70	4	that	that	SCONJ
hls-11379	70	5	these	these	DET
hls-11379	70	6	factors	factor	NOUN
hls-11379	70	7	were	be	AUX
hls-11379	70	8	independent	independent	ADJ
hls-11379	70	9	risk	risk	NOUN
hls-11379	70	10	factors	factor	NOUN
hls-11379	70	11	for	for	ADP
hls-11379	70	12	nafld	nafld	ADJ
hls-11379	70	13	(	(	PUNCT
hls-11379	70	14	table	table	NOUN
hls-11379	70	15	5	5	NUM
hls-11379	70	16	)	)	PUNCT
hls-11379	70	17	.	.	PUNCT
hls-11379	71	1	discussion	discussion	NOUN
hls-11379	71	2	non	non	ADJ
hls-11379	71	3	-	-	ADJ
hls-11379	71	4	alcoholic	alcoholic	ADJ
hls-11379	71	5	fatty	fatty	NOUN
hls-11379	71	6	liver	liver	NOUN
hls-11379	71	7	disease	disease	NOUN
hls-11379	71	8	is	be	AUX
hls-11379	71	9	a	a	DET
hls-11379	71	10	common	common	ADJ
hls-11379	71	11	metabolic	metabolic	NOUN
hls-11379	71	12	health	health	NOUN
hls-11379	71	13	problem	problem	NOUN
hls-11379	71	14	that	that	PRON
hls-11379	71	15	has	have	AUX
hls-11379	71	16	become	become	VERB
hls-11379	71	17	a	a	DET
hls-11379	71	18	public	public	ADJ
hls-11379	71	19	health	health	NOUN
hls-11379	71	20	concern	concern	NOUN
hls-11379	71	21	.	.	PUNCT
hls-11379	72	1	the	the	DET
hls-11379	72	2	peak	peak	NOUN
hls-11379	72	3	of	of	ADP
hls-11379	72	4	fatty	fatty	ADJ
hls-11379	72	5	liver	liver	NOUN
hls-11379	72	6	incidence	incidence	NOUN
hls-11379	72	7	is	be	AUX
hls-11379	72	8	between	between	ADP
hls-11379	72	9	40	40	NUM
hls-11379	72	10	-	-	SYM
hls-11379	72	11	50	50	NUM
hls-11379	72	12	years	year	NOUN
hls-11379	72	13	of	of	ADP
hls-11379	72	14	age	age	NOUN
hls-11379	72	15	in	in	ADP
hls-11379	72	16	males	male	NOUN
hls-11379	72	17	and	and	CCONJ
hls-11379	72	18	60	60	NUM
hls-11379	72	19	-	-	SYM
hls-11379	72	20	69	69	NUM
hls-11379	72	21	years	year	NOUN
hls-11379	72	22	in	in	ADP
hls-11379	72	23	females	female	NOUN
hls-11379	72	24	,	,	PUNCT
hls-11379	72	25	with	with	ADP
hls-11379	72	26	minimal	minimal	ADJ
hls-11379	72	27	reduction	reduction	NOUN
hls-11379	72	28	in	in	ADP
hls-11379	72	29	older	old	ADJ
hls-11379	72	30	(	(	PUNCT
hls-11379	72	31	>	>	SYM
hls-11379	72	32	70	70	NUM
hls-11379	72	33	yrs	yr	NOUN
hls-11379	72	34	)	)	PUNCT
hls-11379	72	35	cohorts.16	cohorts.16	NOUN
hls-11379	72	36	in	in	ADP
hls-11379	72	37	a	a	DET
hls-11379	72	38	retrospective	retrospective	ADJ
hls-11379	72	39	cohort	cohort	NOUN
hls-11379	72	40	study	study	NOUN
hls-11379	72	41	conducted	conduct	VERB
hls-11379	72	42	on	on	ADP
hls-11379	72	43	351	351	NUM
hls-11379	72	44	patients	patient	NOUN
hls-11379	72	45	with	with	ADP
hls-11379	72	46	nafld	nafld	ADV
hls-11379	72	47	diagnosed	diagnose	VERB
hls-11379	72	48	by	by	ADP
hls-11379	72	49	biopsy	biopsy	NOUN
hls-11379	72	50	,	,	PUNCT
hls-11379	72	51	the	the	DET
hls-11379	72	52	patients	patient	NOUN
hls-11379	72	53	were	be	AUX
hls-11379	72	54	divided	divide	VERB
hls-11379	72	55	into	into	ADP
hls-11379	72	56	(	(	PUNCT
hls-11379	72	57	≥60	≥60	PROPN
hls-11379	72	58	yrs	yr	NOUN
hls-11379	72	59	)	)	PUNCT
hls-11379	72	60	,	,	PUNCT
hls-11379	72	61	(	(	PUNCT
hls-11379	72	62	≥50	≥50	X
hls-11379	72	63	to	to	ADP
hls-11379	72	64	<	<	X
hls-11379	72	65	60	60	NUM
hls-11379	72	66	yrs	yr	NOUN
hls-11379	72	67	)	)	PUNCT
hls-11379	72	68	,	,	PUNCT
hls-11379	72	69	and	and	CCONJ
hls-11379	72	70	a	a	DET
hls-11379	72	71	younger	young	ADJ
hls-11379	72	72	(	(	PUNCT
hls-11379	72	73	<	<	X
hls-11379	72	74	50	50	NUM
hls-11379	72	75	yrs	yr	NOUN
hls-11379	72	76	)	)	PUNCT
hls-11379	72	77	group	group	NOUN
hls-11379	72	78	.	.	PUNCT
hls-11379	73	1	the	the	DET
hls-11379	73	2	study	study	NOUN
hls-11379	73	3	found	find	VERB
hls-11379	73	4	that	that	SCONJ
hls-11379	73	5	nafld	nafld	ADJ
hls-11379	73	6	was	be	AUX
hls-11379	73	7	more	more	ADV
hls-11379	73	8	prevalent	prevalent	ADJ
hls-11379	73	9	in	in	ADP
hls-11379	73	10	the	the	DET
hls-11379	73	11	middle	middle	NOUN
hls-11379	73	12	-	-	PUNCT
hls-11379	73	13	aged	aged	ADJ
hls-11379	73	14	and	and	CCONJ
hls-11379	73	15	the	the	DET
hls-11379	73	16	elderly.17	elderly.17	PROPN
hls-11379	73	17	in	in	ADP
hls-11379	73	18	our	our	PRON
hls-11379	73	19	study	study	NOUN
hls-11379	73	20	,	,	PUNCT
hls-11379	73	21	we	we	PRON
hls-11379	73	22	found	find	VERB
hls-11379	73	23	that	that	SCONJ
hls-11379	73	24	the	the	DET
hls-11379	73	25	mean	mean	ADJ
hls-11379	73	26	age	age	NOUN
hls-11379	73	27	of	of	ADP
hls-11379	73	28	patients	patient	NOUN
hls-11379	73	29	with	with	ADP
hls-11379	73	30	nafld	nafld	PROPN
hls-11379	73	31	was	be	AUX
hls-11379	73	32	52.5±12.4	52.5±12.4	NUM
hls-11379	73	33	years	year	NOUN
hls-11379	73	34	and	and	CCONJ
hls-11379	73	35	in	in	ADP
hls-11379	73	36	patients	patient	NOUN
hls-11379	73	37	without	without	ADP
hls-11379	73	38	nafld	nafld	ADJ
hls-11379	73	39	it	it	PRON
hls-11379	73	40	was	be	AUX
hls-11379	73	41	38.2±14.3	38.2±14.3	NUM
hls-11379	73	42	years	year	NOUN
hls-11379	73	43	.	.	PUNCT
hls-11379	74	1	hence	hence	ADV
hls-11379	74	2	,	,	PUNCT
hls-11379	74	3	confirming	confirm	VERB
hls-11379	74	4	that	that	SCONJ
hls-11379	74	5	the	the	DET
hls-11379	74	6	incidence	incidence	NOUN
hls-11379	74	7	increases	increase	VERB
hls-11379	74	8	with	with	ADP
hls-11379	74	9	age	age	NOUN
hls-11379	74	10	and	and	CCONJ
hls-11379	74	11	it	it	PRON
hls-11379	74	12	is	be	AUX
hls-11379	74	13	an	an	DET
hls-11379	74	14	independent	independent	ADJ
hls-11379	74	15	risk	risk	NOUN
hls-11379	74	16	factor	factor	NOUN
hls-11379	74	17	for	for	ADP
hls-11379	74	18	nafld	nafld	PROPN
hls-11379	74	19	.	.	PUNCT
hls-11379	75	1	this	this	PRON
hls-11379	75	2	is	be	AUX
hls-11379	75	3	probably	probably	ADV
hls-11379	75	4	due	due	ADJ
hls-11379	75	5	to	to	ADP
hls-11379	75	6	an	an	DET
hls-11379	75	7	increase	increase	NOUN
hls-11379	75	8	in	in	ADP
hls-11379	75	9	all	all	DET
hls-11379	75	10	risk	risk	NOUN
hls-11379	75	11	factors	factor	NOUN
hls-11379	75	12	for	for	ADP
hls-11379	75	13	fatty	fatty	ADJ
hls-11379	75	14	liver	liver	NOUN
hls-11379	75	15	in	in	ADP
hls-11379	75	16	older	old	ADJ
hls-11379	75	17	age	age	NOUN
hls-11379	75	18	groups	group	NOUN
hls-11379	75	19	such	such	ADJ
hls-11379	75	20	as	as	ADP
hls-11379	75	21	hypertension	hypertension	NOUN
hls-11379	75	22	,	,	PUNCT
hls-11379	75	23	diabetes	diabetes	NOUN
hls-11379	75	24	,	,	PUNCT
hls-11379	75	25	hyperlipidemia	hyperlipidemia	NOUN
hls-11379	75	26	,	,	PUNCT
hls-11379	75	27	and	and	CCONJ
hls-11379	75	28	obesity	obesity	NOUN
hls-11379	75	29	.	.	PUNCT
hls-11379	76	1	according	accord	VERB
hls-11379	76	2	to	to	ADP
hls-11379	76	3	previous	previous	ADJ
hls-11379	76	4	longitudinal	longitudinal	ADJ
hls-11379	76	5	studies	study	NOUN
hls-11379	76	6	,	,	PUNCT
hls-11379	76	7	nafld	nafld	ADV
hls-11379	76	8	is	be	AUX
hls-11379	76	9	more	more	ADV
hls-11379	76	10	common	common	ADJ
hls-11379	76	11	in	in	ADP
hls-11379	76	12	males	male	NOUN
hls-11379	76	13	as	as	SCONJ
hls-11379	76	14	compared	compare	VERB
hls-11379	76	15	to	to	ADP
hls-11379	76	16	females.18	females.18	PROPN
hls-11379	76	17	however	however	ADV
hls-11379	76	18	,	,	PUNCT
hls-11379	76	19	a	a	DET
hls-11379	76	20	study	study	NOUN
hls-11379	76	21	specifically	specifically	ADV
hls-11379	76	22	investigating	investigate	VERB
hls-11379	76	23	nafld	nafld	ADV
hls-11379	76	24	in	in	ADP
hls-11379	76	25	females	female	NOUN
hls-11379	76	26	found	find	VERB
hls-11379	76	27	that	that	SCONJ
hls-11379	76	28	the	the	DET
hls-11379	76	29	incidence	incidence	NOUN
hls-11379	76	30	is	be	AUX
hls-11379	76	31	higher	high	ADJ
hls-11379	76	32	in	in	ADP
hls-11379	76	33	menopausal	menopausal	ADJ
hls-11379	76	34	females	female	NOUN
hls-11379	76	35	(	(	PUNCT
hls-11379	76	36	7.5	7.5	NUM
hls-11379	76	37	%	%	NOUN
hls-11379	76	38	)	)	PUNCT
hls-11379	76	39	and	and	CCONJ
hls-11379	76	40	postmenopausal	postmenopausal	ADJ
hls-11379	76	41	females	female	NOUN
hls-11379	76	42	(	(	PUNCT
hls-11379	76	43	6.1	6.1	NUM
hls-11379	76	44	%	%	NOUN
hls-11379	76	45	)	)	PUNCT
hls-11379	76	46	than	than	ADP
hls-11379	76	47	in	in	ADP
hls-11379	76	48	premenopausal	premenopausal	NOUN
hls-11379	76	49	females	female	NOUN
hls-11379	76	50	(	(	PUNCT
hls-11379	76	51	3.5	3.5	NUM
hls-11379	76	52	%	%	NOUN
hls-11379	76	53	)	)	PUNCT
hls-11379	76	54	.	.	PUNCT
hls-11379	77	1	the	the	DET
hls-11379	77	2	study	study	NOUN
hls-11379	77	3	also	also	ADV
hls-11379	77	4	reported	report	VERB
hls-11379	77	5	that	that	SCONJ
hls-11379	77	6	postmenopausal	postmenopausal	ADJ
hls-11379	77	7	women	woman	NOUN
hls-11379	77	8	had	have	VERB
hls-11379	77	9	an	an	DET
hls-11379	77	10	increased	increase	VERB
hls-11379	77	11	risk	risk	NOUN
hls-11379	77	12	of	of	ADP
hls-11379	77	13	nafld	nafld	ADV
hls-11379	77	14	at	at	ADP
hls-11379	77	15	univariate	univariate	ADJ
hls-11379	77	16	but	but	CCONJ
hls-11379	77	17	not	not	PART
hls-11379	77	18	at	at	ADP
hls-11379	77	19	multivariate	multivariate	NOUN
hls-11379	77	20	analysis	analysis	NOUN
hls-11379	77	21	after	after	ADP
hls-11379	77	22	adjustment	adjustment	NOUN
hls-11379	77	23	for	for	ADP
hls-11379	77	24	age	age	NOUN
hls-11379	77	25	,	,	PUNCT
hls-11379	77	26	metabolic	metabolic	NOUN
hls-11379	77	27	syndrome	syndrome	NOUN
hls-11379	77	28	,	,	PUNCT
hls-11379	77	29	and	and	CCONJ
hls-11379	77	30	bmi.19	bmi.19	NOUN
hls-11379	77	31	in	in	ADP
hls-11379	77	32	our	our	PRON
hls-11379	77	33	study	study	NOUN
hls-11379	77	34	,	,	PUNCT
hls-11379	77	35	we	we	PRON
hls-11379	77	36	found	find	VERB
hls-11379	77	37	that	that	SCONJ
hls-11379	77	38	the	the	DET
hls-11379	77	39	incidence	incidence	NOUN
hls-11379	77	40	of	of	ADP
hls-11379	77	41	nafld	nafld	ADJ
hls-11379	77	42	is	be	AUX
hls-11379	77	43	more	more	ADV
hls-11379	77	44	common	common	ADJ
hls-11379	77	45	in	in	ADP
hls-11379	77	46	females	female	NOUN
hls-11379	77	47	but	but	CCONJ
hls-11379	77	48	was	be	AUX
hls-11379	77	49	not	not	PART
hls-11379	77	50	statistically	statistically	ADV
hls-11379	77	51	significant	significant	ADJ
hls-11379	77	52	,	,	PUNCT
hls-11379	77	53	this	this	PRON
hls-11379	77	54	may	may	AUX
hls-11379	77	55	be	be	AUX
hls-11379	77	56	due	due	ADJ
hls-11379	77	57	to	to	ADP
hls-11379	77	58	the	the	DET
hls-11379	77	59	increased	increase	VERB
hls-11379	77	60	age	age	NOUN
hls-11379	77	61	of	of	ADP
hls-11379	77	62	patients	patient	NOUN
hls-11379	77	63	with	with	ADP
hls-11379	77	64	nafld	nafld	ADJ
hls-11379	77	65	in	in	ADP
hls-11379	77	66	our	our	PRON
hls-11379	77	67	study	study	NOUN
hls-11379	77	68	,	,	PUNCT
hls-11379	77	69	and	and	CCONJ
hls-11379	77	70	the	the	DET
hls-11379	77	71	fact	fact	NOUN
hls-11379	77	72	that	that	SCONJ
hls-11379	77	73	most	most	ADJ
hls-11379	77	74	of	of	ADP
hls-11379	77	75	the	the	DET
hls-11379	77	76	females	female	NOUN
hls-11379	77	77	studied	study	VERB
hls-11379	77	78	were	be	AUX
hls-11379	77	79	postmenopausal	postmenopausal	ADJ
hls-11379	77	80	.	.	PUNCT
hls-11379	78	1	female	female	ADJ
hls-11379	78	2	sex	sex	NOUN
hls-11379	78	3	hormones	hormone	NOUN
hls-11379	78	4	are	be	AUX
hls-11379	78	5	known	know	VERB
hls-11379	78	6	to	to	PART
hls-11379	78	7	protect	protect	VERB
hls-11379	78	8	against	against	ADP
hls-11379	78	9	dysmetabolism	dysmetabolism	NOUN
hls-11379	78	10	and	and	CCONJ
hls-11379	78	11	promote	promote	VERB
hls-11379	78	12	the	the	DET
hls-11379	78	13	division	division	NOUN
hls-11379	78	14	of	of	ADP
hls-11379	78	15	fatty	fatty	ADJ
hls-11379	78	16	acids	acid	NOUN
hls-11379	78	17	into	into	ADP
hls-11379	78	18	ketone	ketone	NOUN
hls-11379	78	19	bodies	body	NOUN
hls-11379	78	20	rather	rather	ADV
hls-11379	78	21	than	than	ADP
hls-11379	78	22	into	into	ADP
hls-11379	78	23	very	very	ADV
hls-11379	78	24	low	low	ADJ
hls-11379	78	25	-	-	PUNCT
hls-11379	78	26	density	density	NOUN
hls-11379	78	27	lipoprotein	lipoprotein	NOUN
hls-11379	78	28	-	-	PUNCT
hls-11379	78	29	triacylglycerol	triacylglycerol	NOUN
hls-11379	78	30	.	.	PUNCT
hls-11379	79	1	the	the	DET
hls-11379	79	2	senescence	senescence	NOUN
hls-11379	79	3	of	of	ADP
hls-11379	79	4	the	the	DET
hls-11379	79	5	article	article	NOUN
hls-11379	79	6	table	table	NOUN
hls-11379	79	7	2	2	NUM
hls-11379	79	8	.	.	X
hls-11379	79	9	relation	relation	NOUN
hls-11379	79	10	between	between	ADP
hls-11379	79	11	elastography	elastography	NOUN
hls-11379	79	12	and	and	CCONJ
hls-11379	79	13	different	different	ADJ
hls-11379	79	14	parameters	parameter	NOUN
hls-11379	79	15	.	.	PUNCT
hls-11379	80	1	total	total	ADJ
hls-11379	80	2	n=100	n=100	NUM
hls-11379	80	3	elastography	elastography	NOUN
hls-11379	80	4	test	test	NOUN
hls-11379	80	5	of	of	ADP
hls-11379	80	6	sig	sig	NOUN
hls-11379	80	7	.	.	PUNCT
hls-11379	81	1	p	p	X
hls-11379	81	2	≤248	≤248	PROPN
hls-11379	81	3	db	db	PROPN
hls-11379	81	4	/	/	SYM
hls-11379	81	5	m	m	PROPN
hls-11379	81	6	>	>	X
hls-11379	81	7	248	248	NUM
hls-11379	81	8	db	db	PROPN
hls-11379	81	9	/	/	SYM
hls-11379	81	10	m	m	NOUN
hls-11379	81	11	alt	alt	NOUN
hls-11379	81	12	mean±sd	mean±sd	ADP
hls-11379	81	13	28.7±23.1	28.7±23.1	NUM
hls-11379	81	14	24.2±12.8	24.2±12.8	NUM
hls-11379	81	15	33.3±29.6	33.3±29.6	NUM
hls-11379	81	16	u=1014.0	u=1014.0	VERB
hls-11379	81	17	0.103	0.103	NUM
hls-11379	81	18	median	median	NOUN
hls-11379	81	19	(	(	PUNCT
hls-11379	81	20	min	min	NOUN
hls-11379	81	21	-	-	PUNCT
hls-11379	81	22	max	max	NOUN
hls-11379	81	23	)	)	PUNCT
hls-11379	81	24	23	23	NUM
hls-11379	81	25	(	(	PUNCT
hls-11379	81	26	10	10	NUM
hls-11379	81	27	-	-	SYM
hls-11379	81	28	153	153	NUM
hls-11379	81	29	)	)	PUNCT
hls-11379	81	30	20	20	NUM
hls-11379	81	31	(	(	PUNCT
hls-11379	81	32	11	11	NUM
hls-11379	81	33	-	-	SYM
hls-11379	81	34	72	72	NUM
hls-11379	81	35	)	)	PUNCT
hls-11379	81	36	23	23	NUM
hls-11379	81	37	(	(	PUNCT
hls-11379	81	38	10	10	NUM
hls-11379	81	39	-	-	SYM
hls-11379	81	40	153	153	NUM
hls-11379	81	41	)	)	PUNCT
hls-11379	81	42	ast	ast	NOUN
hls-11379	81	43	mean±sd	mean±sd	ADP
hls-11379	81	44	25.6±16.5	25.6±16.5	NUM
hls-11379	81	45	22.9±8.49	22.9±8.49	NUM
hls-11379	81	46	28.3±21.5	28.3±21.5	NUM
hls-11379	82	1	u=1046.0	u=1046.0	ADP
hls-11379	82	2	0.159	0.159	NUM
hls-11379	82	3	median	median	NOUN
hls-11379	82	4	(	(	PUNCT
hls-11379	82	5	min	min	NOUN
hls-11379	82	6	-	-	PUNCT
hls-11379	82	7	max	max	NOUN
hls-11379	82	8	)	)	PUNCT
hls-11379	82	9	22	22	NUM
hls-11379	82	10	(	(	PUNCT
hls-11379	82	11	11	11	NUM
hls-11379	82	12	-	-	SYM
hls-11379	82	13	125	125	NUM
hls-11379	82	14	)	)	PUNCT
hls-11379	82	15	22	22	NUM
hls-11379	82	16	(	(	PUNCT
hls-11379	82	17	13	13	NUM
hls-11379	82	18	-	-	SYM
hls-11379	82	19	49	49	NUM
hls-11379	82	20	)	)	PUNCT
hls-11379	82	21	26	26	NUM
hls-11379	82	22	(	(	PUNCT
hls-11379	82	23	11	11	NUM
hls-11379	82	24	-	-	SYM
hls-11379	82	25	125	125	NUM
hls-11379	82	26	)	)	PUNCT
hls-11379	82	27	total	total	ADJ
hls-11379	82	28	cholesterol	cholesterol	NOUN
hls-11379	82	29	mean±sd	mean±sd	PROPN
hls-11379	82	30	.	.	PUNCT
hls-11379	82	31	183.7±30	183.7±30	PROPN
hls-11379	83	1	181.6±26.0	181.6±26.0	NUM
hls-11379	83	2	185.8±33.6	185.8±33.6	PROPN
hls-11379	83	3	t	t	NOUN
hls-11379	83	4	0.692	0.692	NUM
hls-11379	83	5	0.490	0.490	NUM
hls-11379	83	6	median	median	NOUN
hls-11379	83	7	(	(	PUNCT
hls-11379	83	8	min.-max	min.-max	X
hls-11379	83	9	.	.	PROPN
hls-11379	83	10	)	)	PUNCT
hls-11379	84	1	181	181	NUM
hls-11379	85	1	(	(	PUNCT
hls-11379	85	2	105	105	NUM
hls-11379	85	3	-	-	SYM
hls-11379	85	4	254	254	NUM
hls-11379	85	5	)	)	PUNCT
hls-11379	85	6	180	180	NUM
hls-11379	85	7	(	(	PUNCT
hls-11379	85	8	137	137	NUM
hls-11379	85	9	-	-	SYM
hls-11379	85	10	245	245	NUM
hls-11379	85	11	)	)	PUNCT
hls-11379	85	12	182	182	NUM
hls-11379	85	13	(	(	PUNCT
hls-11379	85	14	105	105	NUM
hls-11379	85	15	-	-	SYM
hls-11379	85	16	254	254	NUM
hls-11379	85	17	)	)	PUNCT
hls-11379	85	18	ldl	ldl	NOUN
hls-11379	85	19	mean±sd	mean±sd	ADP
hls-11379	85	20	100.7±22.5	100.7±22.5	NUM
hls-11379	85	21	98.5±22	98.5±22	PROPN
hls-11379	85	22	102.9±23.1	102.9±23.1	ADJ
hls-11379	85	23	t=0.985	t=0.985	NOUN
hls-11379	85	24	0.327	0.327	NUM
hls-11379	85	25	median	median	NOUN
hls-11379	85	26	(	(	PUNCT
hls-11379	85	27	min	min	NOUN
hls-11379	85	28	-	-	PUNCT
hls-11379	85	29	max	max	NOUN
hls-11379	85	30	)	)	PUNCT
hls-11379	85	31	95	95	NUM
hls-11379	85	32	(	(	PUNCT
hls-11379	85	33	59	59	NUM
hls-11379	85	34	-	-	SYM
hls-11379	85	35	157	157	NUM
hls-11379	85	36	)	)	PUNCT
hls-11379	85	37	93	93	NUM
hls-11379	85	38	(	(	PUNCT
hls-11379	85	39	68	68	NUM
hls-11379	85	40	-	-	SYM
hls-11379	85	41	155	155	NUM
hls-11379	85	42	)	)	PUNCT
hls-11379	85	43	100	100	NUM
hls-11379	85	44	(	(	PUNCT
hls-11379	85	45	59	59	NUM
hls-11379	85	46	-	-	SYM
hls-11379	85	47	157	157	NUM
hls-11379	85	48	)	)	PUNCT
hls-11379	85	49	hdl	hdl	PROPN
hls-11379	85	50	mean±sd	mean±sd	ADP
hls-11379	85	51	49.96±8.80	49.96±8.80	NUM
hls-11379	85	52	50.5±8.84	50.5±8.84	NUM
hls-11379	85	53	49.4±8.83	49.4±8.83	NUM
hls-11379	85	54	t=0.589	t=0.589	NOUN
hls-11379	85	55	0.557	0.557	NUM
hls-11379	85	56	median	median	NOUN
hls-11379	85	57	(	(	PUNCT
hls-11379	85	58	min	min	NOUN
hls-11379	85	59	-	-	PUNCT
hls-11379	85	60	max	max	NOUN
hls-11379	85	61	)	)	PUNCT
hls-11379	85	62	49	49	NUM
hls-11379	85	63	(	(	PUNCT
hls-11379	85	64	29	29	NUM
hls-11379	85	65	-	-	SYM
hls-11379	85	66	74	74	NUM
hls-11379	85	67	)	)	PUNCT
hls-11379	85	68	53	53	NUM
hls-11379	85	69	(	(	PUNCT
hls-11379	85	70	29	29	NUM
hls-11379	85	71	-	-	SYM
hls-11379	85	72	67	67	NUM
hls-11379	85	73	)	)	PUNCT
hls-11379	85	74	46	46	NUM
hls-11379	85	75	(	(	PUNCT
hls-11379	85	76	38	38	NUM
hls-11379	85	77	-	-	SYM
hls-11379	85	78	74	74	NUM
hls-11379	85	79	)	)	PUNCT
hls-11379	85	80	triglyceride	triglyceride	ADP
hls-11379	85	81	mean±sd	mean±sd	ADP
hls-11379	85	82	114.8±46.49	114.8±46.49	NUM
hls-11379	85	83	112.4±44.52	112.4±44.52	NUM
hls-11379	85	84	117.2±48.72	117.2±48.72	NUM
hls-11379	85	85	u=1250.0	u=1250.0	NUM
hls-11379	85	86	1.000	1.000	NUM
hls-11379	85	87	median	median	NOUN
hls-11379	85	88	(	(	PUNCT
hls-11379	85	89	min	min	NOUN
hls-11379	85	90	-	-	PUNCT
hls-11379	85	91	max	max	NOUN
hls-11379	85	92	)	)	PUNCT
hls-11379	85	93	96.5	96.5	NUM
hls-11379	85	94	(	(	PUNCT
hls-11379	85	95	51	51	NUM
hls-11379	85	96	-	-	SYM
hls-11379	85	97	246	246	NUM
hls-11379	85	98	)	)	PUNCT
hls-11379	85	99	98	98	NUM
hls-11379	85	100	(	(	PUNCT
hls-11379	85	101	51	51	NUM
hls-11379	85	102	-	-	SYM
hls-11379	85	103	246	246	NUM
hls-11379	85	104	)	)	PUNCT
hls-11379	85	105	94	94	NUM
hls-11379	85	106	(	(	PUNCT
hls-11379	85	107	60	60	NUM
hls-11379	85	108	-	-	SYM
hls-11379	85	109	225	225	NUM
hls-11379	85	110	)	)	PUNCT
hls-11379	86	1	h.	h.	NOUN
hls-11379	86	2	pylori	pylori	NOUN
hls-11379	86	3	(	(	PUNCT
hls-11379	86	4	%	%	INTJ
hls-11379	86	5	)	)	PUNCT
hls-11379	86	6	50	50	NUM
hls-11379	86	7	16	16	NUM
hls-11379	86	8	34	34	NUM
hls-11379	86	9	χ2=12.96	χ2=12.96	NUM
hls-11379	86	10	*	*	PUNCT
hls-11379	87	1	<	<	X
hls-11379	87	2	0.001	0.001	NUM
hls-11379	87	3	*	*	SYM
hls-11379	87	4	sd	sd	NOUN
hls-11379	87	5	,	,	PUNCT
hls-11379	87	6	standard	standard	ADJ
hls-11379	87	7	deviation	deviation	NOUN
hls-11379	87	8	;	;	PUNCT
hls-11379	87	9	t	t	PROPN
hls-11379	87	10	,	,	PUNCT
hls-11379	87	11	student	student	NOUN
hls-11379	87	12	t	t	PROPN
hls-11379	87	13	-	-	PUNCT
hls-11379	87	14	test	test	NOUN
hls-11379	87	15	;	;	PUNCT
hls-11379	87	16	u	u	NOUN
hls-11379	87	17	,	,	PUNCT
hls-11379	87	18	mann	mann	PROPN
hls-11379	87	19	-	-	PUNCT
hls-11379	87	20	whitney	whitney	PROPN
hls-11379	87	21	test	test	NOUN
hls-11379	87	22	;	;	PUNCT
hls-11379	87	23	χ2	χ2	PROPN
hls-11379	87	24	,	,	PUNCT
hls-11379	87	25	chi	chi	ADJ
hls-11379	87	26	-	-	PUNCT
hls-11379	87	27	square	square	ADJ
hls-11379	87	28	test	test	NOUN
hls-11379	87	29	.	.	PUNCT
hls-11379	88	1	*	*	PUNCT
hls-11379	88	2	statistically	statistically	ADV
hls-11379	88	3	significant	significant	ADJ
hls-11379	88	4	at	at	ADP
hls-11379	88	5	p≤0.05	p≤0.05	NOUN
hls-11379	88	6	figure	figure	NOUN
hls-11379	88	7	1	1	NUM
hls-11379	88	8	.	.	PUNCT
hls-11379	89	1	roc	roc	PROPN
hls-11379	89	2	curve	curve	NOUN
hls-11379	89	3	for	for	ADP
hls-11379	89	4	elastography	elastography	NOUN
hls-11379	89	5	to	to	PART
hls-11379	89	6	prognoses	prognosis	NOUN
hls-11379	89	7	positive	positive	ADJ
hls-11379	89	8	h.	h.	NOUN
hls-11379	89	9	pylori	pylori	NOUN
hls-11379	89	10	patients	patient	NOUN
hls-11379	89	11	.	.	PUNCT
hls-11379	90	1	[	[	X
hls-11379	90	2	page	page	NOUN
hls-11379	90	3	14	14	NUM
hls-11379	90	4	]	]	PUNCT
hls-11379	91	1	[	[	X
hls-11379	91	2	healthcare	healthcare	NOUN
hls-11379	91	3	in	in	ADP
hls-11379	91	4	low	low	ADJ
hls-11379	91	5	-	-	PUNCT
hls-11379	91	6	resource	resource	NOUN
hls-11379	91	7	settings	setting	NOUN
hls-11379	91	8	2023	2023	NUM
hls-11379	91	9	;	;	PUNCT
hls-11379	91	10	11(s2):11379	11(s2):11379	NUM
hls-11379	91	11	]	]	X
hls-11379	91	12	non	non	ADJ
hls-11379	91	13	-co	-co	PROPN
hls-11379	91	14	mmerc	mmerc	PROPN
hls-11379	91	15	ial	ial	PROPN
hls-11379	91	16	us	us	PROPN
hls-11379	91	17	e	e	NOUN
hls-11379	91	18	o	o	NOUN
hls-11379	91	19	nly	nly	ADV
hls-11379	91	20	ovaries	ovary	NOUN
hls-11379	91	21	also	also	ADV
hls-11379	91	22	increases	increase	VERB
hls-11379	91	23	the	the	DET
hls-11379	91	24	formation	formation	NOUN
hls-11379	91	25	of	of	ADP
hls-11379	91	26	hepatic	hepatic	ADJ
hls-11379	91	27	steatosis	steatosis	NOUN
hls-11379	91	28	and	and	CCONJ
hls-11379	91	29	progression	progression	NOUN
hls-11379	91	30	to	to	ADP
hls-11379	91	31	fibrosis.20	fibrosis.20	NOUN
hls-11379	91	32	obesity	obesity	NOUN
hls-11379	91	33	has	have	AUX
hls-11379	91	34	been	be	AUX
hls-11379	91	35	linked	link	VERB
hls-11379	91	36	to	to	PART
hls-11379	91	37	fatty	fatty	VERB
hls-11379	91	38	liver	liver	NOUN
hls-11379	91	39	disease	disease	NOUN
hls-11379	91	40	in	in	ADP
hls-11379	91	41	all	all	DET
hls-11379	91	42	stages	stage	NOUN
hls-11379	91	43	,	,	PUNCT
hls-11379	91	44	starting	start	VERB
hls-11379	91	45	from	from	ADP
hls-11379	91	46	simple	simple	ADJ
hls-11379	91	47	steatosis	steatosis	NOUN
hls-11379	91	48	to	to	ADP
hls-11379	91	49	steatohepatitis	steatohepatitis	NOUN
hls-11379	91	50	and	and	CCONJ
hls-11379	91	51	fibrosis	fibrosis	NOUN
hls-11379	91	52	.	.	PUNCT
hls-11379	92	1	obesity	obesity	NOUN
hls-11379	92	2	causes	cause	VERB
hls-11379	92	3	the	the	DET
hls-11379	92	4	accumulation	accumulation	NOUN
hls-11379	92	5	of	of	ADP
hls-11379	92	6	fat	fat	ADJ
hls-11379	92	7	inside	inside	ADP
hls-11379	92	8	liver	liver	NOUN
hls-11379	92	9	cells	cell	NOUN
hls-11379	92	10	through	through	ADP
hls-11379	92	11	increasing	increase	VERB
hls-11379	92	12	insulin	insulin	NOUN
hls-11379	92	13	resistance	resistance	NOUN
hls-11379	92	14	and	and	CCONJ
hls-11379	92	15	leads	lead	VERB
hls-11379	92	16	to	to	ADP
hls-11379	92	17	progression	progression	NOUN
hls-11379	92	18	to	to	ADP
hls-11379	92	19	non	non	ADJ
hls-11379	92	20	-	-	ADJ
hls-11379	92	21	alcoholic	alcoholic	ADJ
hls-11379	92	22	steatohepatitis	steatohepatitis	NOUN
hls-11379	92	23	and	and	CCONJ
hls-11379	92	24	its	its	PRON
hls-11379	92	25	related	related	ADJ
hls-11379	92	26	cirrhosis.21	cirrhosis.21	NOUN
hls-11379	92	27	in	in	ADP
hls-11379	92	28	a	a	DET
hls-11379	92	29	cross	cross	ADJ
hls-11379	92	30	-	-	ADJ
hls-11379	92	31	sectional	sectional	ADJ
hls-11379	92	32	study	study	NOUN
hls-11379	92	33	conducted	conduct	VERB
hls-11379	92	34	on	on	ADP
hls-11379	92	35	3202	3202	NUM
hls-11379	92	36	individuals	individual	NOUN
hls-11379	92	37	to	to	PART
hls-11379	92	38	investigate	investigate	VERB
hls-11379	92	39	the	the	DET
hls-11379	92	40	association	association	NOUN
hls-11379	92	41	of	of	ADP
hls-11379	92	42	bmi	bmi	NOUN
hls-11379	92	43	with	with	ADP
hls-11379	92	44	fatty	fatty	NOUN
hls-11379	92	45	liver	liver	NOUN
hls-11379	92	46	found	find	VERB
hls-11379	92	47	that	that	SCONJ
hls-11379	92	48	a	a	DET
hls-11379	92	49	dose	dose	NOUN
hls-11379	92	50	-	-	PUNCT
hls-11379	92	51	response	response	NOUN
hls-11379	92	52	analysis	analysis	NOUN
hls-11379	92	53	with	with	ADP
hls-11379	92	54	adjustment	adjustment	NOUN
hls-11379	92	55	of	of	ADP
hls-11379	92	56	other	other	ADJ
hls-11379	92	57	factors	factor	NOUN
hls-11379	92	58	like	like	ADP
hls-11379	92	59	age	age	NOUN
hls-11379	92	60	,	,	PUNCT
hls-11379	92	61	gender	gender	NOUN
hls-11379	92	62	,	,	PUNCT
hls-11379	92	63	hypertension	hypertension	NOUN
hls-11379	92	64	,	,	PUNCT
hls-11379	92	65	total	total	ADJ
hls-11379	92	66	cholesterol	cholesterol	NOUN
hls-11379	92	67	,	,	PUNCT
hls-11379	92	68	triglycerides	triglyceride	NOUN
hls-11379	92	69	,	,	PUNCT
hls-11379	92	70	glucose	glucose	NOUN
hls-11379	92	71	,	,	PUNCT
hls-11379	92	72	high	high	ADJ
hls-11379	92	73	-	-	PUNCT
hls-11379	92	74	density	density	NOUN
hls-11379	92	75	lipoprotein	lipoprotein	ADJ
hls-11379	92	76	,	,	PUNCT
hls-11379	92	77	low	low	ADJ
hls-11379	92	78	-	-	PUNCT
hls-11379	92	79	density	density	NOUN
hls-11379	92	80	lipoprotein	lipoprotein	ADJ
hls-11379	92	81	,	,	PUNCT
hls-11379	92	82	uric	uric	ADJ
hls-11379	92	83	acid	acid	NOUN
hls-11379	92	84	,	,	PUNCT
hls-11379	92	85	homocysteine	homocysteine	NOUN
hls-11379	92	86	,	,	PUNCT
hls-11379	92	87	creatinine	creatinine	NOUN
hls-11379	92	88	,	,	PUNCT
hls-11379	92	89	aspartate	aspartate	NOUN
hls-11379	92	90	aminotransferase	aminotransferase	NOUN
hls-11379	92	91	,	,	PUNCT
hls-11379	92	92	and	and	CCONJ
hls-11379	92	93	alanine	alanine	NOUN
hls-11379	92	94	transaminase	transaminase	NOUN
hls-11379	92	95	showed	show	VERB
hls-11379	92	96	that	that	SCONJ
hls-11379	92	97	overweight	overweight	NOUN
hls-11379	92	98	and	and	CCONJ
hls-11379	92	99	obesity	obesity	NOUN
hls-11379	92	100	were	be	AUX
hls-11379	92	101	significantly	significantly	ADV
hls-11379	92	102	related	relate	VERB
hls-11379	92	103	to	to	PART
hls-11379	92	104	fatty	fatty	VERB
hls-11379	92	105	liver	liver	NOUN
hls-11379	92	106	risk	risk	NOUN
hls-11379	92	107	(	(	PUNCT
hls-11379	92	108	p=0.004	p=0.004	NOUN
hls-11379	92	109	or	or	CCONJ
hls-11379	92	110	lower	low	ADJ
hls-11379	92	111	)	)	PUNCT
hls-11379	92	112	.	.	PUNCT
hls-11379	93	1	they	they	PRON
hls-11379	93	2	reported	report	VERB
hls-11379	93	3	that	that	SCONJ
hls-11379	93	4	high	high	ADJ
hls-11379	93	5	bmi	bmi	NOUN
hls-11379	93	6	(	(	PUNCT
hls-11379	93	7	overweight	overweight	NOUN
hls-11379	93	8	/	/	SYM
hls-11379	93	9	obesity	obesity	NOUN
hls-11379	93	10	)	)	PUNCT
hls-11379	93	11	is	be	AUX
hls-11379	93	12	an	an	DET
hls-11379	93	13	independent	independent	ADJ
hls-11379	93	14	,	,	PUNCT
hls-11379	93	15	dose	dose	NOUN
hls-11379	93	16	-	-	PUNCT
hls-11379	93	17	dependent	dependent	ADJ
hls-11379	93	18	risk	risk	NOUN
hls-11379	93	19	factor	factor	NOUN
hls-11379	93	20	for	for	ADP
hls-11379	93	21	fatty	fatty	ADJ
hls-11379	93	22	liver.22	liver.22	NOUN
hls-11379	93	23	in	in	ADP
hls-11379	93	24	a	a	DET
hls-11379	93	25	study	study	NOUN
hls-11379	93	26	conducted	conduct	VERB
hls-11379	93	27	on	on	ADP
hls-11379	93	28	the	the	DET
hls-11379	93	29	sudanese	sudanese	ADJ
hls-11379	93	30	population	population	NOUN
hls-11379	93	31	to	to	PART
hls-11379	93	32	assess	assess	VERB
hls-11379	93	33	the	the	DET
hls-11379	93	34	risk	risk	NOUN
hls-11379	93	35	factors	factor	NOUN
hls-11379	93	36	for	for	ADP
hls-11379	93	37	non	non	ADJ
hls-11379	93	38	-	-	ADJ
hls-11379	93	39	alcoholic	alcoholic	ADJ
hls-11379	93	40	fatty	fatty	NOUN
hls-11379	93	41	liver	liver	NOUN
hls-11379	93	42	disease	disease	NOUN
hls-11379	93	43	,	,	PUNCT
hls-11379	93	44	they	they	PRON
hls-11379	93	45	found	find	VERB
hls-11379	93	46	that	that	SCONJ
hls-11379	93	47	increasing	increase	VERB
hls-11379	93	48	age	age	NOUN
hls-11379	93	49	and	and	CCONJ
hls-11379	93	50	obesity	obesity	NOUN
hls-11379	93	51	were	be	AUX
hls-11379	93	52	the	the	DET
hls-11379	93	53	most	most	ADV
hls-11379	93	54	prominent	prominent	ADJ
hls-11379	93	55	predisposing	predispose	VERB
hls-11379	93	56	factors	factor	NOUN
hls-11379	93	57	in	in	ADP
hls-11379	93	58	developing	develop	VERB
hls-11379	93	59	nafld23	nafld23	NOUN
hls-11379	93	60	in	in	ADP
hls-11379	93	61	our	our	PRON
hls-11379	93	62	study	study	NOUN
hls-11379	93	63	,	,	PUNCT
hls-11379	93	64	we	we	PRON
hls-11379	93	65	found	find	VERB
hls-11379	93	66	that	that	SCONJ
hls-11379	93	67	the	the	DET
hls-11379	93	68	mean	mean	ADJ
hls-11379	93	69	bmi	bmi	NOUN
hls-11379	93	70	in	in	ADP
hls-11379	93	71	patients	patient	NOUN
hls-11379	93	72	with	with	ADP
hls-11379	93	73	nafld	nafld	PROPN
hls-11379	93	74	was	be	AUX
hls-11379	93	75	32±3.9	32±3.9	NUM
hls-11379	93	76	kg	kg	NOUN
hls-11379	93	77	/	/	SYM
hls-11379	93	78	m2	m2	PROPN
hls-11379	93	79	,	,	PUNCT
hls-11379	93	80	and	and	CCONJ
hls-11379	93	81	in	in	ADP
hls-11379	93	82	patients	patient	NOUN
hls-11379	93	83	without	without	ADP
hls-11379	93	84	nfld	nfld	PROPN
hls-11379	93	85	it	it	PRON
hls-11379	93	86	was	be	AUX
hls-11379	93	87	28.8±4.3	28.8±4.3	NUM
hls-11379	93	88	kg	kg	NOUN
hls-11379	93	89	/	/	SYM
hls-11379	93	90	m2	m2	PROPN
hls-11379	93	91	,	,	PUNCT
hls-11379	93	92	and	and	CCONJ
hls-11379	93	93	increased	increase	VERB
hls-11379	93	94	bmi	bmi	NOUN
hls-11379	93	95	was	be	AUX
hls-11379	93	96	highly	highly	ADV
hls-11379	93	97	significantly	significantly	ADV
hls-11379	93	98	related	relate	VERB
hls-11379	93	99	to	to	PART
hls-11379	93	100	fatty	fatty	VERB
hls-11379	93	101	liver	liver	NOUN
hls-11379	93	102	p<0.001	p<0.001	NOUN
hls-11379	93	103	and	and	CCONJ
hls-11379	93	104	was	be	AUX
hls-11379	93	105	an	an	DET
hls-11379	93	106	independent	independent	ADJ
hls-11379	93	107	risk	risk	NOUN
hls-11379	93	108	factor	factor	NOUN
hls-11379	93	109	for	for	ADP
hls-11379	93	110	nafld	nafld	ADJ
hls-11379	93	111	p≤0.009	p≤0.009	PROPN
hls-11379	93	112	nafld	nafld	PROPN
hls-11379	93	113	occurs	occur	VERB
hls-11379	93	114	when	when	SCONJ
hls-11379	93	115	there	there	PRON
hls-11379	93	116	is	be	VERB
hls-11379	93	117	an	an	DET
hls-11379	93	118	imbalance	imbalance	NOUN
hls-11379	93	119	between	between	ADP
hls-11379	93	120	the	the	DET
hls-11379	93	121	rate	rate	NOUN
hls-11379	93	122	of	of	ADP
hls-11379	93	123	uptake	uptake	NOUN
hls-11379	93	124	of	of	ADP
hls-11379	93	125	fatty	fatty	ADJ
hls-11379	93	126	acids	acid	NOUN
hls-11379	93	127	and	and	CCONJ
hls-11379	93	128	triglycerides	triglyceride	NOUN
hls-11379	93	129	from	from	ADP
hls-11379	93	130	circulation	circulation	NOUN
hls-11379	93	131	,	,	PUNCT
hls-11379	93	132	increased	increase	VERB
hls-11379	93	133	lipogenesis	lipogenesis	NOUN
hls-11379	93	134	,	,	PUNCT
hls-11379	93	135	and	and	CCONJ
hls-11379	93	136	a	a	DET
hls-11379	93	137	decreased	decrease	VERB
hls-11379	93	138	ability	ability	NOUN
hls-11379	93	139	to	to	PART
hls-11379	93	140	oxidize	oxidize	VERB
hls-11379	93	141	fatty	fatty	ADJ
hls-11379	93	142	acids	acid	NOUN
hls-11379	93	143	and	and	CCONJ
hls-11379	93	144	export	export	VERB
hls-11379	93	145	very	very	ADV
hls-11379	93	146	low	low	ADJ
hls-11379	93	147	-	-	PUNCT
hls-11379	93	148	density	density	NOUN
hls-11379	93	149	lipoprotein	lipoprotein	NOUN
hls-11379	93	150	-	-	PUNCT
hls-11379	93	151	tg	tg	X
hls-11379	93	152	.	.	PUNCT
hls-11379	94	1	therefore	therefore	ADV
hls-11379	94	2	,	,	PUNCT
hls-11379	94	3	changes	change	NOUN
hls-11379	94	4	in	in	ADP
hls-11379	94	5	liver	liver	NOUN
hls-11379	94	6	and	and	CCONJ
hls-11379	94	7	serum	serum	NOUN
hls-11379	94	8	lipid	lipid	NOUN
hls-11379	94	9	parameters	parameter	NOUN
hls-11379	94	10	can	can	AUX
hls-11379	94	11	be	be	AUX
hls-11379	94	12	a	a	DET
hls-11379	94	13	predictor	predictor	NOUN
hls-11379	94	14	of	of	ADP
hls-11379	94	15	disease	disease	NOUN
hls-11379	94	16	development.24	development.24	NOUN
hls-11379	94	17	kantartzis	kantartzi	NOUN
hls-11379	94	18	et	et	PRON
hls-11379	94	19	al.25	al.25	ADV
hls-11379	94	20	in	in	ADP
hls-11379	94	21	their	their	PRON
hls-11379	94	22	study	study	NOUN
hls-11379	94	23	on	on	ADP
hls-11379	94	24	16	16	NUM
hls-11379	94	25	patients	patient	NOUN
hls-11379	94	26	with	with	ADP
hls-11379	94	27	fatty	fatty	NOUN
hls-11379	94	28	liver	liver	NOUN
hls-11379	94	29	and	and	CCONJ
hls-11379	94	30	24	24	NUM
hls-11379	94	31	control	control	NOUN
hls-11379	94	32	subjects	subject	NOUN
hls-11379	94	33	found	find	VERB
hls-11379	94	34	that	that	SCONJ
hls-11379	94	35	fatty	fatty	NOUN
hls-11379	94	36	liver	liver	NOUN
hls-11379	94	37	was	be	AUX
hls-11379	94	38	associated	associate	VERB
hls-11379	94	39	with	with	ADP
hls-11379	94	40	decreased	decrease	VERB
hls-11379	94	41	levels	level	NOUN
hls-11379	94	42	of	of	ADP
hls-11379	94	43	high	high	ADJ
hls-11379	94	44	-	-	PUNCT
hls-11379	94	45	density	density	NOUN
hls-11379	94	46	lipoprotein	lipoprotein	ADJ
hls-11379	94	47	2	2	NUM
hls-11379	94	48	(	(	PUNCT
hls-11379	94	49	hdl2	hdl2	PROPN
hls-11379	94	50	)	)	PUNCT
hls-11379	94	51	which	which	PRON
hls-11379	94	52	is	be	AUX
hls-11379	94	53	potent	potent	ADJ
hls-11379	94	54	antiatherogenic	antiatherogenic	ADJ
hls-11379	94	55	.	.	PUNCT
hls-11379	95	1	moreover	moreover	ADV
hls-11379	95	2	,	,	PUNCT
hls-11379	95	3	in	in	ADP
hls-11379	95	4	patients	patient	NOUN
hls-11379	95	5	with	with	ADP
hls-11379	95	6	nafld	nafld	ADJ
hls-11379	95	7	,	,	PUNCT
hls-11379	95	8	abnormal	abnormal	ADJ
hls-11379	95	9	serum	serum	NOUN
hls-11379	95	10	alt	alt	NOUN
hls-11379	95	11	and	and	CCONJ
hls-11379	95	12	ast	ast	NOUN
hls-11379	95	13	are	be	AUX
hls-11379	95	14	usually	usually	ADV
hls-11379	95	15	present	present	ADJ
hls-11379	95	16	when	when	SCONJ
hls-11379	95	17	the	the	DET
hls-11379	95	18	disease	disease	NOUN
hls-11379	95	19	progress	progress	VERB
hls-11379	95	20	to	to	ADP
hls-11379	95	21	steatohepatitis	steatohepatitis	NOUN
hls-11379	95	22	or	or	CCONJ
hls-11379	95	23	hepatic	hepatic	ADJ
hls-11379	95	24	fibrosis.26	fibrosis.26	PROPN
hls-11379	95	25	however	however	ADV
hls-11379	95	26	,	,	PUNCT
hls-11379	95	27	in	in	ADP
hls-11379	95	28	a	a	DET
hls-11379	95	29	study	study	NOUN
hls-11379	95	30	done	do	VERB
hls-11379	95	31	by	by	ADP
hls-11379	95	32	ma	ma	PROPN
hls-11379	95	33	et	et	PROPN
hls-11379	95	34	al.27	al.27	PROPN
hls-11379	95	35	they	they	PRON
hls-11379	95	36	found	find	VERB
hls-11379	95	37	the	the	DET
hls-11379	95	38	prevalence	prevalence	NOUN
hls-11379	95	39	of	of	ADP
hls-11379	95	40	normal	normal	ADJ
hls-11379	95	41	alt	alt	NOUN
hls-11379	95	42	in	in	ADP
hls-11379	95	43	patients	patient	NOUN
hls-11379	95	44	with	with	ADP
hls-11379	95	45	nafld	nafld	PROPN
hls-11379	95	46	reached	reach	VERB
hls-11379	95	47	over	over	ADP
hls-11379	95	48	90	90	NUM
hls-11379	95	49	%	%	NOUN
hls-11379	95	50	.	.	PUNCT
hls-11379	96	1	in	in	ADP
hls-11379	96	2	our	our	PRON
hls-11379	96	3	study	study	NOUN
hls-11379	96	4	,	,	PUNCT
hls-11379	96	5	we	we	PRON
hls-11379	96	6	found	find	VERB
hls-11379	96	7	that	that	SCONJ
hls-11379	96	8	in	in	ADP
hls-11379	96	9	patients	patient	NOUN
hls-11379	96	10	with	with	ADP
hls-11379	96	11	nafld	nafld	ADJ
hls-11379	96	12	,	,	PUNCT
hls-11379	96	13	total	total	ADJ
hls-11379	96	14	cholesterol	cholesterol	NOUN
hls-11379	96	15	,	,	PUNCT
hls-11379	96	16	ldl	ldl	NOUN
hls-11379	96	17	,	,	PUNCT
hls-11379	96	18	and	and	CCONJ
hls-11379	96	19	tg	tg	INTJ
hls-11379	96	20	,	,	PUNCT
hls-11379	96	21	as	as	ADV
hls-11379	96	22	well	well	ADV
hls-11379	96	23	as	as	ADP
hls-11379	96	24	alt	alt	VERB
hls-11379	96	25	and	and	CCONJ
hls-11379	96	26	ast	ast	NOUN
hls-11379	96	27	were	be	AUX
hls-11379	96	28	higher	high	ADJ
hls-11379	96	29	than	than	ADP
hls-11379	96	30	in	in	ADP
hls-11379	96	31	patients	patient	NOUN
hls-11379	96	32	without	without	ADP
hls-11379	96	33	nafld	nafld	PROPN
hls-11379	96	34	.	.	PUNCT
hls-11379	97	1	however	however	ADV
hls-11379	97	2	,	,	PUNCT
hls-11379	97	3	none	none	NOUN
hls-11379	97	4	of	of	ADP
hls-11379	97	5	these	these	PRON
hls-11379	97	6	were	be	AUX
hls-11379	97	7	statistically	statistically	ADV
hls-11379	97	8	significant	significant	ADJ
hls-11379	97	9	.	.	PUNCT
hls-11379	98	1	this	this	PRON
hls-11379	98	2	may	may	AUX
hls-11379	98	3	be	be	AUX
hls-11379	98	4	attributed	attribute	VERB
hls-11379	98	5	to	to	ADP
hls-11379	98	6	the	the	DET
hls-11379	98	7	low	low	ADJ
hls-11379	98	8	number	number	NOUN
hls-11379	98	9	of	of	ADP
hls-11379	98	10	patients	patient	NOUN
hls-11379	98	11	with	with	ADP
hls-11379	98	12	dyslipidemia	dyslipidemia	NOUN
hls-11379	98	13	involved	involve	VERB
hls-11379	98	14	in	in	ADP
hls-11379	98	15	the	the	DET
hls-11379	98	16	study	study	NOUN
hls-11379	98	17	and	and	CCONJ
hls-11379	98	18	the	the	DET
hls-11379	98	19	early	early	ADJ
hls-11379	98	20	stage	stage	NOUN
hls-11379	98	21	of	of	ADP
hls-11379	98	22	nafld	nafld	ADJ
hls-11379	98	23	in	in	ADP
hls-11379	98	24	those	those	DET
hls-11379	98	25	patients	patient	NOUN
hls-11379	98	26	.	.	PUNCT
hls-11379	99	1	several	several	ADJ
hls-11379	99	2	studies	study	NOUN
hls-11379	99	3	have	have	AUX
hls-11379	99	4	been	be	AUX
hls-11379	99	5	conducted	conduct	VERB
hls-11379	99	6	to	to	PART
hls-11379	99	7	demonstrate	demonstrate	VERB
hls-11379	99	8	the	the	DET
hls-11379	99	9	relationship	relationship	NOUN
hls-11379	99	10	between	between	ADP
hls-11379	99	11	h.	h.	PROPN
hls-11379	99	12	pylori	pylori	ADJ
hls-11379	99	13	infection	infection	NOUN
hls-11379	99	14	and	and	CCONJ
hls-11379	99	15	nafld	nafld	ADJ
hls-11379	99	16	.	.	PUNCT
hls-11379	100	1	this	this	PRON
hls-11379	100	2	is	be	AUX
hls-11379	100	3	because	because	SCONJ
hls-11379	100	4	the	the	DET
hls-11379	100	5	main	main	ADJ
hls-11379	100	6	pathogenic	pathogenic	ADJ
hls-11379	100	7	mechanism	mechanism	NOUN
hls-11379	100	8	in	in	ADP
hls-11379	100	9	nafld	nafld	ADJ
hls-11379	100	10	is	be	AUX
hls-11379	100	11	insulin	insulin	NOUN
hls-11379	100	12	resistance	resistance	NOUN
hls-11379	100	13	which	which	PRON
hls-11379	100	14	makes	make	VERB
hls-11379	100	15	hepatocytes	hepatocyte	NOUN
hls-11379	100	16	more	more	ADV
hls-11379	100	17	susceptible	susceptible	ADJ
hls-11379	100	18	to	to	ADP
hls-11379	100	19	oxidative	oxidative	ADJ
hls-11379	100	20	stress	stress	NOUN
hls-11379	100	21	and	and	CCONJ
hls-11379	100	22	lipid	lipid	NOUN
hls-11379	100	23	peroxidation	peroxidation	NOUN
hls-11379	100	24	.	.	PUNCT
hls-11379	101	1	at	at	ADP
hls-11379	101	2	the	the	DET
hls-11379	101	3	same	same	ADJ
hls-11379	101	4	time	time	NOUN
hls-11379	101	5	,	,	PUNCT
hls-11379	101	6	h.	h.	PROPN
hls-11379	101	7	pylori	pylori	NOUN
hls-11379	101	8	was	be	AUX
hls-11379	101	9	implicated	implicate	VERB
hls-11379	101	10	in	in	ADP
hls-11379	101	11	the	the	DET
hls-11379	101	12	development	development	NOUN
hls-11379	101	13	of	of	ADP
hls-11379	101	14	insulin	insulin	NOUN
hls-11379	101	15	resistance	resistance	NOUN
hls-11379	101	16	through	through	ADP
hls-11379	101	17	increasing	increase	VERB
hls-11379	101	18	proinflammatory	proinflammatory	ADJ
hls-11379	101	19	cytokines	cytokine	NOUN
hls-11379	101	20	and	and	CCONJ
hls-11379	101	21	reactive	reactive	ADJ
hls-11379	101	22	oxygen	oxygen	NOUN
hls-11379	101	23	species	species	NOUN
hls-11379	101	24	production	production	NOUN
hls-11379	101	25	.	.	PUNCT
hls-11379	102	1	numerous	numerous	ADJ
hls-11379	102	2	studies	study	NOUN
hls-11379	102	3	aimed	aim	VERB
hls-11379	102	4	to	to	PART
hls-11379	102	5	find	find	VERB
hls-11379	102	6	out	out	ADP
hls-11379	102	7	whether	whether	SCONJ
hls-11379	102	8	there	there	PRON
hls-11379	102	9	is	be	VERB
hls-11379	102	10	a	a	DET
hls-11379	102	11	relationship	relationship	NOUN
hls-11379	102	12	between	between	ADP
hls-11379	102	13	them	they	PRON
hls-11379	102	14	or	or	CCONJ
hls-11379	102	15	not.28	not.28	NOUN
hls-11379	102	16	in	in	ADP
hls-11379	102	17	a	a	DET
hls-11379	102	18	study	study	NOUN
hls-11379	102	19	done	do	VERB
hls-11379	102	20	by	by	ADP
hls-11379	102	21	polyzos	polyzo	NOUN
hls-11379	102	22	et	et	PROPN
hls-11379	102	23	al.29	al.29	NOUN
hls-11379	102	24	on	on	ADP
hls-11379	102	25	28	28	NUM
hls-11379	102	26	patients	patient	NOUN
hls-11379	102	27	with	with	ADP
hls-11379	102	28	biopsy	biopsy	NOUN
hls-11379	102	29	-	-	PUNCT
hls-11379	102	30	proven	prove	VERB
hls-11379	102	31	nafld	nafld	ADJ
hls-11379	102	32	and	and	CCONJ
hls-11379	102	33	25	25	NUM
hls-11379	102	34	healthy	healthy	ADJ
hls-11379	102	35	controls	control	NOUN
hls-11379	102	36	,	,	PUNCT
hls-11379	102	37	they	they	PRON
hls-11379	102	38	article	article	NOUN
hls-11379	102	39	table	table	VERB
hls-11379	102	40	3	3	NUM
hls-11379	102	41	.	.	X
hls-11379	102	42	relation	relation	NOUN
hls-11379	102	43	between	between	ADP
hls-11379	102	44	h.	h.	PROPN
hls-11379	102	45	pylori	pylori	NOUN
hls-11379	102	46	and	and	CCONJ
hls-11379	102	47	elastography	elastography	NOUN
hls-11379	102	48	.	.	PUNCT
hls-11379	103	1	total	total	ADJ
hls-11379	103	2	n=100	n=100	NUM
hls-11379	103	3	h.	h.	PROPN
hls-11379	103	4	pylori	pylori	PROPN
hls-11379	103	5	test	test	NOUN
hls-11379	103	6	of	of	ADP
hls-11379	103	7	sig	sig	NOUN
hls-11379	103	8	.	.	PUNCT
hls-11379	104	1	p	p	X
hls-11379	104	2	negative	negative	ADJ
hls-11379	104	3	(	(	PUNCT
hls-11379	104	4	n=50	n=50	ADJ
hls-11379	104	5	)	)	PUNCT
hls-11379	104	6	positive	positive	ADJ
hls-11379	104	7	(	(	PUNCT
hls-11379	104	8	n=50	n=50	ADJ
hls-11379	104	9	)	)	PUNCT
hls-11379	104	10	mean±sd	mean±sd	ADP
hls-11379	104	11	239.8±35.18	239.8±35.18	NUM
hls-11379	104	12	229.3±33.83	229.3±33.83	NUM
hls-11379	104	13	250.4±33.59	250.4±33.59	NUM
hls-11379	104	14	3.133	3.133	NUM
hls-11379	104	15	*	*	SYM
hls-11379	104	16	0.002	0.002	NUM
hls-11379	104	17	*	*	NOUN
hls-11379	104	18	median	median	NOUN
hls-11379	104	19	(	(	PUNCT
hls-11379	104	20	min	min	NOUN
hls-11379	104	21	-	-	PUNCT
hls-11379	104	22	max	max	NOUN
hls-11379	104	23	)	)	PUNCT
hls-11379	104	24	248.5	248.5	NUM
hls-11379	104	25	(	(	PUNCT
hls-11379	104	26	150	150	NUM
hls-11379	104	27	-	-	SYM
hls-11379	104	28	296	296	NUM
hls-11379	104	29	)	)	PUNCT
hls-11379	104	30	230	230	NUM
hls-11379	104	31	(	(	PUNCT
hls-11379	104	32	150	150	NUM
hls-11379	104	33	-	-	SYM
hls-11379	104	34	296	296	NUM
hls-11379	104	35	)	)	PUNCT
hls-11379	104	36	259	259	NUM
hls-11379	104	37	(	(	PUNCT
hls-11379	104	38	170	170	NUM
hls-11379	104	39	-	-	NUM
hls-11379	104	40	294	294	NUM
hls-11379	104	41	)	)	PUNCT
hls-11379	104	42	sd	sd	NOUN
hls-11379	104	43	,	,	PUNCT
hls-11379	104	44	standard	standard	ADJ
hls-11379	104	45	deviation	deviation	NOUN
hls-11379	104	46	;	;	PUNCT
hls-11379	104	47	t	t	PROPN
hls-11379	104	48	,	,	PUNCT
hls-11379	104	49	student	student	NOUN
hls-11379	104	50	t	t	PROPN
hls-11379	104	51	-	-	PUNCT
hls-11379	104	52	test	test	NOUN
hls-11379	104	53	;	;	PUNCT
hls-11379	104	54	u.	u.	NOUN
hls-11379	104	55	*	*	PUNCT
hls-11379	104	56	statistically	statistically	ADV
hls-11379	104	57	significant	significant	ADJ
hls-11379	104	58	at	at	ADP
hls-11379	104	59	p≤0.05	p≤0.05	NOUN
hls-11379	104	60	.	.	PUNCT
hls-11379	104	61	table	table	NOUN
hls-11379	104	62	4	4	NUM
hls-11379	104	63	.	.	PUNCT
hls-11379	105	1	prognostic	prognostic	ADJ
hls-11379	105	2	performance	performance	NOUN
hls-11379	105	3	for	for	ADP
hls-11379	105	4	elastography	elastography	NOUN
hls-11379	105	5	to	to	PART
hls-11379	105	6	prognoses	prognosis	NOUN
hls-11379	105	7	positive	positive	ADJ
hls-11379	105	8	h.	h.	NOUN
hls-11379	105	9	pylori	pylori	NOUN
hls-11379	105	10	patients	patient	NOUN
hls-11379	105	11	(	(	PUNCT
hls-11379	105	12	n	n	NOUN
hls-11379	105	13	=	=	SYM
hls-11379	105	14	50	50	NUM
hls-11379	105	15	)	)	PUNCT
hls-11379	105	16	from	from	ADP
hls-11379	105	17	negative	negative	ADJ
hls-11379	105	18	h.	h.	PROPN
hls-11379	105	19	pylori	pylori	NOUN
hls-11379	105	20	patients	patient	NOUN
hls-11379	105	21	(	(	PUNCT
hls-11379	105	22	n	n	NOUN
hls-11379	105	23	=	=	SYM
hls-11379	105	24	50	50	NUM
hls-11379	105	25	)	)	PUNCT
hls-11379	105	26	.	.	PUNCT
hls-11379	106	1	auc	auc	VERB
hls-11379	106	2	p	p	PRON
hls-11379	107	1	95	95	NUM
hls-11379	107	2	%	%	NOUN
hls-11379	107	3	c.i	c.i	NOUN
hls-11379	107	4	cut	cut	VERB
hls-11379	107	5	off	off	ADP
hls-11379	107	6	sensitivity	sensitivity	NOUN
hls-11379	107	7	specificity	specificity	NOUN
hls-11379	107	8	ppv	ppv	NOUN
hls-11379	107	9	npv	npv	NOUN
hls-11379	107	10	elastography	elastography	NOUN
hls-11379	107	11	0.688	0.688	NUM
hls-11379	107	12	0.001	0.001	NUM
hls-11379	107	13	*	*	NUM
hls-11379	107	14	0.582	0.582	NUM
hls-11379	107	15	-	-	SYM
hls-11379	107	16	0.794	0.794	NUM
hls-11379	107	17	>	>	PUNCT
hls-11379	107	18	248	248	NUM
hls-11379	107	19	68.0	68.0	NUM
hls-11379	107	20	68.0	68.0	NUM
hls-11379	107	21	68.0	68.0	NUM
hls-11379	107	22	68.0	68.0	NUM
hls-11379	107	23	auc	auc	NOUN
hls-11379	107	24	,	,	PUNCT
hls-11379	107	25	area	area	NOUN
hls-11379	107	26	under	under	ADP
hls-11379	107	27	a	a	DET
hls-11379	107	28	curve	curve	NOUN
hls-11379	107	29	;	;	PUNCT
hls-11379	107	30	ci	ci	NOUN
hls-11379	107	31	,	,	PUNCT
hls-11379	107	32	confidence	confidence	NOUN
hls-11379	107	33	intervals	interval	NOUN
hls-11379	107	34	;	;	PUNCT
hls-11379	107	35	npv	npv	NOUN
hls-11379	107	36	,	,	PUNCT
hls-11379	107	37	negative	negative	ADJ
hls-11379	107	38	predictive	predictive	ADJ
hls-11379	107	39	value	value	NOUN
hls-11379	107	40	;	;	PUNCT
hls-11379	107	41	ppv	ppv	NOUN
hls-11379	107	42	,	,	PUNCT
hls-11379	107	43	positive	positive	ADJ
hls-11379	107	44	predictive	predictive	ADJ
hls-11379	107	45	value	value	NOUN
hls-11379	107	46	.	.	PUNCT
hls-11379	108	1	*	*	PUNCT
hls-11379	108	2	statistically	statistically	ADV
hls-11379	108	3	significant	significant	ADJ
hls-11379	108	4	at	at	ADP
hls-11379	108	5	p≤0.05	p≤0.05	NOUN
hls-11379	108	6	.	.	PUNCT
hls-11379	108	7	table	table	NOUN
hls-11379	108	8	5	5	NUM
hls-11379	108	9	.	.	PUNCT
hls-11379	108	10	univariate	univariate	ADJ
hls-11379	108	11	and	and	CCONJ
hls-11379	108	12	multivariate	multivariate	VERB
hls-11379	108	13	logistic	logistic	ADJ
hls-11379	108	14	regression	regression	NOUN
hls-11379	108	15	analysis	analysis	NOUN
hls-11379	108	16	for	for	ADP
hls-11379	108	17	the	the	DET
hls-11379	108	18	parameters	parameter	NOUN
hls-11379	108	19	affecting	affect	VERB
hls-11379	108	20	elastography	elastography	NOUN
hls-11379	108	21	>	>	X
hls-11379	108	22	248db	248db	NOUN
hls-11379	108	23	/	/	SYM
hls-11379	108	24	m.	m.	NOUN
hls-11379	108	25	univariate	univariate	ADJ
hls-11379	108	26	multivariate	multivariate	NOUN
hls-11379	108	27	p	p	NOUN
hls-11379	108	28	or	or	CCONJ
hls-11379	108	29	(	(	PUNCT
hls-11379	108	30	ll	ll	NOUN
hls-11379	108	31	–	–	PUNCT
hls-11379	108	32	ul	ul	NOUN
hls-11379	108	33	95%c.i	95%c.i	NUM
hls-11379	108	34	)	)	PUNCT
hls-11379	108	35	p	p	NOUN
hls-11379	108	36	or	or	CCONJ
hls-11379	108	37	(	(	PUNCT
hls-11379	108	38	ll	ll	NOUN
hls-11379	108	39	–	–	PUNCT
hls-11379	108	40	ul	ul	NOUN
hls-11379	108	41	95%c.i	95%c.i	NUM
hls-11379	108	42	)	)	PUNCT
hls-11379	108	43	male	male	NOUN
hls-11379	108	44	0.680	0.680	NUM
hls-11379	108	45	1.185	1.185	NUM
hls-11379	108	46	(	(	PUNCT
hls-11379	108	47	0.528	0.528	NUM
hls-11379	108	48	-	-	SYM
hls-11379	108	49	2.660	2.660	NUM
hls-11379	108	50	)	)	PUNCT
hls-11379	108	51	age	age	NOUN
hls-11379	108	52	(	(	PUNCT
hls-11379	108	53	years	year	NOUN
hls-11379	108	54	)	)	PUNCT
hls-11379	108	55	<	<	X
hls-11379	108	56	0.001	0.001	NUM
hls-11379	108	57	*	*	SYM
hls-11379	108	58	1.075	1.075	NUM
hls-11379	108	59	(	(	PUNCT
hls-11379	108	60	1.041	1.041	NUM
hls-11379	108	61	-	-	SYM
hls-11379	108	62	1.110	1.110	NUM
hls-11379	108	63	)	)	PUNCT
hls-11379	108	64	<	<	X
hls-11379	108	65	0.001	0.001	NUM
hls-11379	108	66	*	*	SYM
hls-11379	108	67	1.082	1.082	NUM
hls-11379	108	68	(	(	PUNCT
hls-11379	108	69	1.039	1.039	NUM
hls-11379	108	70	-	-	SYM
hls-11379	108	71	1.127	1.127	NUM
hls-11379	108	72	)	)	PUNCT
hls-11379	108	73	bmi	bmi	NOUN
hls-11379	108	74	(	(	PUNCT
hls-11379	108	75	kg	kg	NOUN
hls-11379	108	76	/	/	SYM
hls-11379	108	77	m2	m2	PROPN
hls-11379	108	78	)	)	PUNCT
hls-11379	108	79	0.001	0.001	NUM
hls-11379	108	80	*	*	SYM
hls-11379	108	81	1.227	1.227	NUM
hls-11379	108	82	(	(	PUNCT
hls-11379	108	83	1.091	1.091	NUM
hls-11379	108	84	-	-	SYM
hls-11379	108	85	1.380	1.380	NUM
hls-11379	108	86	)	)	PUNCT
hls-11379	108	87	0.009	0.009	NUM
hls-11379	108	88	*	*	SYM
hls-11379	108	89	1.225	1.225	NUM
hls-11379	108	90	(	(	PUNCT
hls-11379	108	91	1.052	1.052	NUM
hls-11379	108	92	-	-	NUM
hls-11379	108	93	1.427	1.427	NUM
hls-11379	108	94	)	)	PUNCT
hls-11379	108	95	alt	alt	VERB
hls-11379	108	96	0.077	0.077	NUM
hls-11379	108	97	1.023	1.023	NUM
hls-11379	108	98	(	(	PUNCT
hls-11379	108	99	0.998	0.998	NUM
hls-11379	108	100	-	-	SYM
hls-11379	108	101	1.049	1.049	NUM
hls-11379	108	102	)	)	PUNCT
hls-11379	108	103	ast	ast	NOUN
hls-11379	108	104	0.151	0.151	NUM
hls-11379	108	105	1.028	1.028	NUM
hls-11379	108	106	(	(	PUNCT
hls-11379	108	107	0.990	0.990	NUM
hls-11379	108	108	-	-	SYM
hls-11379	108	109	1.067	1.067	NUM
hls-11379	108	110	)	)	PUNCT
hls-11379	108	111	total	total	ADJ
hls-11379	108	112	cholesterol	cholesterol	NOUN
hls-11379	108	113	0.487	0.487	NUM
hls-11379	108	114	1.005	1.005	NUM
hls-11379	108	115	(	(	PUNCT
hls-11379	108	116	0.991	0.991	NUM
hls-11379	108	117	-	-	SYM
hls-11379	108	118	1.018	1.018	NUM
hls-11379	108	119	)	)	PUNCT
hls-11379	108	120	ldl	ldl	VERB
hls-11379	108	121	0.324	0.324	NUM
hls-11379	108	122	1.009	1.009	NUM
hls-11379	108	123	(	(	PUNCT
hls-11379	108	124	0.991	0.991	NUM
hls-11379	108	125	-	-	PUNCT
hls-11379	108	126	1.027	1.027	NUM
hls-11379	108	127	)	)	PUNCT
hls-11379	108	128	hdl	hdl	NOUN
hls-11379	108	129	0.553	0.553	NUM
hls-11379	108	130	0.986	0.986	NUM
hls-11379	108	131	(	(	PUNCT
hls-11379	108	132	0.943	0.943	NUM
hls-11379	108	133	-	-	SYM
hls-11379	108	134	1.032	1.032	NUM
hls-11379	108	135	)	)	PUNCT
hls-11379	108	136	triglyceride	triglyceride	ADP
hls-11379	108	137	0.607	0.607	NUM
hls-11379	108	138	1.002	1.002	NUM
hls-11379	108	139	(	(	PUNCT
hls-11379	108	140	0.994	0.994	NUM
hls-11379	108	141	-	-	SYM
hls-11379	108	142	1.011	1.011	NUM
hls-11379	108	143	)	)	PUNCT
hls-11379	108	144	h.	h.	NOUN
hls-11379	108	145	pylori	pylori	NOUN
hls-11379	108	146	<	<	NOUN
hls-11379	108	147	0.001	0.001	NUM
hls-11379	108	148	*	*	SYM
hls-11379	108	149	4.516	4.516	NUM
hls-11379	108	150	(	(	PUNCT
hls-11379	108	151	1.949	1.949	NUM
hls-11379	108	152	-	-	SYM
hls-11379	108	153	10.463	10.463	NUM
hls-11379	108	154	)	)	PUNCT
hls-11379	108	155	0.001	0.001	NUM
hls-11379	108	156	*	*	SYM
hls-11379	108	157	5.632	5.632	NUM
hls-11379	108	158	(	(	PUNCT
hls-11379	108	159	1.967	1.967	NUM
hls-11379	108	160	-	-	NUM
hls-11379	108	161	16.130	16.130	NUM
hls-11379	108	162	)	)	PUNCT
hls-11379	108	163	or	or	CCONJ
hls-11379	108	164	,	,	PUNCT
hls-11379	108	165	odd	odd	ADJ
hls-11379	108	166	’s	’s	PART
hls-11379	108	167	ratio	ratio	NOUN
hls-11379	108	168	;	;	PUNCT
hls-11379	108	169	ci	ci	NOUN
hls-11379	108	170	,	,	PUNCT
hls-11379	108	171	confidence	confidence	NOUN
hls-11379	108	172	interval	interval	NOUN
hls-11379	108	173	;	;	PUNCT
hls-11379	108	174	ll	ll	AUX
hls-11379	108	175	,	,	PUNCT
hls-11379	108	176	lower	low	ADJ
hls-11379	108	177	limit	limit	NOUN
hls-11379	108	178	;	;	PUNCT
hls-11379	108	179	ul	ul	INTJ
hls-11379	108	180	,	,	PUNCT
hls-11379	108	181	upper	upper	ADJ
hls-11379	108	182	limit	limit	NOUN
hls-11379	108	183	.	.	PUNCT
hls-11379	109	1	*	*	PUNCT
hls-11379	109	2	statistically	statistically	ADV
hls-11379	109	3	significant	significant	ADJ
hls-11379	109	4	at	at	ADP
hls-11379	109	5	p≤0.05	p≤0.05	NOUN
hls-11379	109	6	.	.	PUNCT
hls-11379	110	1	[	[	X
hls-11379	110	2	healthcare	healthcare	NOUN
hls-11379	110	3	in	in	ADP
hls-11379	110	4	low	low	ADJ
hls-11379	110	5	-	-	PUNCT
hls-11379	110	6	resource	resource	NOUN
hls-11379	110	7	settings	setting	NOUN
hls-11379	110	8	2023	2023	NUM
hls-11379	110	9	;	;	PUNCT
hls-11379	111	1	11(s2):11379	11(s2):11379	NUM
hls-11379	111	2	]	]	X
hls-11379	112	1	[	[	X
hls-11379	112	2	page	page	NOUN
hls-11379	112	3	15	15	NUM
hls-11379	112	4	]	]	X
hls-11379	112	5	non	non	ADJ
hls-11379	112	6	-co	-co	PROPN
hls-11379	112	7	mmerc	mmerc	PROPN
hls-11379	112	8	ial	ial	PROPN
hls-11379	112	9	us	us	PROPN
hls-11379	112	10	e	e	NOUN
hls-11379	112	11	o	o	NOUN
hls-11379	112	12	nly	nly	ADV
hls-11379	112	13	found	find	VERB
hls-11379	112	14	that	that	SCONJ
hls-11379	112	15	h.	h.	PROPN
hls-11379	112	16	pylori	pylori	NOUN
hls-11379	112	17	diagnosed	diagnose	VERB
hls-11379	112	18	by	by	ADP
hls-11379	112	19	serology	serology	NOUN
hls-11379	112	20	were	be	AUX
hls-11379	112	21	found	find	VERB
hls-11379	112	22	in	in	ADP
hls-11379	112	23	82	82	NUM
hls-11379	112	24	%	%	NOUN
hls-11379	112	25	of	of	ADP
hls-11379	112	26	nafld	nafld	ADJ
hls-11379	112	27	patients	patient	NOUN
hls-11379	112	28	and	and	CCONJ
hls-11379	112	29	56	56	NUM
hls-11379	112	30	%	%	NOUN
hls-11379	112	31	of	of	ADP
hls-11379	112	32	healthy	healthy	ADJ
hls-11379	112	33	controls	control	NOUN
hls-11379	112	34	.	.	PUNCT
hls-11379	113	1	meta	meta	ADJ
hls-11379	113	2	-	-	PUNCT
hls-11379	113	3	analysis	analysis	NOUN
hls-11379	113	4	of	of	ADP
hls-11379	113	5	data	datum	NOUN
hls-11379	113	6	from	from	ADP
hls-11379	113	7	cross	cross	ADJ
hls-11379	113	8	-	-	ADJ
hls-11379	113	9	sectional	sectional	ADJ
hls-11379	113	10	and	and	CCONJ
hls-11379	113	11	case	case	NOUN
hls-11379	113	12	-	-	PUNCT
hls-11379	113	13	control	control	NOUN
hls-11379	113	14	studies	study	NOUN
hls-11379	113	15	involving	involve	VERB
hls-11379	113	16	91,958	91,958	NUM
hls-11379	113	17	individuals	individual	NOUN
hls-11379	113	18	concluded	conclude	VERB
hls-11379	113	19	that	that	SCONJ
hls-11379	113	20	h.	h.	PROPN
hls-11379	113	21	pylori	pylori	NOUN
hls-11379	113	22	infection	infection	NOUN
hls-11379	113	23	was	be	AUX
hls-11379	113	24	also	also	ADV
hls-11379	113	25	associated	associate	VERB
hls-11379	113	26	with	with	ADP
hls-11379	113	27	increased	increase	VERB
hls-11379	113	28	nafld	nafld	ADJ
hls-11379	113	29	incidence.30	incidence.30	NOUN
hls-11379	113	30	in	in	ADP
hls-11379	113	31	addition	addition	NOUN
hls-11379	113	32	,	,	PUNCT
hls-11379	113	33	another	another	DET
hls-11379	113	34	study	study	NOUN
hls-11379	113	35	found	find	VERB
hls-11379	113	36	a	a	DET
hls-11379	113	37	remarkable	remarkable	ADJ
hls-11379	113	38	effect	effect	NOUN
hls-11379	113	39	of	of	ADP
hls-11379	113	40	h.	h.	PROPN
hls-11379	113	41	pylori	pylori	ADJ
hls-11379	113	42	infection	infection	NOUN
hls-11379	113	43	on	on	ADP
hls-11379	113	44	nafld	nafld	ADV
hls-11379	113	45	after	after	ADP
hls-11379	113	46	ruling	rule	VERB
hls-11379	113	47	out	out	ADP
hls-11379	113	48	many	many	ADJ
hls-11379	113	49	confounding	confound	VERB
hls-11379	113	50	factors	factor	NOUN
hls-11379	113	51	like	like	ADP
hls-11379	113	52	age	age	NOUN
hls-11379	113	53	,	,	PUNCT
hls-11379	113	54	dyslipidemia	dyslipidemia	NOUN
hls-11379	113	55	,	,	PUNCT
hls-11379	113	56	diabetes	diabetes	NOUN
hls-11379	113	57	,	,	PUNCT
hls-11379	113	58	hypertension	hypertension	NOUN
hls-11379	113	59	,	,	PUNCT
hls-11379	113	60	and	and	CCONJ
hls-11379	113	61	liver	liver	NOUN
hls-11379	113	62	enzymes	enzyme	NOUN
hls-11379	113	63	,	,	PUNCT
hls-11379	113	64	h.	h.	PROPN
hls-11379	113	65	pylori	pylori	NOUN
hls-11379	113	66	infection	infection	NOUN
hls-11379	113	67	was	be	AUX
hls-11379	113	68	found	find	VERB
hls-11379	113	69	to	to	PART
hls-11379	113	70	be	be	AUX
hls-11379	113	71	an	an	DET
hls-11379	113	72	independent	independent	ADJ
hls-11379	113	73	risk	risk	NOUN
hls-11379	113	74	factor	factor	NOUN
hls-11379	113	75	for	for	ADP
hls-11379	113	76	nafld	nafld	ADJ
hls-11379	113	77	(	(	PUNCT
hls-11379	113	78	95	95	NUM
hls-11379	113	79	%	%	NOUN
hls-11379	113	80	ci	ci	NOUN
hls-11379	113	81	1.021.79	1.021.79	NUM
hls-11379	113	82	,	,	PUNCT
hls-11379	113	83	or	or	CCONJ
hls-11379	113	84	1.35	1.35	NUM
hls-11379	113	85	,	,	PUNCT
hls-11379	113	86	p=0.036).31	p=0.036).31	PROPN
hls-11379	113	87	yan	yan	PROPN
hls-11379	113	88	et	et	PROPN
hls-11379	113	89	al.32	al.32	PROPN
hls-11379	113	90	conducted	conduct	VERB
hls-11379	113	91	a	a	DET
hls-11379	113	92	wide	wide	ADJ
hls-11379	113	93	-	-	PUNCT
hls-11379	113	94	scale	scale	NOUN
hls-11379	113	95	study	study	NOUN
hls-11379	113	96	on	on	ADP
hls-11379	113	97	1185	1185	NUM
hls-11379	113	98	patients	patient	NOUN
hls-11379	113	99	.	.	PUNCT
hls-11379	114	1	abdominal	abdominal	ADJ
hls-11379	114	2	color	color	NOUN
hls-11379	114	3	doppler	doppler	NOUN
hls-11379	114	4	ultrasound	ultrasound	NOUN
hls-11379	114	5	was	be	AUX
hls-11379	114	6	used	use	VERB
hls-11379	114	7	to	to	PART
hls-11379	114	8	assess	assess	VERB
hls-11379	114	9	nonalcoholic	nonalcoholic	NOUN
hls-11379	114	10	fatty	fatty	NOUN
hls-11379	114	11	liver	liver	NOUN
hls-11379	114	12	disease	disease	NOUN
hls-11379	114	13	and13	and13	PROPN
hls-11379	114	14	c	c	NOUN
hls-11379	114	15	-	-	PUNCT
hls-11379	114	16	urea	urea	NOUN
hls-11379	114	17	breath	breath	NOUN
hls-11379	114	18	test	test	NOUN
hls-11379	114	19	was	be	AUX
hls-11379	114	20	used	use	VERB
hls-11379	114	21	to	to	PART
hls-11379	114	22	diagnose	diagnose	VERB
hls-11379	114	23	h.	h.	NOUN
hls-11379	114	24	pylori	pylori	ADJ
hls-11379	114	25	infection	infection	NOUN
hls-11379	114	26	,	,	PUNCT
hls-11379	114	27	nafld	nafld	PROPN
hls-11379	114	28	was	be	AUX
hls-11379	114	29	found	find	VERB
hls-11379	114	30	in	in	ADP
hls-11379	114	31	44.6	44.6	NUM
hls-11379	114	32	%	%	NOUN
hls-11379	114	33	(	(	PUNCT
hls-11379	114	34	n=529	n=529	ADV
hls-11379	114	35	)	)	PUNCT
hls-11379	114	36	,	,	PUNCT
hls-11379	114	37	distributed	distribute	VERB
hls-11379	114	38	in	in	ADP
hls-11379	114	39	362	362	NUM
hls-11379	114	40	males	male	NOUN
hls-11379	114	41	and	and	CCONJ
hls-11379	114	42	167	167	NUM
hls-11379	114	43	females	female	NOUN
hls-11379	114	44	.	.	PUNCT
hls-11379	115	1	the	the	DET
hls-11379	115	2	study	study	NOUN
hls-11379	115	3	concluded	conclude	VERB
hls-11379	115	4	that	that	SCONJ
hls-11379	115	5	h.	h.	PROPN
hls-11379	115	6	pylori	pylori	NOUN
hls-11379	115	7	is	be	AUX
hls-11379	115	8	a	a	DET
hls-11379	115	9	significant	significant	ADJ
hls-11379	115	10	and	and	CCONJ
hls-11379	115	11	independent	independent	ADJ
hls-11379	115	12	risk	risk	NOUN
hls-11379	115	13	factor	factor	NOUN
hls-11379	115	14	for	for	ADP
hls-11379	115	15	nafld	nafld	ADJ
hls-11379	115	16	(	(	PUNCT
hls-11379	115	17	95	95	NUM
hls-11379	115	18	%	%	NOUN
hls-11379	115	19	ci	ci	NOUN
hls-11379	115	20	1.02	1.02	NUM
hls-11379	115	21	-	-	SYM
hls-11379	115	22	1.79	1.79	NUM
hls-11379	115	23	,	,	PUNCT
hls-11379	115	24	p=0.036	p=0.036	NOUN
hls-11379	115	25	,	,	PUNCT
hls-11379	115	26	or=1.35	or=1.35	NOUN
hls-11379	115	27	)	)	PUNCT
hls-11379	115	28	.	.	PUNCT
hls-11379	116	1	on	on	ADP
hls-11379	116	2	the	the	DET
hls-11379	116	3	other	other	ADJ
hls-11379	116	4	hand	hand	NOUN
hls-11379	116	5	,	,	PUNCT
hls-11379	116	6	a	a	DET
hls-11379	116	7	similar	similar	ADJ
hls-11379	116	8	study	study	NOUN
hls-11379	116	9	was	be	AUX
hls-11379	116	10	conducted	conduct	VERB
hls-11379	116	11	using	use	VERB
hls-11379	116	12	abdominal	abdominal	ADJ
hls-11379	116	13	color	color	NOUN
hls-11379	116	14	doppler	doppler	NOUN
hls-11379	116	15	ultrasonography	ultrasonography	NOUN
hls-11379	116	16	as	as	ADV
hls-11379	116	17	well	well	ADV
hls-11379	116	18	as	as	ADP
hls-11379	116	19	transient	transient	ADJ
hls-11379	116	20	elastography	elastography	NOUN
hls-11379	116	21	,	,	PUNCT
hls-11379	116	22	fat	fat	ADJ
hls-11379	116	23	attenuation	attenuation	NOUN
hls-11379	116	24	parameter	parameter	NOUN
hls-11379	116	25	,	,	PUNCT
hls-11379	116	26	and	and	CCONJ
hls-11379	116	27	liver	liver	NOUN
hls-11379	116	28	stiffness	stiffness	NOUN
hls-11379	116	29	for	for	ADP
hls-11379	116	30	diagnosis	diagnosis	NOUN
hls-11379	116	31	of	of	ADP
hls-11379	116	32	nafld,13	nafld,13	NOUN
hls-11379	116	33	c	c	NOUN
hls-11379	116	34	-	-	PUNCT
hls-11379	116	35	urea	urea	NOUN
hls-11379	116	36	breath	breath	NOUN
hls-11379	116	37	was	be	AUX
hls-11379	116	38	the	the	DET
hls-11379	116	39	method	method	NOUN
hls-11379	116	40	for	for	ADP
hls-11379	116	41	diagnosis	diagnosis	NOUN
hls-11379	116	42	of	of	ADP
hls-11379	116	43	h.	h.	PROPN
hls-11379	116	44	pylori	pylori	ADJ
hls-11379	116	45	infection	infection	NOUN
hls-11379	116	46	.	.	PUNCT
hls-11379	117	1	the	the	DET
hls-11379	117	2	study	study	NOUN
hls-11379	117	3	found	find	VERB
hls-11379	117	4	no	no	DET
hls-11379	117	5	association	association	NOUN
hls-11379	117	6	between	between	ADP
hls-11379	117	7	h.	h.	PROPN
hls-11379	117	8	pylori	pylori	ADJ
hls-11379	117	9	infection	infection	NOUN
hls-11379	117	10	and	and	CCONJ
hls-11379	117	11	nafld	nafld	ADJ
hls-11379	117	12	or	or	CCONJ
hls-11379	117	13	elevated	elevated	ADJ
hls-11379	117	14	liver	liver	NOUN
hls-11379	117	15	steatosis	steatosis	NOUN
hls-11379	117	16	,	,	PUNCT
hls-11379	117	17	but	but	CCONJ
hls-11379	117	18	it	it	PRON
hls-11379	117	19	could	could	AUX
hls-11379	117	20	be	be	AUX
hls-11379	117	21	a	a	DET
hls-11379	117	22	risk	risk	NOUN
hls-11379	117	23	of	of	ADP
hls-11379	117	24	increased	increase	VERB
hls-11379	117	25	liver	liver	NOUN
hls-11379	117	26	stiffness	stiffness	NOUN
hls-11379	117	27	in	in	ADP
hls-11379	117	28	males.33	males.33	PROPN
hls-11379	117	29	other	other	ADJ
hls-11379	117	30	studies	study	NOUN
hls-11379	117	31	intended	intend	VERB
hls-11379	117	32	to	to	PART
hls-11379	117	33	demonstrate	demonstrate	VERB
hls-11379	117	34	the	the	DET
hls-11379	117	35	effect	effect	NOUN
hls-11379	117	36	of	of	ADP
hls-11379	117	37	h.	h.	PROPN
hls-11379	117	38	pylori	pylori	ADJ
hls-11379	117	39	eradication	eradication	NOUN
hls-11379	117	40	on	on	ADP
hls-11379	117	41	hepatic	hepatic	ADJ
hls-11379	117	42	fat	fat	ADJ
hls-11379	117	43	contents	content	NOUN
hls-11379	117	44	.	.	PUNCT
hls-11379	118	1	one	one	NUM
hls-11379	118	2	of	of	ADP
hls-11379	118	3	these	these	DET
hls-11379	118	4	studies	study	NOUN
hls-11379	118	5	performed	perform	VERB
hls-11379	118	6	by	by	ADP
hls-11379	118	7	jamali	jamali	PROPN
hls-11379	118	8	et	et	PROPN
hls-11379	118	9	al.34	al.34	PROPN
hls-11379	118	10	on	on	ADP
hls-11379	118	11	100	100	NUM
hls-11379	118	12	patients	patient	NOUN
hls-11379	118	13	diagnosed	diagnose	VERB
hls-11379	118	14	h.	h.	PROPN
hls-11379	118	15	pylori	pylori	NOUN
hls-11379	118	16	positive	positive	ADJ
hls-11379	118	17	and	and	CCONJ
hls-11379	118	18	given	give	VERB
hls-11379	118	19	slandered	slander	VERB
hls-11379	118	20	treatment	treatment	NOUN
hls-11379	118	21	and	and	CCONJ
hls-11379	118	22	re	re	VERB
hls-11379	118	23	-	-	VERB
hls-11379	118	24	tested	test	VERB
hls-11379	118	25	again	again	ADV
hls-11379	118	26	to	to	PART
hls-11379	118	27	confirm	confirm	VERB
hls-11379	118	28	eradication	eradication	NOUN
hls-11379	118	29	,	,	PUNCT
hls-11379	118	30	found	find	VERB
hls-11379	118	31	no	no	DET
hls-11379	118	32	effect	effect	NOUN
hls-11379	118	33	of	of	ADP
hls-11379	118	34	eradication	eradication	NOUN
hls-11379	118	35	on	on	ADP
hls-11379	118	36	hepatic	hepatic	ADJ
hls-11379	118	37	fat	fat	ADJ
hls-11379	118	38	content	content	NOUN
hls-11379	118	39	checked	check	VERB
hls-11379	118	40	by	by	ADP
hls-11379	118	41	nafld	nafld	ADJ
hls-11379	118	42	liver	liver	PROPN
hls-11379	118	43	fat	fat	ADJ
hls-11379	118	44	score	score	NOUN
hls-11379	118	45	.	.	PUNCT
hls-11379	119	1	in	in	ADP
hls-11379	119	2	our	our	PRON
hls-11379	119	3	study	study	NOUN
hls-11379	119	4	,	,	PUNCT
hls-11379	119	5	h.	h.	PROPN
hls-11379	119	6	pylori	pylori	PROPN
hls-11379	119	7	infection	infection	NOUN
hls-11379	119	8	was	be	AUX
hls-11379	119	9	significantly	significantly	ADV
hls-11379	119	10	associated	associate	VERB
hls-11379	119	11	with	with	ADP
hls-11379	119	12	nafld	nafld	ADJ
hls-11379	119	13	,	,	PUNCT
hls-11379	119	14	where	where	SCONJ
hls-11379	119	15	it	it	PRON
hls-11379	119	16	existed	exist	VERB
hls-11379	119	17	in	in	ADP
hls-11379	119	18	68	68	NUM
hls-11379	119	19	%	%	NOUN
hls-11379	119	20	of	of	ADP
hls-11379	119	21	patients	patient	NOUN
hls-11379	119	22	with	with	ADP
hls-11379	119	23	elastography	elastography	NOUN
hls-11379	119	24	>	>	X
hls-11379	119	25	248	248	NUM
hls-11379	119	26	db	db	PROPN
hls-11379	119	27	/	/	SYM
hls-11379	119	28	m	m	PROPN
hls-11379	119	29	(	(	PUNCT
hls-11379	119	30	95	95	NUM
hls-11379	119	31	%	%	NOUN
hls-11379	119	32	ci	ci	NOUN
hls-11379	119	33	0.582	0.582	NUM
hls-11379	119	34	-	-	PUNCT
hls-11379	119	35	0.794	0.794	NUM
hls-11379	119	36	,	,	PUNCT
hls-11379	119	37	p=0.001	p=0.001	NUM
hls-11379	119	38	,	,	PUNCT
hls-11379	119	39	sensitivity	sensitivity	NOUN
hls-11379	119	40	68	68	NUM
hls-11379	119	41	%	%	NOUN
hls-11379	119	42	and	and	CCONJ
hls-11379	119	43	specificity	specificity	NOUN
hls-11379	119	44	68	68	NUM
hls-11379	119	45	%	%	NOUN
hls-11379	119	46	)	)	PUNCT
hls-11379	119	47	.	.	PUNCT
hls-11379	120	1	univariate	univariate	ADJ
hls-11379	120	2	analysis	analysis	NOUN
hls-11379	120	3	showed	show	VERB
hls-11379	120	4	that	that	SCONJ
hls-11379	120	5	age	age	NOUN
hls-11379	120	6	,	,	PUNCT
hls-11379	120	7	bmi	bmi	NOUN
hls-11379	120	8	,	,	PUNCT
hls-11379	120	9	and	and	CCONJ
hls-11379	120	10	h.	h.	PROPN
hls-11379	120	11	pylori	pylori	NOUN
hls-11379	120	12	infection	infection	NOUN
hls-11379	120	13	were	be	AUX
hls-11379	120	14	associated	associate	VERB
hls-11379	120	15	with	with	ADP
hls-11379	120	16	nafld	nafld	PROPN
hls-11379	120	17	after	after	ADP
hls-11379	120	18	adjustment	adjustment	NOUN
hls-11379	120	19	with	with	ADP
hls-11379	120	20	alt	alt	ADJ
hls-11379	120	21	,	,	PUNCT
hls-11379	120	22	ast	ast	ADJ
hls-11379	120	23	,	,	PUNCT
hls-11379	120	24	total	total	ADJ
hls-11379	120	25	cholesterol	cholesterol	NOUN
hls-11379	120	26	,	,	PUNCT
hls-11379	120	27	ldl	ldl	NOUN
hls-11379	120	28	,	,	PUNCT
hls-11379	120	29	hdl	hdl	PROPN
hls-11379	120	30	,	,	PUNCT
hls-11379	120	31	and	and	CCONJ
hls-11379	120	32	tg	tg	PROPN
hls-11379	120	33	,	,	PUNCT
hls-11379	120	34	multivariate	multivariate	VERB
hls-11379	120	35	analysis	analysis	NOUN
hls-11379	120	36	showed	show	VERB
hls-11379	120	37	that	that	SCONJ
hls-11379	120	38	they	they	PRON
hls-11379	120	39	were	be	AUX
hls-11379	120	40	still	still	ADV
hls-11379	120	41	independent	independent	ADJ
hls-11379	120	42	risk	risk	NOUN
hls-11379	120	43	factors	factor	NOUN
hls-11379	120	44	for	for	ADP
hls-11379	120	45	nafld	nafld	ADJ
hls-11379	120	46	.	.	PUNCT
hls-11379	121	1	conclusions	conclusion	NOUN
hls-11379	121	2	increasing	increase	VERB
hls-11379	121	3	age	age	NOUN
hls-11379	121	4	,	,	PUNCT
hls-11379	121	5	weight	weight	NOUN
hls-11379	121	6	,	,	PUNCT
hls-11379	121	7	and	and	CCONJ
hls-11379	121	8	h.	h.	PROPN
hls-11379	121	9	pylori	pylori	NOUN
hls-11379	121	10	infection	infection	NOUN
hls-11379	121	11	are	be	AUX
hls-11379	121	12	independent	independent	ADJ
hls-11379	121	13	risk	risk	NOUN
hls-11379	121	14	factors	factor	NOUN
hls-11379	121	15	for	for	ADP
hls-11379	121	16	the	the	DET
hls-11379	121	17	development	development	NOUN
hls-11379	121	18	of	of	ADP
hls-11379	121	19	nafld	nafld	PROPN
hls-11379	121	20	.	.	PUNCT
hls-11379	122	1	therefore	therefore	ADV
hls-11379	122	2	,	,	PUNCT
hls-11379	122	3	weight	weight	NOUN
hls-11379	122	4	reduction	reduction	NOUN
hls-11379	122	5	and	and	CCONJ
hls-11379	122	6	treatment	treatment	NOUN
hls-11379	122	7	of	of	ADP
hls-11379	122	8	h.	h.	PROPN
hls-11379	122	9	pylori	pylori	ADJ
hls-11379	122	10	infection	infection	NOUN
hls-11379	122	11	may	may	AUX
hls-11379	122	12	help	help	VERB
hls-11379	122	13	to	to	PART
hls-11379	122	14	reduce	reduce	VERB
hls-11379	122	15	the	the	DET
hls-11379	122	16	incidence	incidence	NOUN
hls-11379	122	17	of	of	ADP
hls-11379	122	18	fatty	fatty	NOUN
hls-11379	122	19	liver	liver	NOUN
hls-11379	122	20	.	.	PUNCT
hls-11379	123	1	references	reference	NOUN
hls-11379	123	2	1	1	NUM
hls-11379	123	3	.	.	PUNCT
hls-11379	124	1	narayanan	narayanan	PROPN
hls-11379	124	2	m	m	PROPN
hls-11379	124	3	,	,	PUNCT
hls-11379	124	4	reddy	reddy	PROPN
hls-11379	124	5	k	k	PROPN
hls-11379	124	6	,	,	PUNCT
hls-11379	124	7	marsicano	marsicano	PROPN
hls-11379	124	8	e.	e.	PROPN
hls-11379	124	9	peptic	peptic	ADJ
hls-11379	124	10	ulcer	ulcer	NOUN
hls-11379	124	11	disease	disease	NOUN
hls-11379	124	12	and	and	CCONJ
hls-11379	124	13	helicobacter	helicobacter	NOUN
hls-11379	124	14	pylori	pylori	ADJ
hls-11379	124	15	infection	infection	NOUN
hls-11379	124	16	.	.	PUNCT
hls-11379	125	1	mo	mo	PROPN
hls-11379	125	2	med	med	PROPN
hls-11379	125	3	2018;115:219	2018;115:219	PROPN
hls-11379	125	4	-	-	SYM
hls-11379	125	5	24	24	NUM
hls-11379	125	6	.	.	PUNCT
hls-11379	125	7	2	2	NUM
hls-11379	125	8	.	.	X
hls-11379	125	9	waluga	waluga	PROPN
hls-11379	125	10	m	m	PROPN
hls-11379	125	11	,	,	PUNCT
hls-11379	125	12	kukla	kukla	PROPN
hls-11379	125	13	m	m	PROPN
hls-11379	125	14	,	,	PUNCT
hls-11379	125	15	zorniak	zorniak	PROPN
hls-11379	125	16	m.	m.	NOUN
hls-11379	125	17	from	from	ADP
hls-11379	125	18	the	the	DET
hls-11379	125	19	stomach	stomach	NOUN
hls-11379	125	20	to	to	ADP
hls-11379	125	21	other	other	ADJ
hls-11379	125	22	organs	organ	NOUN
hls-11379	125	23	:	:	PUNCT
hls-11379	125	24	helicobacter	helicobacter	NOUN
hls-11379	125	25	pylori	pylori	NOUN
hls-11379	125	26	and	and	CCONJ
hls-11379	125	27	the	the	DET
hls-11379	125	28	liver	liver	NOUN
hls-11379	125	29	.	.	PUNCT
hls-11379	126	1	world	world	PROPN
hls-11379	126	2	j	j	PROPN
hls-11379	126	3	hepatol	hepatol	ADV
hls-11379	126	4	2015;18:2136	2015;18:2136	NUM
hls-11379	126	5	-	-	SYM
hls-11379	126	6	46	46	NUM
hls-11379	126	7	.	.	PUNCT
hls-11379	127	1	3	3	X
hls-11379	127	2	.	.	X
hls-11379	128	1	kim	kim	PROPN
hls-11379	128	2	d	d	PROPN
hls-11379	128	3	,	,	PUNCT
hls-11379	128	4	kim	kim	PROPN
hls-11379	128	5	wr	wr	PROPN
hls-11379	128	6	.	.	PUNCT
hls-11379	129	1	non	non	ADJ
hls-11379	129	2	-	-	ADJ
hls-11379	129	3	obese	obese	ADJ
hls-11379	129	4	.	.	PUNCT
hls-11379	130	1	clin	clin	PROPN
hls-11379	130	2	gastroenterol	gastroenterol	VERB
hls-11379	130	3	hepatol	hepatol	ADJ
hls-11379	130	4	2017;15:474	2017;15:474	NOUN
hls-11379	130	5	-	-	SYM
hls-11379	130	6	85	85	NUM
hls-11379	130	7	.	.	PUNCT
hls-11379	131	1	4	4	NUM
hls-11379	131	2	.	.	X
hls-11379	132	1	younossi	younossi	PROPN
hls-11379	132	2	z	z	PROPN
hls-11379	132	3	,	,	PUNCT
hls-11379	132	4	anstee	anstee	PROPN
hls-11379	132	5	m	m	PROPN
hls-11379	132	6	,	,	PUNCT
hls-11379	132	7	marietti	marietti	PROPN
hls-11379	132	8	m.	m.	NOUN
hls-11379	132	9	global	global	ADJ
hls-11379	132	10	burden	burden	NOUN
hls-11379	132	11	of	of	ADP
hls-11379	132	12	nafld	nafld	ADJ
hls-11379	132	13	and	and	CCONJ
hls-11379	132	14	nash	nash	NOUN
hls-11379	132	15	:	:	PUNCT
hls-11379	132	16	trends	trend	NOUN
hls-11379	132	17	,	,	PUNCT
hls-11379	132	18	predictions	prediction	NOUN
hls-11379	132	19	,	,	PUNCT
hls-11379	132	20	risk	risk	NOUN
hls-11379	132	21	factors	factor	NOUN
hls-11379	132	22	and	and	CCONJ
hls-11379	132	23	prevention	prevention	NOUN
hls-11379	132	24	.	.	PUNCT
hls-11379	133	1	nat	nat	PROPN
hls-11379	133	2	rev	rev	PROPN
hls-11379	133	3	gastroenterol	gastroenterol	NOUN
hls-11379	133	4	hepatol	hepatol	ADJ
hls-11379	133	5	2018;15:11	2018;15:11	NUM
hls-11379	133	6	-	-	SYM
hls-11379	133	7	20	20	NUM
hls-11379	133	8	.	.	PUNCT
hls-11379	134	1	5	5	X
hls-11379	134	2	.	.	X
hls-11379	134	3	anstee	anstee	PROPN
hls-11379	134	4	m	m	PROPN
hls-11379	134	5	,	,	PUNCT
hls-11379	134	6	targher	targher	ADV
hls-11379	134	7	g	g	NOUN
hls-11379	134	8	,	,	PUNCT
hls-11379	134	9	day	day	NOUN
hls-11379	134	10	p.	p.	NOUN
hls-11379	134	11	progression	progression	NOUN
hls-11379	134	12	of	of	ADP
hls-11379	134	13	nafld	nafld	ADV
hls-11379	134	14	to	to	PART
hls-11379	134	15	diabetes	diabetes	VERB
hls-11379	134	16	mellitus	mellitus	NOUN
hls-11379	134	17	,	,	PUNCT
hls-11379	134	18	cardiovascular	cardiovascular	ADJ
hls-11379	134	19	disease	disease	NOUN
hls-11379	134	20	or	or	CCONJ
hls-11379	134	21	cirrhosis	cirrhosis	NOUN
hls-11379	134	22	.	.	PUNCT
hls-11379	135	1	nat	nat	PROPN
hls-11379	135	2	rev	rev	PROPN
hls-11379	135	3	gastroenterol	gastroenterol	NOUN
hls-11379	135	4	hepatol	hepatol	ADJ
hls-11379	135	5	2013;10:330	2013;10:330	NUM
hls-11379	135	6	-	-	SYM
hls-11379	135	7	44	44	NUM
hls-11379	135	8	.	.	PUNCT
hls-11379	136	1	6	6	NUM
hls-11379	136	2	.	.	X
hls-11379	136	3	arab	arab	PROPN
hls-11379	136	4	p	p	X
hls-11379	136	5	,	,	PUNCT
hls-11379	136	6	arrrese	arrrese	PROPN
hls-11379	136	7	m	m	PROPN
hls-11379	136	8	,	,	PUNCT
hls-11379	136	9	trauner	trauner	NOUN
hls-11379	136	10	m.	m.	NOUN
hls-11379	136	11	recent	recent	ADJ
hls-11379	136	12	insight	insight	NOUN
hls-11379	136	13	into	into	ADP
hls-11379	136	14	pathogenesis	pathogenesis	NOUN
hls-11379	136	15	of	of	ADP
hls-11379	136	16	nonalcoholic	nonalcoholic	ADJ
hls-11379	136	17	fatty	fatty	NOUN
hls-11379	136	18	liver	liver	NOUN
hls-11379	136	19	disease	disease	NOUN
hls-11379	136	20	.	.	PUNCT
hls-11379	137	1	annu	annu	PROPN
hls-11379	137	2	rev	rev	PROPN
hls-11379	137	3	pathol	pathol	PROPN
hls-11379	137	4	2018;13:321	2018;13:321	NOUN
hls-11379	137	5	-	-	SYM
hls-11379	137	6	50	50	NUM
hls-11379	137	7	.	.	PUNCT
hls-11379	138	1	7	7	X
hls-11379	138	2	.	.	X
hls-11379	138	3	berlanga	berlanga	PROPN
hls-11379	138	4	a	a	PRON
hls-11379	138	5	,	,	PUNCT
hls-11379	138	6	guiu	guiu	NOUN
hls-11379	138	7	-	-	PUNCT
hls-11379	138	8	jurado	jurado	PROPN
hls-11379	138	9	e	e	PROPN
hls-11379	138	10	,	,	PUNCT
hls-11379	138	11	porras	porras	PROPN
hls-11379	138	12	a	a	X
hls-11379	138	13	,	,	PUNCT
hls-11379	138	14	auguet	auguet	VERB
hls-11379	138	15	t.	t.	NOUN
hls-11379	138	16	molecular	molecular	ADJ
hls-11379	138	17	pathways	pathway	NOUN
hls-11379	138	18	in	in	ADP
hls-11379	138	19	non	non	ADJ
hls-11379	138	20	-	-	ADJ
hls-11379	138	21	alcoholic	alcoholic	ADJ
hls-11379	138	22	fatty	fatty	NOUN
hls-11379	138	23	liver	liver	NOUN
hls-11379	138	24	disease	disease	NOUN
hls-11379	138	25	.	.	PUNCT
hls-11379	139	1	clin.exp	clin.exp	X
hls-11379	139	2	.	.	PROPN
hls-11379	139	3	gastroenterol	gastroenterol	PROPN
hls-11379	139	4	2014;7:221	2014;7:221	NOUN
hls-11379	139	5	-	-	SYM
hls-11379	139	6	39	39	NUM
hls-11379	139	7	.	.	PUNCT
hls-11379	140	1	8	8	NUM
hls-11379	140	2	.	.	X
hls-11379	140	3	basaranoglu	basaranoglu	PROPN
hls-11379	140	4	m	m	PROPN
hls-11379	140	5	,	,	PUNCT
hls-11379	140	6	basaranoglu	basaranoglu	NOUN
hls-11379	140	7	g	g	NOUN
hls-11379	140	8	,	,	PUNCT
hls-11379	140	9	senturk	senturk	PROPN
hls-11379	140	10	h.	h.	PROPN
hls-11379	141	1	from	from	ADP
hls-11379	141	2	fatty	fatty	NOUN
hls-11379	141	3	liver	liver	NOUN
hls-11379	141	4	to	to	ADP
hls-11379	141	5	fibrosis	fibrosis	NOUN
hls-11379	141	6	:	:	PUNCT
hls-11379	141	7	a	a	DET
hls-11379	141	8	tale	tale	NOUN
hls-11379	141	9	of	of	ADP
hls-11379	141	10	"	"	PUNCT
hls-11379	141	11	second	second	ADJ
hls-11379	141	12	hit	hit	NOUN
hls-11379	141	13	.	.	PUNCT
hls-11379	141	14	"	"	PUNCT
hls-11379	142	1	world	world	PROPN
hls-11379	142	2	j	j	PROPN
hls-11379	142	3	gastroenterol	gastroenterol	PROPN
hls-11379	142	4	2013;19:1158	2013;19:1158	NUM
hls-11379	142	5	-	-	SYM
hls-11379	142	6	65	65	NUM
hls-11379	142	7	.	.	NOUN
hls-11379	142	8	9	9	NUM
hls-11379	142	9	.	.	PUNCT
hls-11379	142	10	takaki	takaki	PROPN
hls-11379	142	11	a	a	X
hls-11379	142	12	,	,	PUNCT
hls-11379	142	13	kawai	kawai	PROPN
hls-11379	142	14	d	d	PROPN
hls-11379	142	15	,	,	PUNCT
hls-11379	142	16	yamamoto	yamamoto	PROPN
hls-11379	142	17	k.	k.	PROPN
hls-11379	142	18	multiple	multiple	PROPN
hls-11379	142	19	hits	hit	VERB
hls-11379	142	20	including	include	VERB
hls-11379	142	21	oxidative	oxidative	ADJ
hls-11379	142	22	stress	stress	NOUN
hls-11379	142	23	,	,	PUNCT
hls-11379	142	24	as	as	ADP
hls-11379	142	25	pathogenesis	pathogenesis	NOUN
hls-11379	142	26	and	and	CCONJ
hls-11379	142	27	treatment	treatment	NOUN
hls-11379	142	28	target	target	NOUN
hls-11379	142	29	in	in	ADP
hls-11379	142	30	nonalcoholic	nonalcoholic	PROPN
hls-11379	142	31	steatohepatitis	steatohepatitis	PROPN
hls-11379	142	32	(	(	PUNCT
hls-11379	142	33	nash	nash	PROPN
hls-11379	142	34	)	)	PUNCT
hls-11379	142	35	.	.	PUNCT
hls-11379	143	1	int	int	PROPN
hls-11379	143	2	j	j	PROPN
hls-11379	143	3	mol	mol	ADP
hls-11379	143	4	sci	sci	PROPN
hls-11379	143	5	2013;14	2013;14	NUM
hls-11379	143	6	:	:	PUNCT
hls-11379	143	7	20704	20704	NUM
hls-11379	143	8	-	-	SYM
hls-11379	143	9	28	28	NUM
hls-11379	143	10	.	.	PUNCT
hls-11379	144	1	10	10	NUM
hls-11379	144	2	.	.	PUNCT
hls-11379	145	1	buzzetti	buzzetti	PROPN
hls-11379	145	2	e	e	PROPN
hls-11379	145	3	,	,	PUNCT
hls-11379	145	4	pinzani	pinzani	PROPN
hls-11379	145	5	m	m	PROPN
hls-11379	145	6	,	,	PUNCT
hls-11379	145	7	tsochatzis	tsochatzi	NOUN
hls-11379	145	8	a.	a.	VERB
hls-11379	145	9	the	the	DET
hls-11379	145	10	multiplehit	multiplehit	ADJ
hls-11379	145	11	pathogenesis	pathogenesis	NOUN
hls-11379	145	12	of	of	ADP
hls-11379	145	13	non	non	ADJ
hls-11379	145	14	-	-	ADJ
hls-11379	145	15	alcoholic	alcoholic	ADJ
hls-11379	145	16	fatty	fatty	NOUN
hls-11379	145	17	liver	liver	NOUN
hls-11379	145	18	(	(	PUNCT
hls-11379	145	19	nafld	nafld	ADJ
hls-11379	145	20	)	)	PUNCT
hls-11379	145	21	.	.	PUNCT
hls-11379	146	1	metabolism	metabolism	NOUN
hls-11379	146	2	2016;65:1038	2016;65:1038	NUM
hls-11379	146	3	-	-	SYM
hls-11379	146	4	48	48	NUM
hls-11379	146	5	.	.	PUNCT
hls-11379	146	6	11	11	NUM
hls-11379	146	7	.	.	PUNCT
hls-11379	147	1	khosravi	khosravi	PROPN
hls-11379	147	2	y	y	PROPN
hls-11379	147	3	,	,	PUNCT
hls-11379	147	4	seow	seow	PROPN
hls-11379	147	5	s	s	PROPN
hls-11379	147	6	,	,	PUNCT
hls-11379	147	7	moyo	moyo	PROPN
hls-11379	147	8	a	a	X
hls-11379	147	9	,	,	PUNCT
hls-11379	147	10	et	et	PROPN
hls-11379	147	11	al	al	PROPN
hls-11379	147	12	.	.	PUNCT
hls-11379	148	1	helicobacter	helicobacter	NOUN
hls-11379	148	2	pylori	pylori	NOUN
hls-11379	148	3	infection	infection	NOUN
hls-11379	148	4	can	can	AUX
hls-11379	148	5	affect	affect	VERB
hls-11379	148	6	energy	energy	NOUN
hls-11379	148	7	modulating	modulate	VERB
hls-11379	148	8	hormones	hormone	NOUN
hls-11379	148	9	and	and	CCONJ
hls-11379	148	10	body	body	NOUN
hls-11379	148	11	weight	weight	NOUN
hls-11379	148	12	in	in	ADP
hls-11379	148	13	germ	germ	NOUN
hls-11379	148	14	free	free	ADJ
hls-11379	148	15	mice	mouse	NOUN
hls-11379	148	16	.	.	PUNCT
hls-11379	149	1	sci	sci	PROPN
hls-11379	149	2	rep	rep	PROPN
hls-11379	149	3	2015;5:8731	2015;5:8731	PROPN
hls-11379	149	4	.	.	PUNCT
hls-11379	150	1	12	12	NUM
hls-11379	150	2	.	.	PUNCT
hls-11379	151	1	sumida	sumida	PROPN
hls-11379	151	2	y	y	PROPN
hls-11379	151	3	,	,	PUNCT
hls-11379	151	4	kanemasa	kanemasa	PROPN
hls-11379	151	5	k	k	PROPN
hls-11379	151	6	,	,	PUNCT
hls-11379	151	7	imai	imai	PROPN
hls-11379	151	8	s	s	PROPN
hls-11379	151	9	,	,	PUNCT
hls-11379	151	10	et	et	PROPN
hls-11379	151	11	al	al	PROPN
hls-11379	151	12	.	.	PUNCT
hls-11379	152	1	helicobacter	helicobacter	NOUN
hls-11379	152	2	pylori	pylori	NOUN
hls-11379	152	3	infection	infection	NOUN
hls-11379	152	4	might	might	AUX
hls-11379	152	5	have	have	VERB
hls-11379	152	6	a	a	DET
hls-11379	152	7	potential	potential	ADJ
hls-11379	152	8	role	role	NOUN
hls-11379	152	9	in	in	ADP
hls-11379	152	10	hepatocyte	hepatocyte	NOUN
hls-11379	152	11	ballooning	ballooning	NOUN
hls-11379	152	12	in	in	ADP
hls-11379	152	13	nonalcoholic	nonalcoholic	ADJ
hls-11379	152	14	fatty	fatty	NOUN
hls-11379	152	15	liver	liver	NOUN
hls-11379	152	16	disease	disease	NOUN
hls-11379	152	17	.	.	PUNCT
hls-11379	153	1	j	j	PROPN
hls-11379	153	2	gastroenterol	gastroenterol	PROPN
hls-11379	153	3	2016;50	2016;50	NUM
hls-11379	153	4	:	:	PUNCT
hls-11379	153	5	996	996	NUM
hls-11379	153	6	-	-	SYM
hls-11379	153	7	1004	1004	NUM
hls-11379	153	8	.	.	PUNCT
hls-11379	154	1	13	13	NUM
hls-11379	154	2	.	.	PUNCT
hls-11379	155	1	doust	doust	PROPN
hls-11379	155	2	j	j	PROPN
hls-11379	155	3	,	,	PUNCT
hls-11379	155	4	glasziou	glasziou	NOUN
hls-11379	155	5	p.	p.	NOUN
hls-11379	155	6	monitoring	monitoring	NOUN
hls-11379	155	7	in	in	ADP
hls-11379	155	8	clinical	clinical	ADJ
hls-11379	155	9	biochemistry	biochemistry	NOUN
hls-11379	155	10	.	.	PUNCT
hls-11379	156	1	clin	clin	PROPN
hls-11379	156	2	biochem	biochem	PROPN
hls-11379	156	3	rev	rev	VERB
hls-11379	156	4	2013;34:85	2013;34:85	NUM
hls-11379	156	5	-	-	SYM
hls-11379	156	6	92	92	NUM
hls-11379	156	7	.	.	PUNCT
hls-11379	157	1	14	14	NUM
hls-11379	157	2	.	.	PUNCT
hls-11379	158	1	sabbagh	sabbagh	PROPN
hls-11379	158	2	p	p	X
hls-11379	158	3	,	,	PUNCT
hls-11379	158	4	mohammadnia	mohammadnia	PROPN
hls-11379	158	5	-	-	PUNCT
hls-11379	158	6	afrouzi	afrouzi	PROPN
hls-11379	158	7	m	m	PROPN
hls-11379	158	8	,	,	PUNCT
hls-11379	158	9	javanian	javanian	PROPN
hls-11379	158	10	m	m	PROPN
hls-11379	158	11	,	,	PUNCT
hls-11379	158	12	et	et	PROPN
hls-11379	158	13	al	al	PROPN
hls-11379	158	14	.	.	PUNCT
hls-11379	159	1	diagnostic	diagnostic	ADJ
hls-11379	159	2	methods	method	NOUN
hls-11379	159	3	for	for	ADP
hls-11379	159	4	helicobacter	helicobacter	NOUN
hls-11379	159	5	pylori	pylori	ADJ
hls-11379	159	6	infection	infection	NOUN
hls-11379	159	7	:	:	PUNCT
hls-11379	159	8	ideals	ideal	NOUN
hls-11379	159	9	,	,	PUNCT
hls-11379	159	10	options	option	NOUN
hls-11379	159	11	,	,	PUNCT
hls-11379	159	12	and	and	CCONJ
hls-11379	159	13	limitations	limitation	NOUN
hls-11379	159	14	.	.	PUNCT
hls-11379	160	1	eur	eur	PROPN
hls-11379	160	2	j	j	PROPN
hls-11379	160	3	clin	clin	PROPN
hls-11379	160	4	microbiol	microbiol	PROPN
hls-11379	160	5	infect	infect	VERB
hls-11379	160	6	dis	dis	PROPN
hls-11379	160	7	2019	2019	NUM
hls-11379	160	8	;	;	PUNCT
hls-11379	160	9	38:55	38:55	NUM
hls-11379	160	10	-	-	SYM
hls-11379	160	11	66	66	NUM
hls-11379	160	12	.	.	PUNCT
hls-11379	161	1	15	15	NUM
hls-11379	161	2	.	.	PUNCT
hls-11379	161	3	tapper	tapper	PROPN
hls-11379	161	4	eb	eb	PROPN
hls-11379	161	5	,	,	PUNCT
hls-11379	161	6	loomba	loomba	PROPN
hls-11379	161	7	r.	r.	PROPN
hls-11379	161	8	noninvasive	noninvasive	PROPN
hls-11379	161	9	imaging	imaging	PROPN
hls-11379	161	10	biomarker	biomarker	NOUN
hls-11379	161	11	assessment	assessment	NOUN
hls-11379	161	12	of	of	ADP
hls-11379	161	13	liver	liver	NOUN
hls-11379	161	14	fibrosis	fibrosis	NOUN
hls-11379	161	15	by	by	ADP
hls-11379	161	16	elastography	elastography	NOUN
hls-11379	161	17	in	in	ADP
hls-11379	161	18	nafld	nafld	PROPN
hls-11379	161	19	.	.	PUNCT
hls-11379	162	1	nat	nat	PROPN
hls-11379	162	2	rev	rev	PROPN
hls-11379	162	3	gastroenterol	gastroenterol	NOUN
hls-11379	162	4	hepatol	hepatol	ADJ
hls-11379	162	5	2018;15:274	2018;15:274	NUM
hls-11379	162	6	-	-	SYM
hls-11379	162	7	82	82	NUM
hls-11379	162	8	.	.	PUNCT
hls-11379	162	9	16	16	NUM
hls-11379	162	10	.	.	PUNCT
hls-11379	163	1	allen	allen	PROPN
hls-11379	163	2	a	a	PRON
hls-11379	163	3	,	,	PUNCT
hls-11379	163	4	therneau	therneau	PROPN
hls-11379	163	5	t	t	PROPN
hls-11379	163	6	,	,	PUNCT
hls-11379	163	7	larson	larson	PROPN
hls-11379	163	8	j	j	PROPN
hls-11379	163	9	,	,	PUNCT
hls-11379	163	10	et	et	PROPN
hls-11379	163	11	al	al	PROPN
hls-11379	163	12	.	.	PROPN
hls-11379	164	1	nonalcoholic	nonalcoholic	PROPN
hls-11379	164	2	fatty	fatty	NOUN
hls-11379	164	3	liver	liver	NOUN
hls-11379	164	4	disease	disease	NOUN
hls-11379	164	5	incidence	incidence	NOUN
hls-11379	164	6	and	and	CCONJ
hls-11379	164	7	impact	impact	NOUN
hls-11379	164	8	on	on	ADP
hls-11379	164	9	metabolic	metabolic	NOUN
hls-11379	164	10	burden	burden	NOUN
hls-11379	164	11	and	and	CCONJ
hls-11379	164	12	death	death	NOUN
hls-11379	164	13	:	:	PUNCT
hls-11379	164	14	a	a	DET
hls-11379	164	15	20	20	NUM
hls-11379	164	16	yearcommunity	yearcommunity	NOUN
hls-11379	164	17	study	study	NOUN
hls-11379	164	18	.	.	PUNCT
hls-11379	165	1	hepatology	hepatology	NOUN
hls-11379	165	2	2018;67:1726	2018;67:1726	NUM
hls-11379	165	3	-	-	SYM
hls-11379	165	4	36	36	NUM
hls-11379	165	5	.	.	PUNCT
hls-11379	165	6	17	17	NUM
hls-11379	165	7	.	.	PUNCT
hls-11379	165	8	alqahtani	alqahtani	PROPN
hls-11379	166	1	schattenberg	schattenberg	PROPN
hls-11379	166	2	j.	j.	PROPN
hls-11379	166	3	nafld	nafld	PROPN
hls-11379	166	4	in	in	ADP
hls-11379	166	5	the	the	DET
hls-11379	166	6	elderly	elderly	ADJ
hls-11379	166	7	.	.	PUNCT
hls-11379	167	1	clin	clin	PROPN
hls-11379	167	2	interv	interv	VERB
hls-11379	167	3	aging	age	VERB
hls-11379	167	4	2021;16:1633	2021;16:1633	NUM
hls-11379	167	5	-	-	SYM
hls-11379	167	6	49	49	NUM
hls-11379	167	7	.	.	PUNCT
hls-11379	168	1	18	18	NUM
hls-11379	168	2	.	.	X
hls-11379	169	1	ballestri	ballestri	PROPN
hls-11379	169	2	s	s	PROPN
hls-11379	169	3	,	,	PUNCT
hls-11379	169	4	nascimbeni	nascimbeni	NOUN
hls-11379	169	5	f	f	PROPN
hls-11379	169	6	,	,	PUNCT
hls-11379	169	7	baldelli	baldelli	PROPN
hls-11379	169	8	e	e	PROPN
hls-11379	169	9	,	,	PUNCT
hls-11379	169	10	et	et	PROPN
hls-11379	169	11	al	al	PROPN
hls-11379	169	12	.	.	PUNCT
hls-11379	170	1	nafld	nafld	ADV
hls-11379	170	2	as	as	ADP
hls-11379	170	3	a	a	DET
hls-11379	170	4	sexual	sexual	ADJ
hls-11379	170	5	dimorphic	dimorphic	ADJ
hls-11379	170	6	disease	disease	NOUN
hls-11379	170	7	:	:	PUNCT
hls-11379	170	8	role	role	NOUN
hls-11379	170	9	of	of	ADP
hls-11379	170	10	gender	gender	NOUN
hls-11379	170	11	and	and	CCONJ
hls-11379	170	12	reproductive	reproductive	ADJ
hls-11379	170	13	status	status	NOUN
hls-11379	170	14	in	in	ADP
hls-11379	170	15	the	the	DET
hls-11379	170	16	development	development	NOUN
hls-11379	170	17	and	and	CCONJ
hls-11379	170	18	progression	progression	NOUN
hls-11379	170	19	of	of	ADP
hls-11379	170	20	nonalcoholic	nonalcoholic	ADJ
hls-11379	170	21	fatty	fatty	NOUN
hls-11379	170	22	liver	liver	NOUN
hls-11379	170	23	disease	disease	NOUN
hls-11379	170	24	and	and	CCONJ
hls-11379	170	25	inherent	inherent	ADJ
hls-11379	170	26	cardiovascular	cardiovascular	ADJ
hls-11379	170	27	risk	risk	NOUN
hls-11379	170	28	.	.	PUNCT
hls-11379	171	1	adv	adv	INTJ
hls-11379	171	2	ther	ther	ADV
hls-11379	172	1	2017;34	2017;34	NUM
hls-11379	172	2	:	:	PUNCT
hls-11379	172	3	1291	1291	NUM
hls-11379	172	4	-	-	SYM
hls-11379	172	5	326	326	NUM
hls-11379	172	6	.	.	NOUN
hls-11379	173	1	19	19	NUM
hls-11379	173	2	.	.	PUNCT
hls-11379	174	1	hamaguchi	hamaguchi	PROPN
hls-11379	174	2	m	m	PROPN
hls-11379	174	3	,	,	PUNCT
hls-11379	174	4	kojima	kojima	PROPN
hls-11379	174	5	t	t	PROPN
hls-11379	174	6	,	,	PUNCT
hls-11379	174	7	ohbora	ohbora	NOUN
hls-11379	174	8	a.	a.	NOUN
hls-11379	174	9	aging	aging	NOUN
hls-11379	174	10	is	be	AUX
hls-11379	174	11	a	a	DET
hls-11379	174	12	risk	risk	NOUN
hls-11379	174	13	factor	factor	NOUN
hls-11379	174	14	of	of	ADP
hls-11379	174	15	nonalcoholic	nonalcoholic	ADJ
hls-11379	174	16	fatty	fatty	NOUN
hls-11379	174	17	liver	liver	NOUN
hls-11379	174	18	disease	disease	NOUN
hls-11379	174	19	in	in	ADP
hls-11379	174	20	premenopausal	premenopausal	ADJ
hls-11379	174	21	women	woman	NOUN
hls-11379	174	22	.	.	PUNCT
hls-11379	175	1	world	world	PROPN
hls-11379	175	2	j	j	PROPN
hls-11379	175	3	gastroenterol	gastroenterol	PROPN
hls-11379	175	4	2012;18:237	2012;18:237	PROPN
hls-11379	175	5	-	-	SYM
hls-11379	175	6	43	43	NUM
hls-11379	175	7	.	.	PUNCT
hls-11379	175	8	20	20	NUM
hls-11379	175	9	.	.	PUNCT
hls-11379	176	1	wang	wang	PROPN
hls-11379	176	2	z	z	PROPN
hls-11379	176	3	,	,	PUNCT
hls-11379	176	4	xu	xu	PROPN
hls-11379	176	5	m	m	PROPN
hls-11379	176	6	,	,	PUNCT
hls-11379	176	7	hu	hu	PROPN
hls-11379	176	8	z.	z.	PROPN
hls-11379	176	9	prevalence	prevalence	NOUN
hls-11379	176	10	of	of	ADP
hls-11379	176	11	nonalcoholic	nonalcoholic	NOUN
hls-11379	176	12	fatty	fatty	NOUN
hls-11379	176	13	liver	liver	NOUN
hls-11379	176	14	disease	disease	NOUN
hls-11379	176	15	and	and	CCONJ
hls-11379	176	16	its	its	PRON
hls-11379	176	17	metabolic	metabolic	NOUN
hls-11379	176	18	risk	risk	NOUN
hls-11379	176	19	factors	factor	NOUN
hls-11379	176	20	in	in	ADP
hls-11379	176	21	women	woman	NOUN
hls-11379	176	22	of	of	ADP
hls-11379	176	23	different	different	ADJ
hls-11379	176	24	ages	age	NOUN
hls-11379	176	25	and	and	CCONJ
hls-11379	176	26	body	body	NOUN
hls-11379	176	27	mass	mass	PROPN
hls-11379	176	28	index	index	NOUN
hls-11379	176	29	.	.	PUNCT
hls-11379	177	1	menopause	menopause	NOUN
hls-11379	177	2	2015;22:667	2015;22:667	NUM
hls-11379	177	3	-	-	SYM
hls-11379	177	4	73	73	NUM
hls-11379	177	5	.	.	PUNCT
hls-11379	178	1	21	21	NUM
hls-11379	178	2	.	.	PUNCT
hls-11379	179	1	polyzos	polyzos	PROPN
hls-11379	179	2	s	s	PROPN
hls-11379	179	3	,	,	PUNCT
hls-11379	179	4	kountouras	kountouras	PROPN
hls-11379	179	5	j	j	PROPN
hls-11379	179	6	,	,	PUNCT
hls-11379	179	7	mantzoros	mantzoros	PROPN
hls-11379	179	8	c.	c.	PROPN
hls-11379	179	9	adipose	adipose	NOUN
hls-11379	179	10	tissue	tissue	NOUN
hls-11379	179	11	,	,	PUNCT
hls-11379	179	12	obesity	obesity	NOUN
hls-11379	179	13	and	and	CCONJ
hls-11379	179	14	non	non	ADJ
hls-11379	179	15	-	-	ADJ
hls-11379	179	16	alcoholic	alcoholic	ADJ
hls-11379	179	17	fatty	fatty	NOUN
hls-11379	179	18	liver	liver	NOUN
hls-11379	179	19	disease	disease	NOUN
hls-11379	179	20	.	.	PUNCT
hls-11379	180	1	minerva	minerva	PROPN
hls-11379	180	2	endocrinologica	endocrinologica	PROPN
hls-11379	180	3	2017;42:92	2017;42:92	NUM
hls-11379	180	4	-	-	SYM
hls-11379	180	5	108	108	NUM
hls-11379	180	6	.	.	PUNCT
hls-11379	181	1	22	22	NUM
hls-11379	181	2	.	.	PUNCT
hls-11379	182	1	fan	fan	PROPN
hls-11379	182	2	wang	wang	PROPN
hls-11379	182	3	j	j	PROPN
hls-11379	182	4	,	,	PUNCT
hls-11379	182	5	du	du	PROPN
hls-11379	182	6	j.	j.	PROPN
hls-11379	182	7	association	association	PROPN
hls-11379	182	8	between	between	ADP
hls-11379	182	9	body	body	NOUN
hls-11379	182	10	mass	mass	NOUN
hls-11379	182	11	index	index	NOUN
hls-11379	182	12	and	and	CCONJ
hls-11379	182	13	fatty	fatty	ADJ
hls-11379	182	14	liver	liver	NOUN
hls-11379	182	15	risk	risk	NOUN
hls-11379	182	16	:	:	PUNCT
hls-11379	182	17	a	a	DET
hls-11379	182	18	dose	dose	VERB
hls-11379	182	19	-	-	PUNCT
hls-11379	182	20	response	response	NOUN
hls-11379	182	21	analysis	analysis	NOUN
hls-11379	182	22	.	.	PUNCT
hls-11379	183	1	sci	sci	PROPN
hls-11379	183	2	rep	rep	PROPN
hls-11379	183	3	2018;8:15273	2018;8:15273	PROPN
hls-11379	183	4	.	.	PUNCT
hls-11379	184	1	23	23	NUM
hls-11379	184	2	.	.	PUNCT
hls-11379	184	3	almobarak	almobarak	PROPN
hls-11379	184	4	a	a	PRON
hls-11379	184	5	,	,	PUNCT
hls-11379	184	6	barakat	barakat	PROPN
hls-11379	184	7	s	s	PROPN
hls-11379	184	8	,	,	PUNCT
hls-11379	184	9	kalifa	kalifa	PROPN
hls-11379	184	10	m	m	PROPN
hls-11379	184	11	,	,	PUNCT
hls-11379	184	12	et	et	PROPN
hls-11379	184	13	al	al	PROPN
hls-11379	184	14	.	.	PUNCT
hls-11379	185	1	non	non	ADJ
hls-11379	185	2	-	-	ADJ
hls-11379	185	3	alcoholic	alcoholic	ADJ
hls-11379	185	4	fatty	fatty	NOUN
hls-11379	185	5	liver	liver	NOUN
hls-11379	185	6	disease	disease	NOUN
hls-11379	185	7	(	(	PUNCT
hls-11379	185	8	nafld	nafld	ADV
hls-11379	185	9	)	)	PUNCT
hls-11379	185	10	in	in	ADP
hls-11379	185	11	a	a	DET
hls-11379	185	12	sudanese	sudanese	ADJ
hls-11379	185	13	population	population	NOUN
hls-11379	185	14	:	:	PUNCT
hls-11379	185	15	what	what	PRON
hls-11379	185	16	is	be	AUX
hls-11379	185	17	the	the	DET
hls-11379	185	18	prevalence	prevalence	NOUN
hls-11379	185	19	and	and	CCONJ
hls-11379	185	20	risk	risk	NOUN
hls-11379	185	21	factors	factor	NOUN
hls-11379	185	22	.	.	PUNCT
hls-11379	186	1	arab	arab	PROPN
hls-11379	186	2	j	j	PROPN
hls-11379	186	3	gastroenterol	gastroenterol	PROPN
hls-11379	186	4	2014;15:125	2014;15:125	NUM
hls-11379	186	5	.	.	PUNCT
hls-11379	187	1	24	24	NUM
hls-11379	187	2	.	.	PUNCT
hls-11379	188	1	mato	mato	PROPN
hls-11379	188	2	j	j	PROPN
hls-11379	188	3	,	,	PUNCT
hls-11379	188	4	alons	alons	PROPN
hls-11379	188	5	c	c	NOUN
hls-11379	188	6	,	,	PUNCT
hls-11379	188	7	noureddin	noureddin	PROPN
hls-11379	188	8	m	m	PROPN
hls-11379	188	9	,	,	PUNCT
hls-11379	188	10	lu	lu	PROPN
hls-11379	188	11	sc	sc	PROPN
hls-11379	188	12	.	.	PUNCT
hls-11379	188	13	biomarkers	biomarker	NOUN
hls-11379	188	14	and	and	CCONJ
hls-11379	188	15	subtypes	subtype	NOUN
hls-11379	188	16	of	of	ADP
hls-11379	188	17	deranged	deranged	ADJ
hls-11379	188	18	lipid	lipid	NOUN
hls-11379	188	19	metabolism	metabolism	NOUN
hls-11379	188	20	in	in	ADP
hls-11379	188	21	non	non	ADJ
hls-11379	188	22	-	-	ADJ
hls-11379	188	23	alcoholic	alcoholic	ADJ
hls-11379	188	24	fatty	fatty	NOUN
hls-11379	188	25	liver	liver	NOUN
hls-11379	188	26	disease	disease	NOUN
hls-11379	188	27	.	.	PUNCT
hls-11379	189	1	world	world	PROPN
hls-11379	189	2	j	j	PROPN
hls-11379	189	3	gastroenterol	gastroenterol	PROPN
hls-11379	189	4	2019;25:3009	2019;25:3009	NUM
hls-11379	189	5	-	-	SYM
hls-11379	189	6	20	20	NUM
hls-11379	189	7	.	.	PUNCT
hls-11379	189	8	25	25	NUM
hls-11379	189	9	.	.	PUNCT
hls-11379	190	1	kantartzis	kantartzis	PROPN
hls-11379	190	2	k	k	PROPN
hls-11379	190	3	,	,	PUNCT
hls-11379	190	4	stefan	stefan	PROPN
hls-11379	190	5	n.	n.	PROPN
hls-11379	190	6	cardiovascular	cardiovascular	ADJ
hls-11379	190	7	disease	disease	NOUN
hls-11379	190	8	in	in	ADP
hls-11379	190	9	patients	patient	NOUN
hls-11379	190	10	with	with	ADP
hls-11379	190	11	non	non	ADJ
hls-11379	190	12	-	-	ADJ
hls-11379	190	13	alcoholic	alcoholic	ADJ
hls-11379	190	14	fatty	fatty	NOUN
hls-11379	190	15	liver	liver	NOUN
hls-11379	190	16	disease	disease	NOUN
hls-11379	190	17	.	.	PUNCT
hls-11379	191	1	ann	ann	PROPN
hls-11379	191	2	gastroenterol	gastroenterol	PROPN
hls-11379	191	3	article	article	NOUN
hls-11379	191	4	[	[	X
hls-11379	191	5	page	page	NOUN
hls-11379	191	6	16	16	NUM
hls-11379	191	7	]	]	PUNCT
hls-11379	192	1	[	[	X
hls-11379	192	2	healthcare	healthcare	NOUN
hls-11379	192	3	in	in	ADP
hls-11379	192	4	low	low	ADJ
hls-11379	192	5	-	-	PUNCT
hls-11379	192	6	resource	resource	NOUN
hls-11379	192	7	settings	setting	NOUN
hls-11379	192	8	2023	2023	NUM
hls-11379	192	9	;	;	PUNCT
hls-11379	192	10	11(s2):11379	11(s2):11379	NUM
hls-11379	192	11	]	]	X
hls-11379	192	12	non	non	ADJ
hls-11379	192	13	-co	-co	PROPN
hls-11379	192	14	mmerc	mmerc	PROPN
hls-11379	192	15	ial	ial	PROPN
hls-11379	192	16	us	us	PROPN
hls-11379	192	17	e	e	NOUN
hls-11379	192	18	o	o	NOUN
hls-11379	192	19	nly	nly	ADV
hls-11379	192	20	2012;25:276	2012;25:276	NUM
hls-11379	192	21	.	.	PROPN
hls-11379	192	22	26	26	NUM
hls-11379	192	23	.	.	PUNCT
hls-11379	193	1	sookoian	sookoian	PROPN
hls-11379	193	2	s	s	PROPN
hls-11379	193	3	,	,	PUNCT
hls-11379	193	4	castano	castano	PRON
hls-11379	193	5	c	c	NOUN
hls-11379	193	6	,	,	PUNCT
hls-11379	193	7	scian	scian	ADJ
hls-11379	193	8	r	r	NOUN
hls-11379	193	9	,	,	PUNCT
hls-11379	193	10	et	et	PROPN
hls-11379	193	11	al	al	PROPN
hls-11379	193	12	.	.	PROPN
hls-11379	194	1	serum	serum	PROPN
hls-11379	194	2	aminotransferases	aminotransferase	NOUN
hls-11379	194	3	in	in	ADP
hls-11379	194	4	nonalcoholic	nonalcoholic	ADJ
hls-11379	194	5	fatty	fatty	NOUN
hls-11379	194	6	liver	liver	NOUN
hls-11379	194	7	disease	disease	NOUN
hls-11379	194	8	are	be	AUX
hls-11379	194	9	a	a	DET
hls-11379	194	10	signature	signature	NOUN
hls-11379	194	11	of	of	ADP
hls-11379	194	12	liver	liver	NOUN
hls-11379	194	13	metabolic	metabolic	NOUN
hls-11379	194	14	perturbatins	perturbatin	NOUN
hls-11379	194	15	at	at	ADP
hls-11379	194	16	the	the	DET
hls-11379	194	17	amino	amino	NOUN
hls-11379	194	18	acid	acid	NOUN
hls-11379	194	19	and	and	CCONJ
hls-11379	194	20	krebs	krebs	NOUN
hls-11379	194	21	cycle	cycle	NOUN
hls-11379	194	22	level	level	NOUN
hls-11379	194	23	.	.	PUNCT
hls-11379	195	1	am	be	AUX
hls-11379	195	2	j	j	PROPN
hls-11379	195	3	clin	clin	PROPN
hls-11379	195	4	nutr	nutr	PROPN
hls-11379	195	5	2016;103:422	2016;103:422	PROPN
hls-11379	195	6	-	-	SYM
hls-11379	195	7	34	34	NUM
hls-11379	195	8	.	.	PUNCT
hls-11379	196	1	27	27	NUM
hls-11379	196	2	.	.	PUNCT
hls-11379	197	1	ma	ma	PROPN
hls-11379	197	2	x	x	PROPN
hls-11379	197	3	,	,	PUNCT
hls-11379	197	4	liu	liu	PROPN
hls-11379	197	5	s	s	PROPN
hls-11379	197	6	,	,	PUNCT
hls-11379	197	7	zhang	zhang	PROPN
hls-11379	197	8	j	j	PROPN
hls-11379	197	9	,	,	PUNCT
hls-11379	197	10	et	et	PROPN
hls-11379	197	11	al	al	PROPN
hls-11379	197	12	.	.	PROPN
hls-11379	197	13	proportion	proportion	NOUN
hls-11379	197	14	of	of	ADP
hls-11379	197	15	nafld	nafld	ADJ
hls-11379	197	16	patients	patient	NOUN
hls-11379	197	17	with	with	ADP
hls-11379	197	18	normal	normal	ADJ
hls-11379	197	19	alt	alt	NOUN
hls-11379	197	20	value	value	NOUN
hls-11379	197	21	in	in	ADP
hls-11379	197	22	overall	overall	ADJ
hls-11379	197	23	nafld	nafld	ADJ
hls-11379	197	24	patients	patient	NOUN
hls-11379	197	25	:	:	PUNCT
hls-11379	197	26	a	a	DET
hls-11379	197	27	systematic	systematic	ADJ
hls-11379	197	28	review	review	NOUN
hls-11379	197	29	and	and	CCONJ
hls-11379	197	30	meta	meta	ADJ
hls-11379	197	31	-	-	PUNCT
hls-11379	197	32	analysis	analysis	NOUN
hls-11379	197	33	.	.	PUNCT
hls-11379	198	1	bmc	bmc	ADJ
hls-11379	198	2	gastroenterol	gastroenterol	NOUN
hls-11379	198	3	2020	2020	NUM
hls-11379	198	4	;	;	PUNCT
hls-11379	198	5	14:10	14:10	NUM
hls-11379	198	6	.	.	PUNCT
hls-11379	199	1	28	28	NUM
hls-11379	199	2	.	.	PUNCT
hls-11379	200	1	santos	santos	PROPN
hls-11379	200	2	c	c	PROPN
hls-11379	200	3	,	,	PUNCT
hls-11379	200	4	de	de	PROPN
hls-11379	200	5	brito	brito	PROPN
hls-11379	200	6	b	b	PROPN
hls-11379	200	7	,	,	PUNCT
hls-11379	200	8	da	da	PROPN
hls-11379	200	9	silva	silva	PROPN
hls-11379	200	10	f	f	PROPN
hls-11379	200	11	,	,	PUNCT
hls-11379	200	12	et	et	PROPN
hls-11379	200	13	al	al	PROPN
hls-11379	200	14	.	.	PUNCT
hls-11379	201	1	helicobacter	helicobacter	NOUN
hls-11379	201	2	pylori	pylori	NOUN
hls-11379	201	3	infection	infection	NOUN
hls-11379	201	4	:	:	PUNCT
hls-11379	201	5	beyond	beyond	ADP
hls-11379	201	6	gastric	gastric	ADJ
hls-11379	201	7	manifestations	manifestation	NOUN
hls-11379	201	8	.	.	PUNCT
hls-11379	202	1	world	world	PROPN
hls-11379	202	2	j	j	PROPN
hls-11379	202	3	gastroenterol	gastroenterol	PROPN
hls-11379	202	4	2020;26:4076	2020;26:4076	NUM
hls-11379	202	5	-	-	SYM
hls-11379	202	6	93	93	NUM
hls-11379	202	7	.	.	PUNCT
hls-11379	202	8	29	29	NUM
hls-11379	202	9	.	.	PUNCT
hls-11379	203	1	polyzos	polyzos	PROPN
hls-11379	203	2	a	a	X
hls-11379	203	3	,	,	PUNCT
hls-11379	203	4	kountouras	kountouras	PROPN
hls-11379	203	5	j	j	PROPN
hls-11379	203	6	,	,	PUNCT
hls-11379	203	7	paptheodorou	paptheodorou	NOUN
hls-11379	203	8	a	a	PRON
hls-11379	203	9	,	,	PUNCT
hls-11379	203	10	et	et	PROPN
hls-11379	203	11	al	al	PROPN
hls-11379	203	12	.	.	PUNCT
hls-11379	204	1	helicobacter	helicobacter	NOUN
hls-11379	204	2	pylori	pylori	NOUN
hls-11379	204	3	infection	infection	NOUN
hls-11379	204	4	in	in	ADP
hls-11379	204	5	patients	patient	NOUN
hls-11379	204	6	with	with	ADP
hls-11379	204	7	nonalcoholic	nonalcoholic	NOUN
hls-11379	204	8	fatty	fatty	NOUN
hls-11379	204	9	liver	liver	NOUN
hls-11379	204	10	disease	disease	NOUN
hls-11379	204	11	.	.	PUNCT
hls-11379	205	1	metabolism	metabolism	NOUN
hls-11379	205	2	2013;62:121	2013;62:121	NUM
hls-11379	205	3	-	-	SYM
hls-11379	205	4	6	6	NUM
hls-11379	205	5	.	.	NOUN
hls-11379	205	6	30	30	NUM
hls-11379	205	7	.	.	PUNCT
hls-11379	206	1	wei	wei	PROPN
hls-11379	206	2	l	l	PROPN
hls-11379	206	3	,	,	PUNCT
hls-11379	206	4	guo	guo	PROPN
hls-11379	206	5	ding	ding	PROPN
hls-11379	206	6	h.	h.	PROPN
hls-11379	206	7	relationship	relationship	NOUN
hls-11379	206	8	between	between	ADP
hls-11379	206	9	helicobacter	helicobacter	NOUN
hls-11379	206	10	pylori	pylori	NOUN
hls-11379	206	11	infection	infection	NOUN
hls-11379	206	12	and	and	CCONJ
hls-11379	206	13	nonalcoholic	nonalcoholic	NOUN
hls-11379	206	14	fatty	fatty	NOUN
hls-11379	206	15	liver	liver	NOUN
hls-11379	206	16	disease	disease	NOUN
hls-11379	206	17	:	:	PUNCT
hls-11379	206	18	what	what	PRON
hls-11379	206	19	should	should	AUX
hls-11379	206	20	we	we	PRON
hls-11379	206	21	expect	expect	VERB
hls-11379	206	22	from	from	ADP
hls-11379	206	23	a	a	DET
hls-11379	206	24	meta	meta	ADJ
hls-11379	206	25	-	-	PUNCT
hls-11379	206	26	analysis	analysis	NOUN
hls-11379	206	27	?	?	PUNCT
hls-11379	207	1	medicine	medicine	NOUN
hls-11379	207	2	(	(	PUNCT
hls-11379	207	3	baltimore	baltimore	PROPN
hls-11379	207	4	)	)	PUNCT
hls-11379	207	5	2021;100	2021;100	NUM
hls-11379	207	6	:	:	PUNCT
hls-11379	207	7	e26706	e26706	PROPN
hls-11379	207	8	.	.	PROPN
hls-11379	207	9	31	31	NUM
hls-11379	207	10	.	.	PUNCT
hls-11379	208	1	liu	liu	PROPN
hls-11379	208	2	r	r	PROPN
hls-11379	208	3	,	,	PUNCT
hls-11379	208	4	liu	liu	PROPN
hls-11379	208	5	q	q	PROPN
hls-11379	208	6	,	,	PUNCT
hls-11379	208	7	he	he	PRON
hls-11379	208	8	y	y	PROPN
hls-11379	208	9	,	,	PUNCT
hls-11379	208	10	et	et	PROPN
hls-11379	208	11	al	al	PROPN
hls-11379	208	12	.	.	PROPN
hls-11379	208	13	association	association	NOUN
hls-11379	208	14	between	between	ADP
hls-11379	208	15	helicobacter	helicobacter	NOUN
hls-11379	208	16	pylori	pylori	NOUN
hls-11379	208	17	infection	infection	NOUN
hls-11379	208	18	and	and	CCONJ
hls-11379	208	19	nonalcoholic	nonalcoholic	NOUN
hls-11379	208	20	fatty	fatty	NOUN
hls-11379	208	21	liver	liver	NOUN
hls-11379	208	22	:	:	PUNCT
hls-11379	208	23	a	a	DET
hls-11379	208	24	meta	meta	ADJ
hls-11379	208	25	-	-	PUNCT
hls-11379	208	26	analysis	analysis	NOUN
hls-11379	208	27	.	.	PUNCT
hls-11379	209	1	medicine	medicine	NOUN
hls-11379	209	2	(	(	PUNCT
hls-11379	209	3	baltimore	baltimore	PROPN
hls-11379	209	4	)	)	PUNCT
hls-11379	209	5	2019;98	2019;98	NUM
hls-11379	209	6	:	:	PUNCT
hls-11379	209	7	e17781	e17781	NUM
hls-11379	209	8	.	.	PUNCT
hls-11379	209	9	32	32	NUM
hls-11379	209	10	.	.	PUNCT
hls-11379	209	11	yan	yan	PROPN
hls-11379	210	1	p	p	X
hls-11379	210	2	,	,	PUNCT
hls-11379	210	3	yu	yu	PROPN
hls-11379	210	4	b	b	PROPN
hls-11379	210	5	,	,	PUNCT
hls-11379	210	6	li	li	PROPN
hls-11379	210	7	m	m	PROPN
hls-11379	210	8	,	,	PUNCT
hls-11379	210	9	zhao	zhao	PROPN
hls-11379	210	10	w.	w.	PROPN
hls-11379	210	11	association	association	PROPN
hls-11379	210	12	between	between	ADP
hls-11379	210	13	nonalcoholic	nonalcoholic	NOUN
hls-11379	210	14	fatty	fatty	NOUN
hls-11379	210	15	liver	liver	NOUN
hls-11379	210	16	disease	disease	NOUN
hls-11379	210	17	and	and	CCONJ
hls-11379	210	18	helicobacter	helicobacter	NOUN
hls-11379	210	19	pylori	pylori	NOUN
hls-11379	210	20	infection	infection	NOUN
hls-11379	210	21	in	in	ADP
hls-11379	210	22	dali	dali	PROPN
hls-11379	210	23	city	city	PROPN
hls-11379	210	24	,	,	PUNCT
hls-11379	210	25	china	china	PROPN
hls-11379	210	26	.	.	PUNCT
hls-11379	211	1	saudi	saudi	PROPN
hls-11379	211	2	med	med	PROPN
hls-11379	211	3	j	j	PROPN
hls-11379	211	4	2021;42:735	2021;42:735	PROPN
hls-11379	211	5	-	-	SYM
hls-11379	211	6	41	41	NUM
hls-11379	211	7	.	.	PUNCT
hls-11379	212	1	33	33	NUM
hls-11379	212	2	.	.	PUNCT
hls-11379	213	1	liu	liu	PROPN
hls-11379	213	2	y	y	PROPN
hls-11379	213	3	,	,	PUNCT
hls-11379	213	4	li	li	PROPN
hls-11379	213	5	d	d	PROPN
hls-11379	213	6	,	,	PUNCT
hls-11379	213	7	li	li	PROPN
hls-11379	213	8	y	y	PROPN
hls-11379	213	9	,	,	PUNCT
hls-11379	213	10	shuai	shuai	PROPN
hls-11379	213	11	p.	p.	PROPN
hls-11379	213	12	association	association	NOUN
hls-11379	213	13	between	between	ADP
hls-11379	213	14	helicobacter	helicobacter	NOUN
hls-11379	213	15	pylori	pylori	NOUN
hls-11379	213	16	infection	infection	NOUN
hls-11379	213	17	and	and	CCONJ
hls-11379	213	18	non	non	ADJ
hls-11379	213	19	-	-	ADJ
hls-11379	213	20	alcoholic	alcoholic	ADJ
hls-11379	213	21	fatty	fatty	NOUN
hls-11379	213	22	liver	liver	NOUN
hls-11379	213	23	disease	disease	NOUN
hls-11379	213	24	,	,	PUNCT
hls-11379	213	25	hepatic	hepatic	ADJ
hls-11379	213	26	adipose	adipose	ADJ
hls-11379	213	27	deposition	deposition	NOUN
hls-11379	213	28	and	and	CCONJ
hls-11379	213	29	stiffness	stiffness	NOUN
hls-11379	213	30	in	in	ADP
hls-11379	213	31	southwest	southwest	PROPN
hls-11379	213	32	china	china	PROPN
hls-11379	213	33	.	.	PUNCT
hls-11379	214	1	front	front	PROPN
hls-11379	214	2	med	med	PROPN
hls-11379	214	3	(	(	PUNCT
hls-11379	214	4	lausanne	lausanne	PROPN
hls-11379	214	5	)	)	PUNCT
hls-11379	214	6	2021;8:764472	2021;8:764472	NOUN
hls-11379	214	7	.	.	PUNCT
hls-11379	215	1	34	34	NUM
hls-11379	215	2	.	.	PUNCT
hls-11379	215	3	jamali	jamali	PROPN
hls-11379	215	4	r	r	PROPN
hls-11379	215	5	,	,	PUNCT
hls-11379	215	6	mofid	mofid	NOUN
hls-11379	215	7	vahedi	vahedi	VERB
hls-11379	215	8	farzaneh	farzaneh	PROPN
hls-11379	215	9	r	r	PROPN
hls-11379	215	10	,	,	PUNCT
hls-11379	215	11	dowlatshahi	dowlatshahi	ADJ
hls-11379	215	12	s.	s.	PROPN
hls-11379	215	13	the	the	DET
hls-11379	215	14	effect	effect	NOUN
hls-11379	215	15	of	of	ADP
hls-11379	215	16	helicobacter	helicobacter	NOUN
hls-11379	215	17	pylori	pylori	ADJ
hls-11379	215	18	eradication	eradication	NOUN
hls-11379	215	19	on	on	ADP
hls-11379	215	20	liver	liver	NOUN
hls-11379	215	21	fat	fat	ADJ
hls-11379	215	22	content	content	NOUN
hls-11379	215	23	in	in	ADP
hls-11379	215	24	subjects	subject	NOUN
hls-11379	215	25	with	with	ADP
hls-11379	215	26	non	non	ADJ
hls-11379	215	27	-	-	ADJ
hls-11379	215	28	alcoholic	alcoholic	ADJ
hls-11379	215	29	fatty	fatty	NOUN
hls-11379	215	30	liver	liver	NOUN
hls-11379	215	31	disease	disease	NOUN
hls-11379	215	32	:	:	PUNCT
hls-11379	215	33	a	a	DET
hls-11379	215	34	randomized	randomize	VERB
hls-11379	215	35	open	open	ADJ
hls-11379	215	36	-	-	PUNCT
hls-11379	215	37	label	label	NOUN
hls-11379	215	38	clinical	clinical	ADJ
hls-11379	215	39	trial	trial	NOUN
hls-11379	215	40	.	.	PUNCT
hls-11379	216	1	hepatol	hepatol	ADJ
hls-11379	216	2	2013;13	2013;13	NOUN
hls-11379	216	3	:	:	PUNCT
hls-11379	216	4	e14679	e14679	NOUN
hls-11379	216	5	.	.	PUNCT
hls-11379	217	1	article	article	NOUN
hls-11379	218	1	[	[	X
hls-11379	218	2	healthcare	healthcare	NOUN
hls-11379	218	3	in	in	ADP
hls-11379	218	4	low	low	ADJ
hls-11379	218	5	-	-	PUNCT
hls-11379	218	6	resource	resource	NOUN
hls-11379	218	7	settings	setting	NOUN
hls-11379	218	8	2023	2023	NUM
hls-11379	218	9	;	;	PUNCT
hls-11379	218	10	11(s2):11379	11(s2):11379	NUM
hls-11379	218	11	]	]	X
hls-11379	219	1	[	[	X
hls-11379	219	2	page	page	NOUN
hls-11379	219	3	17	17	NUM
hls-11379	219	4	]	]	X
hls-11379	219	5	non	non	ADJ
hls-11379	219	6	-co	-co	PROPN
hls-11379	219	7	mmerc	mmerc	PROPN
hls-11379	219	8	ial	ial	PROPN
hls-11379	219	9	us	us	PROPN
hls-11379	219	10	e	e	NOUN
hls-11379	219	11	o	o	NOUN
hls-11379	219	12	nly	nly	ADV